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Abstract 
 
The ability of cells to respond to stress is fundamental for survival. The palmoplantar 
epidermis, by its very nature, is subjected to substantial external forces. At birth, the skin at 
these sites is similar to the skin elsewhere, however, as we expose it to physical stresses such 
as walking and gripping, it thickens to adapt.  The palmoplantar keratodermas (PPKs) are a 
heterogeneous group of disorders characterised by abnormal thickening of the palmoplantar 
epidermis.  Causative mutations have been identified in a diverse array of genes, such as 
those encoding the TNFα sheddase, ADAM17, and the water channel protein, Aquaporin 5.   
 
Three distinct PPK’s were studied in order to unravel the molecular basis of their associated 
diseases. The work presented here identifies the palmoplantar and stress-associated Keratin 
16 as a novel interacting protein for iRHOM2, and demonstrates that this regulatory 
relationship contributes to palmoplantar thickness in Tylosis with Oesophageal Cancer.  The 
deep clinical phenotyping of patients with ARVC caused by dominantly inherited mutations 
in desmoplakin revealed an unreported cutaneous phenotype of PPK and curly hair which 
may prove useful in the diagnosis of this complex disease. Finally, this Thesis includes the 
discovery of the first human disease-causing mutation in FAM83G, which presented with a 
unique phenotype of PPK and abundant curly hair and linked FAM83G to Wnt signaling.  By 
correlating the clinical phenotype with the genotype in each case, and extrapolating from 
rare monogenic diseases to more common disorders, the PPK’s provide a unique resource in 
which to study the genetic basis of disease.   
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1.1 The Skin 
 
The skin forms our first defense against the hostilities of the external environment, including 
pressure, water, light, heat, cold, trauma or infection.  The skin is composed of several layers, 
each delineating a particular function.  The epidermis comprises the most superficial of the 
skin and in humans, contains keratinocytes, melanocytes and Langerhans cells. The stratum 
corneum lies above the epidermis, with a typical basket-weave like pattern, and acts as a 
semi-permeable barrier to chemicals, infectious agents and prevents water and solute loss 
from within. Beneath the epidermis lies the dermis, which is highly vascularized and 
responsible for nutritional support of the epidermal layers.  It is composed of a collagen and 
elastin-containing fibrous matrix.  It also contains nerves and therefore mediates cutaneous 
sensation.  Immune surveillance cells reside in the dermis, including Langerhans cells, dermal 
dendritic cells and leukocytes.  
 
The skin is a highly dynamic structure, and its exact cell population adapts physiologically in 
response to particular cues such as wound healing. However, skin diseases can occur when 
the skin is unable to respond appropriately to exogenous challenges. For example, the skin 
is a highly immunologic organ and circulating immune cells recognize and defend against 
foreign pathogens. Failure to do so can result in infections such as cutaneous warts and 
fungal infections.  In contrast, mis-direction of the immune system and recognition of “self” 
as foreign, results in auto-immunity, which, in the skin can manifest as a multitude of 
diseases including Pemphigus Vulgaris. Auto-antibodies in this disease are directed against 
the intercellular desmosome, which plays a role in cell-cell adhesion and therefore this 
disease is characterised by widespread blistering and erosions.   
 
1.2 The Skin as a Marker of Internal Disease 
 
The skin is a remarkable indicator of internal disease. In fact, skin “signs” can pre-date the 
onset of other more sinister diseases and allow for earlier diagnosis and screening. Several 
internal malignancies are associated with cutaneous features, which can precede a diagnosis 
of cancer. For example, the presence of acanthosis nigricans (hyperpigmented velvety 
thickening of the flexures) can be associated with breast, ovary, uterine or renal carcinomas. 
Another example is Tylosis with Oesophageal Cancer (TOC), which will be discussed in detail 
later in this thesis. Cutaneous features of this rare disease include thickened skin overlying 
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the palms and soles typically present in childhood, and oesophageal cancer in mid to later 
life.   
 
The skin can therefore reflect underlying internal disease and in some instances, it may be 
the only visible clue. Inherited cardiocutaneous disease e.g. Naxos syndrome and 
Arrhythomogenic Right Ventricular Cardiomyopathy (ARVC), are characterised by the early 
presence of specific skin and hair changes which are linked to potentially fatal cardiac 
anomalies that present later in life.  By identifying cutaneous clues to underlying disease, 
affected individuals can be diagnosed earlier and enter into appropriate surveillance 
progammes.   
 
The Kelsell group recently identified the first example of a functional knockout of ADAM17 
in humans, as the cause of a recessively inherited neonatal inflammatory skin and bowel 
syndrome.  ADAM17, is a pivotal membrane bound sheddase, whose targets include TNFa 
and EGFR family ligands. These findings contribute to the increasingly expanding body of 
evidence that links the skin to internal diseases affecting the gut, joints, heart and central 
nervous system.  In recent years there has been a shift in the way skin research is perceived.  
It is now widely acknowledged that the skin is a valuable “proof-of principle” organ, which is 
both convenient to monitor and sample with minimal intervention, and from which we can 
gain greater insights into complex multi-system diseases.  
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1.3 The Epidermis  
 
The epidermis consists of four layers whose thickness varies according to site and situation. 
These layers stratify from the basal layer, the spinous layer, the granular layer to the stratum 
corneum which is shed during desquamation Keratinocytes make up 80% of the cells forming 
the epidermal layers, the remaining 20% is composed of other cells such as melanocytes, 
Langerhans cells, Merkel cells and lymphocytes (Houben et al., 2008). 
 
 
Figure 1.1 A schematic representation of the epidermis illustrating important structures and 
the site of expression of a number of skin-disease associated proteins (Adapted from 
Maruthappu & Kelsell, 2018) 
 
Keratinocyte differentiation occurs in the basal layer and is a genetically-programmed 
carefully regulated process. The basal layer contains mitotically active keratinocytes whose 
columnar shape is determined by the expression of keratins (K5) and 14 (K14) (Figure 1.1). 
These keratins also bind hemidesmosomes, through linker proteins Plectin and BPAG1e 
which determine adhesion of the epidermis to the basement membrane.  Melanocytes, 
another epidermal cell type, produce melanin, which is the pigment in these cells, and are 
responsible for skin pigmentation. Several studies have shown that the basal layer can 
exhibit three proliferative potentials, as stem cells, transit amplifying cells and post mitotic 
cells. Stem cells are capable of forming the entire pilo-sebaceous unit but also the 
interfollicular epidermis (Wolff et al., 2007). Stem cells will be discussed in greater detail in 
Chapter 5.  
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The spinous layer is so named owing to the shape the adopted by the composing 
keratinocytes, which alters as the cells differentiate into the granular layer. These 
keratinocytes retain K5 and K10 filaments produced in the basal layer, predominantly 
localised around the nucleus and tethered to desmosomes, but do not synthesize any new 
mRNA, instead they produce K1 and K10 specific to this epidermal layer. These keratins are 
specifically expressed in differentiated/keratinised cells and their downregulation together 
with the up-regulation of K6 and K16 are a hallmark of hyperproliferative disorders (Wolff et 
al., 2007). The granular layer is composed of basophilic keratohyalin granule-containing cells 
which give this layer its characteristic “granular” appearance. These granules contain 
profilaggrin, keratin filaments and loricrin. This layer is responsible for several characteristics 
of the epidermal barrier. Release of profilaggrin from the granules results in its calcium-
dependent cleavage into filaggrin monomers which aggregate with keratin to form 
macrofilaments. Filaggrin is eventually degraded into UV protective molecules (Wolff et al., 
2007). The final stage of epidermal differentiation in the skin ends with flattened cornified 
cells that form the stratum corneum. During this differentiation process, regulated apoptosis 
results in the destruction of the nucleus together with all intracellular components except 
the keratin filaments and filaggrin matrix.  
 
The corneocytes play an essential role in the regulation of permeability, desquamation, 
antimicrobial peptide activity, toxin exclusion and selective chemical absorption, which are 
some of the most critical functions of the extracellular lipid matrix. They also provide 
mechanical reinforcement, hydration, cytokine-mediated inflammation and protection from 
UV damage. As such, corneocytes represent the first defence barriers of the human organism 
against external factors (Egberts et al., 2004, Houben et al., 2007, Fuchs, 1990, Fuchs, 2007). 
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1.4 The Palmoplantar Epidermis 
 
The ridged skin of the palms and soles (palmoplantar sites) in mammals is uniquely adapted 
to withstand remarkable physical stress. The skin at this site differs from the skin elsewhere 
in several ways. Firstly, the stratum corneum is 8-10 times thicker than interfollicular skin 
(Figure 1.2), the stratum granulosum is absent, it lacks hair and has an increased number of 
nerve endings and sweat glands. Unlike interfollicular skin, irrespective of an individuals 
ethnicity, the palmoplantar skin lacks pigmentation (Swensson et al., 1998).  
 
Figure 1.2 Haematoxylin and Eosin stained sections comparing interfollicular skin and palm 
skin showing markedly increased thickness of the stratum corneum in the palm.  
 
The actual physical resilience of the palmoplantar epidermis is predominantly due to an 
abundance of cytoskeletal scaffolding proteins known as keratin intermediate filaments.  
Keratins constitute up to 85% of the protein content of differentiated epithelial cells and 
provide both flexibility and strength by forming a framework within the cytoplasm. The 
palmoplantar epidermis contains significantly greater keratin than the interfollicular skin 
(Swensson and Eady, 1996). 
 
Several genetic skin disorders, known as the Palmoplantar Keratodermas “PPK’s” show a 
striking predilection for the palms and soles, and can present exclusively at these sites but 
may not show differences at birth (Swensson et al. 1998).  
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1.5 The Palmoplantar Keratodermas 
 
The palmoplantar keratodermas (PPK) are a heterogeneous collection of skin disorders 
characterised by abnormal thickening of the skin of the volar surfaces of the hands and feet. 
They can be divided clinically into diffuse, focal and punctate types, histologically into 
epidermolytic and non-epidermolytic types and into hereditary and acquired types. Further 
subdivisions into simple (involvement of the palms and soles only), complex (involvement of 
non-volar skin including its appendages and, in certain cases, the buccal mucosa) and 
syndromic (associated with abnormalities in other bodily systems) are also made(Itin and 
Fistarol, 2005). Diffuse epidermolytic PPK (EPPK) (Figure 1.3) has been shown to be due to 
mutations in the gene encoding the palmoplantar specific keratin, KRT9 (Reis et al., 1994); 
whilst diffuse, non-epidermolytic PPK (NEPPK) has been associated with mutations in KRT1, 
KRT16 and, recently, the gene encoding the water channel protein, Aquaporin 5(Yang et al., 
1994, Blaydon et al., 2013, Terrinoni et al., 2001). In focal PPK, the hyperkeratosis is less 
extensive and restricted to areas of weight bearing and/or friction (Table 1.1). Quite often 
the focal PPKs are complex and associated with abnormalities of the hair, nails, teeth and/or 
sweat glands. There are several types of focal PPK with abnormalities in other organs 
including hearing loss and cardiomyopathy due to defective gap junctions or 
desmosomes(Brooke et al., 2012), respectively. Using high throughput sequencing 
platforms, more genes underlying other forms of keratodermas are also being identified 
(Maruthappu et al., 2014). 
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Figure 1.3 Genetics of diffuse palmoplantar keratoderma (adapted from Maruthappu & 
Kelsell, 2016). Clinical photographs of diffuse non epidermolytic PPK caused by mutations in 
AQP5, images courtesy of Prof E A O’Toole.  
 
 
 
Type of Diffuse PPK Associated Disorder Genetic Defect
EPPK (Epidermolytic 
palmoplantar keratoderma)
Keratin 9
NEPPK (non-epidermolytic
PPK)
Umbilical hyperkeratosis Keratin 1
NEPPK
Diffuse Nagashima-type 
NEPPK
Aquaporin 5
Serpin B7
Syndromic NEPPK (Naxos 
Disease)
Woolly hair and 
cardiomyopathy
Plakoglobin
Desmoplakin
Vohwinkel’s Syndrome Sensorineural Deafness
Ichthyosis
Connexin 26
Loricrin
Erythrokeratoderma
variabilis
Generalised erythroderma Connexin 31
Clouston’s syndrome Alopecia, nail dystrophy 
sensorineural deafness
Connexin 30 
Connexin 30.3
Ectodermal dysplasia skin 
fragility syndrome
Skin fragility, blistering, 
abnormal hair growth nail 
dystrophy and occasionally 
defective sweating 
Plakophilin 1
Mal de Meleda Hyperhidrosis an perioral 
erythema
SLURP-1
Olmsted syndrome Perioroficial keratosis TRPV3
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Table 1.1 Genetics of focal palmoplantar keratoderma (Adapted from Maruthappu & Kelsell, 
2016).  
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1.6 Tylosis with Oesophageal Cancer 
 
Tylosis with oesophageal cancer (TOC; OMIM 148500) is a rare but highly penetrant disease 
in which affected individuals initially develop a focal non-epidermolytic palmoplantar 
keratoderma (thickening of the palms and soles, particularly prevalent in areas which 
undergo repeated trauma) (Figure 1.4A). In addition to oral leukokeratosis, follicular 
hyperkeratosis. The term “Tylosis” is derived from the Greek tulosis, making a callous, which 
describes the marked thickening that develops on the palmoplantar epidermis. Importantly, 
affected individuals carry a very high risk of developing squamous cell carcinoma of the 
oesophagus (95% by the age of 65 years)(Howel-Evans et al., 1958, Ellis et al., 2015).  
Although a comparatively rare condition, TOC has been reported to date in five extensive 
family pedigrees worldwide. It was first described in two large Liverpool families by Howel–
Evans et al. (1958).  The larger of the two families were reviewed in 1994 (Ellis et al., 1994). 
At that stage, 345 family members had been identified, 89 of whom had been diagnosed 
with Tylosis with 57 still alive. A total of 21 Tylotic members had died of oesophageal 
neoplasia and 11 had died of other causes. It has since been determined that the two 
Liverpool families are in fact distant kindreds, There is no known increase in the incidence of 
other common carcinomas in these patients. Similar but smaller pedigrees have been 
reported from Germany (Hennies et al., 1995), the United States (Stevens et al., 1996), 
Finland (Saarinen et al, 2012), Spain (Varela et al., 2011) and Brazil (De Souza et al., 2009). 
The frequency of the disorder in the general population is unknown, but is likely to be less 
than 1 in 1,000,000. 
 
TOC is inherited as an autosomal dominant trait with complete penetrance. Our group 
identified three missense mutations in the RHBDF2 gene, encoding the catalytically inactive 
rhomboid protein iRhom2 as the underlying cause of this disease in the UK, US and German 
families (Blaydon et al., 2012) (Figure 1.4B). The UK and US families share the same missense 
mutation – p.ille186Thr – however the mutation in the German family lies three amino acids 
away, p.Pro189Leu.  In addition, a further missense mutation p.Asp188Asn, has been 
confirmed in the Finnish family (Saarinen et al., 2012). It is pertinent to note that all three 
reported mutations lie within three amino acids of one another in the highly conserved N 
Terminus domain (Figure 1.4C).  
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Figure 1.4(A) Focal keratoderma and oral leukokeratoses in patient with TOC. (B) Site of 
missense mutation in iRHOM2 in UK/US and German TOC kindreds. (C) Structure of 
iRHOM2 showing clustering of TOC-causing mutations and the high degree of conservation 
in the affected residues between multiple species.   
 
This obvious clustering of mutations, along with the fact that each residue affected is highly 
conserved both between species and between iRhom2 and its close family member iRhom1 
strongly suggests the mutations alter a site-specific function of iRhom2 to give rise to TOC. 
In addition to offering strong clues as to the pathogenesis of TOC, this discovery also 
represents the first linkage of any gene to inherited oesophageal cancer. 
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1.7 Rhomboid Proteins 
 
Rhomboids are a protease family conserved across all kingdoms of life, whose catalytically 
active members function as intramembrane proteases, a class of enzyme whose active sites 
reside within a transmembrane domain, and which function to cleave their substrates within 
or immediately adjacent to the substrate’s own transmembrane domain(s) (Freeman, 2016). 
The Rhomboid family of proteins were first described in Drosophilia Melanogaster, and were 
identified to play a role in EGFR signaling, by cleaving Spitz which is homologus to human 
TGFα  (Urban et al., 2001). Rhomboids are a family of intramembrane serine proteases, 
whose active site is located within the lipid bilayer, enabling them to cut substrate 
transmembrane domains. They play a key role in the release of membrane tethered proteins 
as a mechanism of intercellular signaling(Freeman, 2004). Mammalian Rhomboids have been 
subdivided into 4 groups: Secretase A and B, PARL and iRhoms  (Bergbold and Lemberg, 
2013). The diverse members of this group are universally conserved and fulfill a range of 
activities such as Regulated Intramembrane Proteolyisis(RIP) and degradation.  They are 
characterised by their structure, comprised of 6 or 7 transmembrane spanning domains in 
addition to a cytoplasmic N terminus and luminal C terminus (Etheridge et al., 2013).  
 
1.8 Inactive Rhomboids iRHOM1 and iRHOM2 
 
Although the inactive rhomboids iRhom1 and iRhom2 show topological similarity to active 
Rhomboids, they are proteolytically inactive and lack the necessary catalytic residues present 
in active rhomboid proteases.  iRhoms were initially identified through gene alignment data 
with known rhomboid proteins. They are highly conserved and exist in all metazoans 
(Freeman, 2009). All iRhoms have a proline in the x-position of the GxSG catalytic motif, 
which is predicted to alter rhomboid folding such that proteolytic activity is lost. In 
accordance with this, all iRhoms tested have not been shown to cleave known rhomboid 
substrates. iRhom1 and 2 are 57% identical and 69% similar (Lemberg & Freeman 2007). 
iRhoms have two unique features which differentiate them from other rhomboid proteases 
(Zettl et al., 2011).  The highly conserved N Terminus domain has a numerous potential 
phosphorylation sites, which could regulate its activity.  In addition, both iRhom1 and 
iRhom2 have an extended cysteine rich loop spanning between the transmembrane domains 
1 and 2.  This highly conserved region is known as the iRhom homology domain (Zettl et al., 
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2011). The high degree of conservation of these two regions suggests they confer an 
important functional significance.   Gain of function mutations in iRhom2 arise as a 
consequence of missense mutations in its N Terminus and underlie TOC (Blaydon et al., 
2012). In addition, iRhom2 has been reported to play a role in the genetics of epithelial 
ovarian cancers (Wojnarowicz et al., 2012).  
 
In mice, iRhom1 and iRhom2 are expressed in most cell types. Both are highly expressed in 
the skin and iRhom2 is also significantly expressed in macrophages, although overall iRhom1 
is expressed more highly than iRhom2 (Christova et al., 2013).  To date, little is known about 
the function and substrate selectivity of iRhoms in mammals, despite intense investigation.  
The study of the molecular effects of Tylosis, caused by gain of function mutations in the N 
terminus region, may shed light on their activity and regulation.   
 
1.9 iRHOMs and ADAM17 (TACE) Maturation/Processing 
 
ADAM17, also known as TNFα converting enzyme (TACE), is a membrane bound 
metalloproteinase which sheds a diverse range of substrates including TNFα and EGFR family 
ligands (Gooz et al., 2011).  
 
iRHOM2 has been shown to be a critical regulator of the maturation and processing of 
ADAM17 (McIlwain et al., 2012, Adrain et al., 2012). In mice, ER-located iRHOM2 binds 
ADAM17 and promotes its transfer to the golgi, where it undergoes furination, and is cleaved 
to become the active/mature form. This is subsequently trafficked to the cell surface 
membrane, where it is able to shed TNFα and its other substrates. In macrophages derived 
from iRhom2 KO mice, ADAM17 is unable to exit the ER and therefore does not undergo 
maturation and trafficking and TNFα shedding in response to LPS stimulation is abolished 
(Adrain et al., 2012).  iRHOM2 KO mice appear phenotypically normal, however they do not 
release TNFα in response to lipopolysaccharide stimulation or bacterial infection as a 
consequence of reduced ADAM17 activity (McIlwain et al., 2012).  There appears to be a 
degree of functional redundancy in cells other than macrophages between iRHOM1 and 
iRHOM2 in the trafficking and maturation of ADAM17 (Christova et al., 2013).   
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1.10 iRHOM2, ADAM17 and TOC 
 
TOC is associated with gain-of-function mutations in the highly conserved cytoplasmic N-
terminus of iRHOM2 (Blaydon et al, 2012; Saarinen et al, 2012).  This has been shown to 
result in increased processing and maturation of ADAM17.  In mammalian myeloid and 
epithelial cells, iRHOM2 promotes the maturation and trafficking of ADAM17 in the 
endoplasmic reticulum and Golgi (Adrain et al., 2012). Activated ADAM17 then transits to 
the plasma membrane where it is able to cleave its substrates including TNFα, IL6R and EGFR-
family ligands (Brooke et al., 2014, Rose-John, 2013) (Figure 1.5A). In TOC-derived 
keratinocytes, iRHOM2 mutation leads to high levels of constitutive ADAM17 activity with 
elevated ectodomain shedding of many of its substrates, which can be effectively inhibited 
by an ADAM17 sheddase inhibitor (Unpublished data, Matthew Brooke, Figure 1.5 B and C). 
Furthermore, PMA-stimulated peripheral blood mononuclear cells (PBMCs) from TOC 
patients also have increased TNFα  release compared to control PBMC’s (Brooke et al., 
2014). In contrast, PBMCs/macrophages from irhom2-/- mice have impaired ADAM17 
maturation and consequently, TNFα shedding from these cells is almost entirely abolished 
in response to bacterial stressors (Adrain et al., 2012, McIlwain et al., 2012). 
 
 
 
 
 
Figure 1.5 (A) Illustration depicts trafficking of ADAM17 by iRHOM2 from the ER to the Golgi 
where it undergoes maturation by furination and is then transported to the cell membranes 
where it cleaves a range of substrates such as EGFR ligands, IL6R and TNFa. (B) and (C) 
Graphs showing production of Amphiregulin (Areg), IL6R and TNFα measured by ELISA in TOC 
keratinocytes, significantly reduced by the ADAM17 sheddase inhibitor, TMI 005. (Figure 
courtesy of Matthew Brooke) 
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1.11 TOC: A Constitutive Wound Healing State 
 
In vitro, TOC keratinocytes also show increased migration in monolayer scratch-wound 
assays when compared with control keratinocytes (Blaydon et al., 2012). In fact, TOC 
keratinocytes can close a scratch wound within 4 hours whereas control keratinocytes 
required 24 hours to close a wound of similar size. Like other squamous cancer cell lines, TOC 
keratinocytes are also hyperproliferative.  
 
An additional rather unusual feature of the TOC epidermis is the presence of “immature 
desmosomes”.  Examination of the desmosomes in skin biopsies from patients with TOC was 
undertaken by electron microscopy (Brooke et al., 2014). Desmosomes in all layers of TOC 
epidermis lacked the electron-dense midline seen in mature desmosomes in normal 
epidermis which suggests that they are in the immature form typically seen in wound healing 
(Garrod et al 2005). 
   
The presence of increased shedding of ADAM17 substrates implicated in wound healing 
TNFα, IL6 and IL8, the presence of immature desmosomes, hyperproliferation and increased 
migratory behaviour all suggest that TOC exhibits features of a constitutive “wound-healing” 
state (Brooke et al., 2014).  
 
1.12 iRHOM2 Expression in Human Skin and Keratinocytes 
 
In the skin, iRHOM2 typically shows a cell surface membrane and cytoplasmic distribution.  
This is in contrast to the distribution of iRhom1, whose expression is predominantly basal 
and cytoplasmic.  This is reproducible in cells, when overexpressed with GFP-tagged WT-
iRHOM2. In keratinocytes, iRHOM2 is localized to the cytoplasm and cell membrane, 
however this is not observed in cells derived from non-epithelial sites where it is 
predominantly located in the ER and cytoplasm (PhD Thesis, Sarah Etheridge 2015).  This may 
suggest a unique role for iRHOM2 in keratinocytes and in the skin.  iRHOM2 has previously 
been shown to be highly expressed in murine macrophages (McIlwain et al 2012, Adrain et 
al 2012). In the human epidermis, iRHOM2 is also observed brightly in spindle-shaped cells 
infiltrating the dermis. These cells have been shown to be macrophages by colocalisation 
studies with the macrophage marker CD68 (PhD Thesis, Sarah Etheridge). This suggests a 
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dual role for iRHOM2 in the skin – both in the keratinocytes themselves but also in the 
infiltrating immune cells.  
 
1.13 Keratins and the skin 
 
Keratin intermediate filaments are a large, diverse group of epithelial proteins, which play a 
key role in the epidermal architecture. Keratin expression is tightly regulated and dependent 
on epithelial type and stage in differentiation.  Much is now known about the expression 
characteristics of keratins in different cell types as a result of naturally occurring mutations 
in human diseases or experimental knockout experiments in transgenic mice. These have 
provided a wealth of information about their likely functions (Moll et al., 1982).  
 
Keratins are composed of a common a-helical rod domain of approximately 310 amino acids 
flanked by non-helical head (N Terminus) and tail regions (C Terminus) (Figure 1.6). The 4 
helical regions are denoted Coil 1A, Coil 1B, Coil 2A and Coil 2B and are combined by “linker” 
segments (Steinert et al., 1994).   
 
Figure 1.6 Structure of the Keratin filament. Keratins are composed of the non-helical N-
terminal head, C-terminal tail and 4 helical rod domains. 
 
Keratins are typically expressed in a pairwise fashion forming heteropolymers composed of 
one Type I keratin (acidic, K9-20) paired with its specific Type II partner (basic, K1-8) for 
example K6/K16 and K1/K10. Specific pairs initiate heterodimerisation through their coil-coil 
domains, forming 10nm filaments which self-assemble to form the keratin filament network 
(Yamada et al., 2002). Type 1 and 2 pairs are specific, for example, K1 & K10, K5 and 14, K6 
and K16 are well described pairings and the expression of Type I and Type II keratins usually 
occurs as a ratio of 1:1 in all cells (Moll et al., 1982).   
 
Simple epithelia of the liver intestine and pancreas characteristically express K7, K8, K18, K18 
and K20. In the the interfollicular epidermis, K5 and K14 are expressed basally, and K1/K10 
are confined to the suprabasal layers (Moll et al., 1982, Fuchs and Green, 1980) (Table 1.2).   
    Coil 1A Coil 2B Coil 2A Coil 1B 
Head Tail 
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Table 1.2 Expression patterns of Type I and II Keratins in human epithelia.  
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Live cell imaging studies have shown that, rather than being static structures, keratins are 
highly dynamic and transit between phases of assembly and disassembly (Windoffer et al., 
2011, Kolsch et al., 2010, Leube et al., 2011).  The “keratin cycle” describes the process by 
which keratins “turn over” within the cell. It is initiated by “nucleation” of the keratin 
filaments at the cell periphery proximal to focal adhesions. Elongation of new keratin units 
then occurs, guided by the actin cytoskeleton, towards the peripheral keratin network.   
Keratins then move towards the nucleus where they bundle. The cycle is continued when 
keratin pairs disassemble into oligomers that diffuse into the cytosol (Figure 1.7)(Windoffer 
et al., 2011), available for the next round of nucleation.  This process of filament turnover 
and rearrangement is important in permitting changes in cell size and shape required for 
migration and proliferation (Haines and Lane, 2012). 
 
Figure 1.7 Keratin filament cycling: soluble keratins assemble at the cell periphery and 
polymerise, resulting in elongation. Elongated keratins move towards the nucleus guided by 
actin, resulting in bundling of keratins around the nucleus. Subsequent disassembly 
redistributes keratin oligomers to the cytoplasmic pool where they are available for a further 
cycle of filament formation (Schematic diagram adapted from Kim et al., 2015). 
 
The keratin cytoskeleton is anchored at various sites on the cell membrane, creating a 
branch-like network that offers mechanical support. Desmoplakin, a major component of the 
desmosomal adhesion complex, binds Type II keratins by direct interaction between its 
carboxy terminal and the amino terminal of the type II keratin (Green et al., 2010, Kouklis et 
al., 1994).   Keratins also bind hemidesmosomes, the major junction complexes adhering 
epithelial cells to the basal layer. Keratins link plectin and BPAG1e at hemidesmosome cell-
matrix adhesions.  This step required for correct assembly of hemisdesmosomes (Green et 
al.,2010).  
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1.14 Keratins in the palmoplantar epidermis 
 
Over 50 Keratin isotypes are expressed in stratified and pseudostratified epithelia however, 
their precise expression pattern is both site and situation specific. Unlike inter-follicular skin, 
the ridged skin of the palms and soles is characterized by the constitutive expression of 
Keratins 6, 16, 17 and uniquely, Keratin 9 (K9) (Swensson et al, 1998). The expression of 
specific keratins at this site is indicative of regional adaptions of this epidermis to a high cell 
turnover rate.  Of all the epidermal tissues in the body, the palmoplantar epidermis is 
exposed to the most extreme physical stress, bearing an individuals entire bodyweight 
millions of times during their lifetime.  To withstand this stress, the particular combination 
of keratins expressed here provides a combination of resilience and flexibility. Early studies 
considered K16 to be primarily associated with hyperproliferation however, owing to its 
expression in wound healing and constitutive expression in non-keratinized barrier epithelia 
such as the oral mucosa and oesophagus it has become clear that its actual function may be 
to provide flexibility (Swensson et al 1998), (Leigh et al., 1995)(McGowan et al. 1998).   
Keratin 9 expression is confined to the suprabasal layers of the palmoplantar epidermis.  
Mutations in the gene encoding K9 are known to cause epidermolytic palmoplantar 
keratoderma, a rare dominant-negative skin disorder(Reis et al., 1994).  Transgenic mice 
lacking K9 develop hyperkeratotic calluses and compensatory upregulation of K6 and K16(Fu 
et al., 2014).  K16 knock-out mice also develop a severe inflammatory palmoplantar 
keratoderma associated with pain and reduced mobility (Lessard and Coulombe, 2012).  The 
two mice studies point to critical roles for K9 and K16 in the proper formation and function 
of the footpad epidermis.   
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1.15 Keratins and Disease 
 
Keratinopathies comprise a diverse group of over 60 different diseases which have been 
linked to inherited keratin changes (www.interfil.org).  Although rare, these diseases have 
provided insight into the functions of specific keratins (Haines and Lane, 2012). 
 
1.15.1 Keratin 1/10 
 
Keratins 1 and 10 are expressed in suprabasal differentiated cells of the epidermis.  Loss-of-
function mutations in KRT1 or KRT10 underlie Epidermolytic Ichthyosis/bullous congenital 
ichthyosiform erythroderma (BCIE) (McLean et al., 1999). BCIE is characterized by 
erythroderma, hyperkeratosis and blistering of the upper layers of the skin.  However, it is 
important to recognize that there is a significant degree of heterogeneity between 
individuals carrying mutations in KRT1. Palmoplantar keratoderma and generalized malodor 
are also common features. (Stevens and Rustin, 1994).   
 
1.15.2 Keratin 5/14 
 
The best studied of the keratinopathies is Epidermolyis Bullosa Simplex (EBS), which is a rare, 
usually autosomal dominant disorder which results from mutations in Keratin 5 or 14(Chen 
et al., 1995, Stephens et al., 1995). The mutations can occur in the rod domain and can rarely 
be caused by homozygous recessive K14 knockout. The loss-of-function mutations causing 
EBS result in dramatically reduced mechanical resilience. Clinically this manifests as 
widespread severe blistering from birth, which can be fatal, although most patients do 
present with localised forms.  From the study of EBS, it has been ascertained that the primary 
function of K5 and K14 is to provide mechanical resilience in response to trauma of the 
epidermis (D'Alessandro et al., 2002, Haines and Lane, 2012, Ishida-Yamamoto et al., 1991).  
 
1.15.3 Keratin 6, 16 and 17 
 
These three keratins are expressed in the skin of the palms and soles as well as the oral 
mucosa. They are also expressed in sebaceous gland tissue and pathologically in response to 
 
41 
wounding or injury. Hence, together they are known as the “wound healing keratins” 
(McGowan and Coulombe, 1998) . 
 
Pachyonychia Congenita (PC) is a group of autosomal dominantly inherited genodermatoses 
caused by mutations in either K6A, K6B, K6C, K16 and K17 (Smith et al., 2005, Terrinoni et 
al., 2001). The mutations cluster in the Coil 1A or Coil 2B domains of the keratin filament. 
This disorder is characterised by painful palmoplanter keratoderma, abnormalities of the 
nails (hyperkeratosis), thickened white plaques affecting the oral mucosa (leukokeratosis) 
and peri-follicular hyperkeratosis.  The exact molecular mechanisms underlying PC remain 
to be elucidated, it is thought there is a dominant negative effect of the mutant keratin, 
resulting in disruption of the remaining wild-type intermediate filament network.  In support 
of this, Krt16-null mice develop oral lesions soon after birth and later, a painful palmoplanter 
keratoderma  (Lessard & Coulombe 2012).  Attempts have been made to subdivide PC on its 
genetic basis (PC1 - K6 and K16, PC2 – K17) and develop gentotype-phentotype correlation, 
however characterization of over 80 PC patients show variability over the clinical 
features(Wilson et al., 2011).   
 
In addition to inherited keratinopathies, altered keratin expression profiles can be 
characteristic of specific disease states. An example of this is psoriasis, an inflammatory skin 
disease in which affected individuals develop widespread red, scaly plaques.  Histologically, 
the psoriatic plaque is characterised by increased expression of Keratin 16 and 17 (Leigh et 
al., 1995).  
 
1.15.4 Keratins and Cancer  
 
Keratin expression patterns are so specific that when abnormally present, the can be 
indicative of neoplasia, as such they are widely considered to be tumour biomarkers. 
Furthermore, they have both a diagnostic and prognostic significance(Karantza, 2011). For 
example, breast adenocarcinomas constitutively express K7, K8, K18 and K19, and in poorly 
differentiated breast adenocarcinomas, they can also express K5/6, K14 and K17 (Sorlie et al 
2001).  Squamous cell carcinomas, independent of their site of origin express K5,14, K6, K16 
and K17. In poorly differentiated SCC, K8, K18 and K19 are also observed – usually, their 
expression is restricted to the liver (Moll et al., 1982, Moll, 1998).  Given this role for keratins 
in cancer, the possibility that the keratins are playing a more direct role in the pathogenesis 
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of tumour development has arisen.  In support of this, there is a growing body of literature 
highlighting the role of keratins in a variety of cell regulatory processes such as size, shape, 
proliferation and inflammation.  Moreover, studies have shown that keratins could 
contribute to cancer cell invasion and metastasis.  Keratin filament re-organisation into a 
peri-nuclear ring-like structure, which can occur upon phosphorylation of specific residues, 
alters the keratin network architecture and “softens” the cytoplasm, which in turn facilitates 
migration and invasion (Beil et al.,2003, Suresh et al., 2005).   
 
1.15.5 Keratins and Wound Healing 
 
The keratin filament cytoskeleton is highly dynamic and flexible to allow cells to proliferate 
during growth and migrate during wound healing.  This dynamicity is the key to re-
organisation and bundling of the keratin filament network in response to shear stress.  The 
expression of Keratins 6, 16 and 17 are all rapidly upregulated in wounded keratinocytes 
within 2-3 hours of injury (Paladini et al., 1996) at the expense of K1 and K10. This response 
is exhibited by many complex epithelia and is conserved from amphibians to mammals 
(McGowan and Coulombe 1998).   Wound edge keratinocytes have characteristic features, 
these “activated” keratinocytes show altered cell adhesion, juxtanuclear reorganization of 
keratin intermediate filament network and generation of cytoplasmic processes in the 
direction of cell migration (lamellopodia) (Kolsch et al., 2010, Leube et al., 2011).   
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1.16 Cell-Cell Connectivity 
 
Cell-cell adhesion is a critical mechanism for maintaining epithelial integrity.  It also plays an 
essential role in regulating communication between cells.  Robust cell-cell adhesion in 
epithelia is maintained by four intercellular junctions, each with unique but complementary 
functions.  The importance of these structures is highlighted by the plethora of human 
disorders arising from their defect.  
 
1.16.1 Gap Junctions 
 
Gap junctions are aggregates of intercellular channels that permit direct cell-cell transfer of 
ions (Ca2+, Mg2+) and other small molecules (<1kDa such as cAMP, cGMP and ATP) by 
diffusion as well as electrical communication of varying conductance. They are evolutionarily 
conserved and were first identified as ion pathways in conductive cells such as nerves and 
muscles (Goodenough et al., 1996). They are expressed in virtually all human tissues.  Gap 
junctions are comprised of connexins, which assemble into hexamers to form connexons. 
The interlocked proteins form channels which cluster into polymorphic plaques containing 
thousands of individual units.  The connexin family of proteins contain over 21 members, 
named according to their molecular mass (Wei et al., 2004). Their expression pattern is 
tightly regulated throughout tissue types, each conferring a specific function due to varied 
permeability to particular molecules and ions (Goldberg et al., 2004).  Greater understanding 
of the role of Gap junctions has come from disorders arising from mutations in specific Gap 
junction proteins. Mutations in GJB2 (encoding Cx26) were identified as the primary cause 
of autosomal recessive non-syndromic hearing loss (Kelsell et al., 1997, Kelsell et al., 2001). 
As CX26 is the most abundant connexin in the cochlea, its diminished function has a profound 
effect on hearing. In the skin, GJB3 mutations have been found to cause autosomal 
dominantly inherited erythrokeratodermia variabilis (EKV, OMIM 133200) (Wilgoss et al., 
1999).  Furthermore, mutations in GJB2 (Cx26) have been linked to congenital hearing loss 
and PPK (Heathcote et al., 2000).   
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1.16.2 Adherens Junctions 
 
Adherens junctions mediate adhesion and cell recognition.  They are present in epithelia as 
well as cardiac myocytes and fibroblasts.  The major component of adherens junctions are 
cadherins, which are structurally formed of repeating extracellular cadherin domains and a 
cytoplasmic region that binds p120 catenin and B-catenin at opposing ends (Oda and Teichi, 
2011). Multiple cadherins are expressed in a context specific manner.  For example, in the 
skin E-cadherin is primarily expressed, whereas in the heart and neuronal tissue, this is 
substituted for N-cadherin.   
 
1.16.3 Tight Junctions 
 
Tight junctions occur at the apical and basolateral domains of epithelia and their main 
function is to prevent the paracellular passage of fluids, electrolytes and macromolecules 
(Bonazzi and Cossart, 2011).  They are composed of 4 main proteins, occludins, claudins, 
junction adhesion molecules (JAM) and the coxsackievirus and adenovirus receptor proteins 
(CAR).  Occludins and Claudins have four transmembrane domains and form homodimers via 
their extracellular loops. JAMs and CARS have only one transmembrane domain and 
extracellular IgG-like domain that mediates adhesion.  These transmembrane components 
bind to intracellular components which then links them to the actin cytoskeleton. Due to 
their apical location, tight junctions are frequently targeted by pathogenic organisms to 
facilitate their invasion into the epidermis.  
 
1.16.4 Desmosomes 
 
Desmosomes are beautifully complex structures located in close proximity to Adherens 
junctions and are more widely distributed along the lateral membranes. They are named 
from the Greek words “desmos” meaning bond and “soma” meaning body.  They function 
to tether the intermediate filament cytoskeleton to the plasma membrane, permitting the 
formation of a flexible structural network within the cell (Green et al., 2000).  They are highly 
adhesive and play a key role in determining the mechanical resistance of the cell and thus 
are highly expressed at sites which require resistance to high mechanical stress such as the 
epidermis and cardiac muscle. In cardiac tissue, they additionally provide electromechanical 
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coupling (Yin and Green 2004).  Ultrastructurally, desmosomes appear as multi-layered 
symmetrical structures, containing a pair of opposing electron-dense plaques between 
which lies an extracellular region of approximately 35nm width.  Between the plaques is 
central dense midline which is comprised of desmosomal cadherin ectodomains (Desai et al., 
2009) Figure 1.8. 
 
 
Figure 1.8 Structure of the Desmosomes. Desmosomes are multicomponent structures 
composed of five key desmosomal proteins and interact with Keratin intermediate filaments 
to form a flexible structural network within the cell (Schematic diagram adapted from Green 
& Gaudry 2000).  
 
In addition to the intermediate filaments, desmosomes also interact with microtubules via 
association of DSP with the microtubule binding protein end-bindin 1 (EB1) (Patel et al., 
2014). Through this interaction, it can regulate microtubule organization and dynamics at 
sites of cell-cell contact. Moreover, desmoplakin-EB1 interactions also influence the 
localisation and function of gap junction proteins including Connexin 43 (Cx43). Therefore, 
Desmosomal defects can have a “knock-on” effect on other junctions.   
 
Desmosomal cadherins are similar to the classic cadherins found in adherens junctions. They 
are subdivided into desmogleins 1-4 and desmocollins 1-3.  The genes encoding these 
proteins are located on Chromosome 18 in both humans and mice (Frank et al., 2001).  They 
are variably expressed in epithelia, for example Dsg1 and Dsc1 are restricted to stratified 
epithelia.  Dsg 4 is predominantly expressed in differentiated layers of the epidermis and hair 
follicles.  The structure of Dsg and Dsc is fairly similar to classical cadherins. They contain a 
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series of highly conserved extracellular repeat(EC) domains followed by a short 
transmembrane domain(TM). Desmosomal cadherins are known to bind to other 
components of the desmosomes such as Plakoglobin and Plakophilins (Green et al., 2000).   
 
The desmosomal armadillo family members include Plakoglobin (Pg) and Plakophilin 1-3 
(PKPs 1-3).  Like B Catenin, they can also translocate to the nucleus and in fact, the Pkp1b 
isoform is exclusively nuclear.  The primary role of Pg is to link intermediate filaments to the 
desmosomal plaque.  It does so by binding the intracellular domain of desmosomal cadherins 
and interacting with the N-terminus of the IF-binding protein Desmoplakin.  As well as its 
structural role, Pg can have further signalling properties through its indirect influence on B-
catenin signalling (Simcha et al., 1998).   
 
Desmoplakin 
 
The third major component of the desmosome are the plakin family of proteins. 
Desmoplakin is one of the most well described desmosomal proteins and the most abundant 
component of the desmosome. It is abundantly expressed in the heart, skin and hair follicle. 
It has a “dumbbell” shaped structure that is divided into three domains, N Terminus, Rod 
domain and C Terminus.  The N-terminal domain primarily binds to armadillo proteins and 
to Dsc1a and targets DP to the desmosomal plaque. The central rod domain mediates 
oligomerisation and the C-terminal domain couples intermediate filaments to the 
desmosomal plaque by direct interaction with Type I keratin intermediate filaments.  Its 
amino terminus binds directly to plakoglobin and the plakophilins, thereby linking 
intermediate filaments to the desmosomal plaque.  The intermediate filament in question 
can differ from tissue to tissue. In the skin, it is the keratins that are anchored to 
desmosomes, whereas in the heart it is desmin, and in other tissues it is vimentin (Desai et 
al., 2009).  
 
DSP I and II 
 
In humans, the DSP mRNA transcript is alternatively spliced to yield two isoforms; 
Desmoplakin I and Desmoplakin II. DSP II is the shorter form, lacking two thirds of the rod 
domain.  In stratified epithelia, the two isoforms are expressed at nearly equivalent levels 
however DSPI is the predominant isoform in the heart (Angst et al., 1990, Uzumcu et al., 
2006). In 2012, Cabral et al. (Cabral et al.,2012) demonstrated in an elegant series of 
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experiements using two mutations in DSP that lead to different dosages of the two major 
DSP splice variants, that DSPII appears to be a key component in intermediate filament 
stability and desmosome mediated adhesion.  Therefore, the two isoforms do not appear to 
be functionally redundant.  They also proposed that changes in the ratio between DSPI and 
DSPII could influence normal desmosomal function.   
 
 
1.16.5 Electromechanical coupling in the Heart: The intercalate Disc 
 
The heart is composed of billions of individual cardiomyocytes, which are able to function as 
a highly co-ordinated structure.  Electromechanical coupling between cardiomyocytes occurs 
at the “intercalate disc”, a structure highly concentrated in adhesive and conductive 
components such as desmosomes, gap junctions and voltage gated channels.  The epidermal 
equivalent to the intercalate disc is the intercellular membrane.  Desmosomes of the 
intercalate disc provide structural integrity by interconnecting actin filaments and desmin 
filaments (the equivalent of Keratin) of adjacent cells (Patel et al., 2014).   
 
Cardiac connexins include Cx43, Cx40 and Cx 45 (Kanter et al. 1993).  Their expression pattern 
within the heart is complex, but as a general rule, Cx43 is predominantly expressed in the 
left ventricle.  Mouse models with selective ablation of Cx43 have shown that 80% reduction 
is required to produce a 50% loss of electrical conductance (Gutstein et al.,2001).   
 
In the epidermis, desmoplakin can alter the localisation of Cx43 through its interaction with 
the microtubule binding protein EB1, providing a mechanism for how desmosomes can 
regulate Gap junctions (Patel et al., 2014). In the heart, there is also evidence that 
desmosomal proteins can regulate both Gap junctions and Voltage gated sodium channels.  
For example, knock-down of PKP-1 results in reduced conduction through Na+ channels 
(Cerrone et al., 2012).  In ARVC, dominantly inherited mutations in desmosomal proteins 
such as PKP2, DSP, JUP and DSG2 result in decreased plakoglobin and Cx43 at the intercalate 
disc (Paul et al., 2013). This is occurs despite the presence of normal cellular levels of these 
proteins, suggesting impaired trafficking as the underlying pathological mechanism.   
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1.16.6 Desmosomes in the Heart versus Skin 
 
The proteins which make up the desmosomes in the heart differ to those present in the 
epidermis, reflecting their function.  In cardiomyocytes, DSP, PG, DSC2, DSG2 and PKP2 are 
the key desmosomal components (Patel et al., 2014) (Figure 1.9).  
         
 
Figure 1.9 Desmosomes in the skin (left) and at the intercalate disc in cardiomyocytes (white 
arrowhead) express different desmosomal proteins. The desmosomal proteins found in the 
basal layers of the skin are also found at the intercalate disc. However DSG1, DSC1 PKP1 and 
PKP3 are only present in the skin.  
 
In the skin, several more desmosomal proteins are expressed depending on the site within 
the epidermis. The composition of the desmosome varies from basal layers to stratum 
corneum, presumably reflecting the different functional properties of the desmosome at 
each site.  DSG2 expression is usually restricted to the proliferative basal layer, becoming 
upregulated in epidermal carcinomas (Brennan & Mahoney 2009).  PG, PKP1 and DP 
expression increases in the suprabasal layers and subsequently DSG1, DSC4 and DSC1 in the 
granular layers. (Mahoney et al., 2006).  The tight regulation of these desmosomal 
components is thought to reflect their role in driving epidermal morphogenesis, particularly 
in controlling differentiation.   
 
With regards to the function of individual components, DSG2 and DSC2 function as the key 
extracellular linkers in the heart. Whereas in the skin, this is performed by DSG1, DSG3, 
DSG4, DSC1 or DSC3.  PKP2 is the sole Plakophilin in the heart, in contrast to the additional 
presence of PKP1 and PKP3 in the skin.  Reflecting their tissue specific expression pattern, 
human genetic diseases showing skin/ectodermal abnormalities in the absence of cardiac 
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involvement have been linked to mutations in DSG1, DSG3 and PKP1 (Rickman et al., 1999, 
Klijuic et al., 2003, McGrath et al., 1997).  In contrast, mutations in DSG2, DSC2, DSP, PG, 
PKP2 (Pilichou et al., 2006, Syrris et al., 2006, Rampazzo et al., 2002, Asimaki et al., 2007) 
have been linked to cardiac disease without cutaneous manifestations. Further examples of 
desmosomes in human disease are described below.   
 
1.16.7 Desmosomal Diseases 
 
Much of our understanding into the function of desmosomal proteins have come from 
diseases arising from their dysfunction. Desmsomal diseases include autoimmune blistering 
disorders, infectious diseases in addition to an array of cardiocutaneous disorders. 
 
Autoimmune Disorders 
 
As desmosomes primarily function to maintain intercellular adhesion, it is unsurprising that 
defects in desmosomal proteins are associated with epidermal blistering disorders.  
Pemphigus vulgaris is an autoimmune blistering disorder caused by autoantibodies targeting 
DSG1 and DSG3 (Shimizu et al., 1995). It typically presents with superficial blisters and/or 
erosions frequently affecting the mucous membranes. Histologically, lesional skin 
demonstrates suprabasal epidermal acantholysis (loss of cohesion between keratinocytes), 
clefting and blister formation.  Patients presenting with limited oral involvement tend to 
have autoantibodies (IgG) targeting DSG3, whereas involvement of both the skin and mucosa 
is linked to autoantibodies to both DSG1 and DSG3 (Amagai et al 1991, Ding et al., 1997).  
The phenotypic differences reflect the expression pattern of these desmosomal cadherins 
between the skin and mucosal tissues (Shirkata et al., 1998) (Figure 1.10).   
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Figure 1.10 Differential expression of DSG1 and DSG3 underlie the phenotypic features of 
Pemphigus Foliaceous and Pemphigus Vulgaris. Autoantibodies to DSG3 underlie PV, 
contributing to the development of oral ulceration where this protein is also expressed 
(Schematic diagram adapted from Simpson et al., 2011).  
 
Pemphigus Foliaceous is a relatively benign form of pemphigus characterised by scaly crusted 
erosions on an erythematous base.  Mucosal involvement is frequently absent.  It is caused 
by autoantibodies to desmoglein 1 which results in very superficial loss of intercellular 
adhesion as DSG1 is primarily expressed in the granular of the epidermis.  However, DSG1 
expression in mucosal tissues is very low, explaining the lack of oral involvement in these 
patients.  As PV can be associated with autoantibodies to both DSG1 and DSG3 it is associated 
with much more severe epidermal and mucosal blistering which can be fatal.   
 
A useful sign when attempting to diagnose PV or PF is the presence of “Nikolsky’s sign”. 
Gentle rubbing of unaffected skin results in blistering or erosion formation. This clinical sign 
neatly demonstrates the importance of functional desmosomes in maintaining epithelial 
integrity in response to mechanical stress.    
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Infectious Diseases 
 
Some strains of pathogenic Staphylococcus aureus are able to produce exfoliative toxins (ET) 
targeting the desmosomal cadherin DSG1 (Amagai et al 2000, Amagai et al 2002). Clinically, 
this can result in either Bullous impetigo or its generalised form, Staphylococcal Scalded Skin 
Syndrome. Typically, both diseases are characterised by superficial blistering and 
histologically, there is evidence of keratinocyte acantholysis.  The exfoliative toxin is a unique 
serine protease that shows “lock and key” specificity for DS1 and not DSG3 hence resulting 
in superficial blistering. 
 
1.16.8 Inherited Cardio-Cutaneous Disease. 
 
Several cardiocutaneous syndromes have been reported to date, often their first 
presentation may be to dermatologists, in whom early recognition could expedite the 
diagnosis of more sinister underlying cardiac pathology. The link between the skin and heart 
is somewhat unsurprising considering their shared embryological derivation from the neural 
crest, the bilaterally paired strips of cells arising from the ectoderm at the margins of the 
neural tube.  Furthermore, the skin and heart require similar mechanoresilient properties, 
both being subjected to phenomenal repeated stress and shearing forces.  One key property 
of both tissues is their ability to respond to stress with both flexibility and strength.  
Desmosomes play an important role in providing these characteristics, as highlighted by the 
cardiac and cutaneous manifestations of diseases resulting from mutations in desmosomal 
genes.  
 
Arrhythmogenic Right Ventricular Cardiomyopathy  
 
Arrythmogenic Right Ventricular Cardiomyopathy (ARVC) or Arrythmogenic Cardiomyopathy 
(AC) is an inherited disorder of the heart muscle with a prevalence of at least 1 in 1000.  As 
there is a high propensity for cardiac arrhythmias in affected individuals, it is the leading 
cause of cardiac death in individuals <35 years old and contributes to 10% of deaths from 
undiagnosed cardiac disease in the <65 age group (Sen-Chowdhry et al., 2005). As such, the 
foremost clinical challenge in ARVC is making an accurate and timely diagnosis. This is 
complicated by the lack of overt symptoms, vast phenotypic heterogeneity and variability of 
cardiac findings. At present, diagnosis can be attempted on the basis of comprehensive non-
invasive evaluation and fulfilment of clinical criteria outlined by the International ARVC Task 
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Force (Marcus et al., 2010). ARVC demonstrates a clear familial preponderance, and 
evaluation of first and second-degree relatives of probands estimates that over 50% of cases 
are inherited, most frequently as an autosomal dominant trait (Corrado et al., 2017, Sen-
Chowdhry et al., 2007) .  The genetic basis of ARVC is however complex, in the majority of 
cases the cause is a mutation in one of the components of the desmosome, as these form 
the major electromechanical adhesion complex between cardiomyocytes. Mutations have 
been reported to occur in five desmosomal genes; Plakoglobin (PG), Desmoplakin (DSP) 
Plakophilin 2 (PKP2), Desmoglein 2 (DSG2) and Desmocollin 2 (DSC2). In 30% of cases, the 
genetic cause remains unknown (Sen-Chowdhry et al., 2007, Brooke et al., 2012). The 100K 
genomes project has recruited patients with ARVC but as yet novel genes have not been 
identified.  
 
Histologically, ARVC may show interstitial fibrosis with fatty replacement.  The presence of 
interstitial fibrosis is a reactive process and occurs in the absence of myocyte necrosis, but 
in response to triggers such as inflammation and ischaemia.  The presence of fatty 
replacement in the myocardium is an unusual feature, reasonably restricted to ACM.  One 
controversy in the field is nomenclature of the disease, although originally known as ARVC, 
the involvement of the right heart can be variable and non-classical, predominantly left sided 
variants have not infrequently been described. Moreover, dual chamber involvement is also 
relatively common.   
 
Naxos Disease 
 
Naxos disease is a triad of ARVC, woolly hair and diffuse keratoderma which develops at sites 
of pressure on the palms and soles (Figure 1.11). The disease was first identified on the Greek 
Island of Naxos, where, despite the autosomal recessive mode of inheritance, the prevalence 
of the disease exceeds 1 in 1000 (Protonotarios et al., 1986).  The initial presenting signs are 
the cutaneous features which facilitates the recognition of affected individuals in early 
childhood.   Cardiac pathology develops later in life, typically during adolescence but can be 
as late as the fourth decade. Typically, affected individuals develop palpitations and syncope.  
The classical ECG findings include QRS prolongation, epsilon waves and inverted T waves in 
the right precordial leads (V1-3). Ventricular tachycardial/fibrilliation is the commonest 
cause of morbidity and mortality in these patients, arising from the right ventricle.  Later, as 
the disease progresses the left ventricle can become involved.  The annual incidence of 
sudden cardiac disease is approximately 3% (Delmar and McKenna, 2010).  
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The causal mutation for Naxos disease is a homozygous two base pair deletion in the gene 
encoding plakoglobin (JUP 2157del2), which result in premature termination of translation 
and was first discovered by McKoy et al. (McKoy et al., 2000). Gene sequences were 
determined by reverse transcriptase PCR from mRNA isolated from skin sample from an 
affected patient. This was further corroborated in two further independent studies 
(Protonotarios and Tsatsopoulou 2004, Delmar and McKenna, 2010).  In a minority of 
heterozygotic carriers of JUP-2157del2  show mild clinical disease expression, such as woolly 
hair (5/40) and minor cardiac abnormalities (8/40) however none fulfilled the diagnostic 
criteria of ARVC. (Protonotarios et al., 2004) 
 
Figure 1.11. Clinical phenotypic features of Naxos Disease and Carvajal Disease. Both 
diseases can present with a triad of curly hair, palmoplantar keratoderma and 
cardiomyopathy. Typically, marked fibrofatty replacement is seen within the cardiac 
ventricles post-mortem, although this is less prominent in Naxos disease. 
 
 
Carvajal Disease 
 
Recessively inherited homozygous deletion mutations in the last exon in DSP were first 
described in cardiocutaenous syndromes in patients from India and Ecuador (by Dr Luis 
Carvajal-Huerta). Norgett et al. (Norgett et al.,2000)  Using a combination of Autozygosity 
mapping, denaturing high performance liquid chromatography and sequence analysis, they 
identified the causative mutation as a homozygous deletion in DSP (7901delG). This results 
in a premature stop codon and a truncated protein product lacking the C terminus domain 
of the tail region. Like Naxos disease, Carvajal syndrome is consists of a palmoplantar 
keratoderma, woolly hair and left dominant arrythomogenic cardiomyopathy (Figure 1.11).  
However, the PPK differs in Carvajal disease in that it is striate rather than diffuse.  Clinically, 
Naxos&Disease Carvajal Disease
Norgett et'al.,'HMG'2000Protonotarios et'al.,'BHJ'1986
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the cardiac phenotype is complicated by frequent and complex ventricular arrhythmia and 
precordial T-wave inversion (V1-3). Post-mortem findings include biventricular cavity 
enlargement, more severe on the left than the right, focal aneurysms in both ventricles, 
myocyte loss and replacement fibrosis in the subepicardial layer.  Adipose replacement is a 
less prominent component of the disease.  
 
Alcalai et al., described a large consanguineous family with recessive ARVC caused by a 
homozygous missense mutation in DSP G2375R.  Eight family members died suddenly before 
the age of 35 years, all of whom had woolly hair, xerotic skin from infancy and the presence 
of skin fragility – vesicular lesions over the peripheries, knees, palms and soles from 
childhood (Alcalai et al., 2003).   
  
Dominantly Inherited ARVC 
 
DSP 
 
The first gene implicated in the more common, dominantly inherited form of ARVC was 
Desmoplakin. Using linkage analysis and direct sequencing, the mutation was found to be a 
missense mutation (S299R) in exon 7 of DSP in an Italian ARVC family, the site of the mutation 
suppresses a potential phosphorylation site in the N-terminal domain of the protein, 
necessary for its interaction with plakoglobin.  Clinically, the patients developed classical 
features of ARVC with predominantly right sided precordial T-wave inversion and arrhythmia 
originating from the right ventricle, presenting clinically as ventricular fibrillation in several 
family members and in some instances sudden cardiac death (Rampazzo et al., 2002).   
 
PKP2 
 
This armadillo protein is likely to account for the highest proportion of ARVC cases.  In large 
scale ARVC studies from the US and Germany, heterozygous variants in PKP2 were found to 
account for 43% and 27% of cases respectively, and up to 70% of familial cases in The 
Netherlands.  The latter was found to result from a founder effect in the Dutch population.  
The phenotype in this cohort of patients tends to be classical right sided involvement.  Skin 
and hair abnormalities linked to PKP mutations have never been reported. It is likely to be 
because in the skin, PKP2 is localised to the nucleus rather than the desmosomal plaque, 
where it is substituted by PKP1 (Syrris et al., 2006). 
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JUP  
Dominantly inherited heterozygous mutations in the gene encoding PG, JUP have also been 
found to cause ARVC.  First in a German family, where the mutation (118_119insGCA), results 
in the insertion of a serine residue at amino acid position 39, which lies within the N-terminal 
domain of the protein product.  The patient was reported to have classical right ventricular 
disease without skin or hair involvement (Asimaki et al., 2007).  
 
DSG2 
 
The fourth desmosomal protein to be implicated in ARVC is DSG2.  Using a candidate gene 
approach, Pillchou et al. (Pilichou et al., 2006) identified 9 heterozygous mutations in DSG2 
(5 missense, 2 insertion-deletions, 1 nonsense and 1 splice site) in 8 of 54 probands.  In a 
further cohort, Syrris et al., (Syrris et al., 2007), described prominent left ventricular 
involvement in 25% of DSG2 cases. It has been estimated that mutations in desmosomal 
cadherins DSG2 and DSC2 account for approximately 10% of cases of ARVC (Sen-Chowdhury 
et al., 2007) 
1.17 Background to the Aims and Hypotheses 
 
It is fascinating to consider that inherited mutations in a multitude of genes can lead to 
abnormalities of the palmoplantar skin. These mutations affect a remarkable array of genes 
including structural proteins (e.g. Keratins), adhesion proteins (e.g. desmosomal 
components) and channel proteins (e.g. connexins) (Maruthappu & Kelsell, 2018). Although 
involvement of these particular proteins could be predicted to result in PPK’s, the discovery 
of many other responsible genes has been surprising.  
 
Examples include mutations in TRPV3, which underlie Olmsted Syndrome (Lin et al., 2012) 
which presents with PPK and periorifical keratotic plaques. TRPV3 protein belongs to a family 
of non-selective cation channels, responsible primarily for thermoregulation, and is 
expressed not only in the skin but also in the brain (Xu et al., 2002).  The discovery of this 
mutation provided novel insight into the role of TRPV3, particularly in the skin. 
 
Many genetic mutations attributed to PPK’s present not only with skin disease but also 
systemic involvement, with the PPK frequently being the only cutaneous manifestation of 
the disease despite the protein being expressed at other skin sites. For example, mutations 
in GJB2 encoding Connexin 26 (Cx26) were found to underlie PPK and congenital deafness 
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(Kelsell et al., 1997). This discovery led to the finding that Cx26 is expressed at high levels in 
human cochlear cells as well as the skin. Interestingly, despite high levels of Cx46 in multiple 
other organ sites including the colon, prostate and breast in humans. 
(www.proteinatlas.org), deafness and PPK appear to be the only overt manifestations of the 
mutation.   
 
What these and other discoveries demonstrate, is that the palmoplantar epidermis is an 
exquisitely sensitive barometer of pathological inherited mutations.  As the palmoplantar 
epidermis is both visible and highly accessible, the PPK’s provide a rich resource for 
genotype-phenotype correlation and their study forms the basis of this Thesis.  
1.18 Aims and Hypotheses of this Study 
 
The overarching theme of this Thesis is to investigate the diverse genetic and functional basis 
of PPK’s and their links to human disease.  The aims can broadly be subdivided into three 
components.  
 
1. Identification of Novel Binding partners for iRHOM2 to help elucidate its primary 
functions in TOC and normal skin, very little is known about the function of iRHOM2 
in human skin but it is clearly expressed at the cell surface membrane and individuals 
with TOC have a clear skin phenotype 
2. Exploration of cutaneous phenotypes in ARVC – discovery of novel mechanisms and 
links to cardiac disease 
3. Novel gene discovery in PPKs.  
 
To Investigate these hypotheses, the following approaches were used: 
 
1. 
 i) A yeast 2 hybrid screen was employed to identify novel interacting binding  
 partners for iRHOM2.  
 ii) In vitro modelling using shRNA iRHOM2 
 ii) In vivo modelling using iRHOM2-KO mice 
 
2.  
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 i) Deep cutaneous and cardiac phenotyping of dominantly inherited DSP 
 mutation carriers with ARVC 
 ii) Molecular characterisation by immunohistochemical staining of patients’ 
 skin biopsies 
 iii) Extraction of cDNA and mRNA from patient skin biopsies to explore the 
 mechanistic basis for the phenotype. 
 
 
3. 
 i) Identification of the first human disease-causing mutation in FAM83G as a 
 cause of PPK and exuberant hair using a combination of exome and Sanger 
 sequencing.  
 ii) Using confocal hair analysis and immunohistochemistry of skin biopsies 
 from affected patients, a possible mechanism for the cutaneous phenotype 
 was identified.  
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2.1  Antibodies 
 
Antibody Reference code WB ICC/IHC 
  Dilution Dilution 
RHBDF2 (Rabbit) HPA018080 (Sigma) 1:500 1:50 
    
RHBDF1 (Rabbit) Ab81342 (Abcam) X 1:100 
Cytokeratin 16 (Mouse) LL0025 (Cancer Research UK) 1:500 1:50 
Cytokeratin 16 (Rabbit) Ab76416 (Abcam) 1:500 1:50 
    
Cytokeratin 16 (Rabbit) Ab182791 (Abcam) 1:500 1:100 
Cytokeratin 6 (Mouse) Ab18586 (Abcam) X 1:100 
Cytokeratin 9 (Rabbit) gift of D Leslie-Pedrioni X 1:250 
 (University of Dundee, UK)   
Ki-67 (Rabbit) Ab15580 (Abcam) X 1:100 
Anti-HA (Rat) 3F10 (Roche) 1:500 X 
ADAM17 (Rabbit) Ab2051 (Abcam) 1:500 X 
Vinculin (Mouse) Ab18058 (Abcam) 1:80000 X 
GAPDH (Rabbit) Ab8245 (Abcam) 1:2000 X 
DSP (Mouse) 11-5F (kind gift from Kathy Green) 1:1000 1:50 
JUP (Mouse) 0BT0651(Abd Serotec) 1:100 1:10 
Connexin 43 (Mouse) Mab3067 (Millipore) 1:2000 1:200 
FAM83G (Mouse) Ab121750 (abcam) 1:1000 1:100 
Filaggrin (Rabbit) Ab81468 (Abcam) X 1:100 
Loricrin (Rabbit) Ab85679 (Abcam) X 1:100 
Cytokeratin 10 (Rabbit) Ab9026, (Abcam) X 1:100 
Active B Catenin (Mouse) Merck Millipore 05-655 Clone 8E7 1:1000 1:100 
B Catenin BD Transduction labs 1:1000 1:100 
Anti-GFP (Mouse) Ab290 (Abcam) 1:500 1:200 
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2.2 Statistical Analysis 
 
Statistical analyses were carried out using the two-tailed paired Student’s t-test *P≤0.05, 
**P≤0.01, ***P≤0.001 
 
2.3 Yeast two-hybrid Analysis 
 
Yeast two-hybrid screening was performed by Hybrigenics Services, S.A.S., Paris, France 
(http://www.hybrigenics-services.com). 
 
The coding sequence for human iRHOM2 N-terminus (aa. 1-403; GenBank accession number 
gi:306035188) was PCR-amplified and cloned into pB29 as an N-terminal  
fusion to LexA (N-iRHOM2-LexA-C). The construct was checked by sequencing the entire 
insert and used as a bait to screen a random-primed Human Reconstituted Skin cDNA library 
constructed into pP6. pB29 and pP6 derive from the original pBTM116 (Vojtek and 
Hollenberg, 1995; Béranger et al., 1997) and pGADGH (Bartel et al., 1993) plasmids, 
respectively. 
 
112 million clones (13-fold the complexity of the library) were screened using a mating 
approach with YHGX13 (mata) yeast strains as previously described (Fromont-Racine et al., 
1997). 28 His+ colonies were selected on a medium lacking tryptophan, leucine and histidine. 
The prey fragments of the positive clones were amplified by PCR and sequenced at their 5’ 
and 3’ junctions. The resulting sequences were used to identify the corresponding interacting 
proteins in the GenBank database (NCBI) using a fully automated procedure. A confidence 
score was attributed, firstly taking into consideration the redundancy and independency of 
the prey fragments and reading frames and stop codons in overlapping fragments. Secondly, 
taking into account the interactions found in all the screens performed at Hybrigenics, using 
the same library. The scores have been shown to positively correlate with the biological 
significance of the interaction (Rain et al., 2001; Wojcik et al., 2002). 
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2.4 Cell Culture 
 
Control (CTRL) and TOC keratinocyte cell lines (previously described in Blaydon et al., 2012) 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) supplemented with 
1% Penicillin/Streptomycin, 10% Foetal Calf Serum, 1% L-glutamine, 1% RM+ supplement 
(containing EGF) and cultured in a humidified incubator at 10% CO2, 37 C. HaCaT cells were 
cultured in DMEM supplemented with 10% Foetal Calf Serum, 1% L-glutamine and 1% 
Penicillin/Streptomycin and cultured in a humidified incubator at 10% CO2, 37°C. 
 
After gaining appropriate consent, a skin biopsy from an affected male with PPK was used to 
produce the PPK K16-R127C cell line. Primary keratinocytes were isolated and grown in the 
presence of a γ-irradiated 3T3 feeder layer. Cells were immortalized with HPV16 (E6/E7) as 
described previously (Rheinwald et al., 1975) All experiments were carried out on cells that 
had been passaged between 10 and 40 times post-immortalization. Cells were cultured in 
the same conditions described above. 
 
2.5 Western Blotting 
 
Protein preparation from cell lysates: 
 
Cells were grown to confluence on 10cm plates and lysed on ice. The cells were washed twice 
with ice-cold PBS and 1ml of lysis buffer (Appendix A) added containing a protease inhibitor 
cocktail (Roche, UK). Cells were left on ice to lyse for 10 minutes. A cell scraper was used to 
remove cells vigorously from the plate and they were transferred to an eppendorf tube. The 
lysate were pre-cleared to remove debris by spinning at 13,000G for 10 minutes at 4°C, the 
supernatant was then removed for protein assay, using the Bradford method (Bio-Rad).  
Following protein assay, lysate inputs could be calculated for western blotting, for example 
20ug of protein per lane, and denaturing 5x Laemelli buffer (0.1 M Tris-HCL (pH6.8), 4% SDS, 
20% Glycerol, 0.001% Bromophenol Blue, 1.44 M Beta-mercaptoethanol) added to enable 
protein epitope availability for probing antibodies.  Lysates were either used immediately or 
stored at -80°C. 
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SDS-PAGE Electrophoresis 
 
SDS-PAGE Electrophoresis was carried out using equipment from Biorad (Hemel Hempsted, 
UK). All equipment was cleaned with hot water and 70% ethanol before use. SDS-
polyacrylamide gels were prepared with an appropriate polyacrylamide percentage for the 
protein being detected with higher percentage gels used for lower molecular weights. 
iRhom2 is around 100KDa and the Keratins are approximately 50KDa in size, so a 10 % gel 
was used. The resolving gel was first made up, which separates the proteins in the lysates by 
size. Every 10ml of 10% gel comprised: 2.7 ml double distilled H2O (ddH2O), 2.5 ml 30% 
polyacrylamide mix (Protogel), 2.5 ml Tris (1.5 M, pH8.8), 0.1 ml SDS (10%), 0.1 ml 
Ammonium Persulphate (APS, 10%) and 6 μl N,N,N-Tetramethylethylenediamine (TEMED). 
APS and TEMED act as setting agents in the gel. Isopropanol was then added to level the top 
of the gel and remove air bubbles. The gel was then left to set for around 20 minutes. 
Once the resolving gel was set, the isopropanol was removed and the top of the gel washed 
with ddH2O. The stacking gel was prepared next, which allows loading of the samples. The 
stacking gel has a lower resistance than the resolving gel, allowing 
the proteins  to  ‘line  up’  at   the same point before entering the resolving gel. Each 5ml 
stacking gel contained: 3.4 ml ddH2O; 0.8 ml 30% polyacrylamide mix; 0.63 ml Tris (1 M, 
pH6.8), 0.05 ml SDS (10%), 0.05ml APS (10%) and 5 μl TEMED. The gel was poured around 
the combs that form the loading wells at the top of the gel avoiding the formation of air 
bubbles and left to set for approximately half an hour. 
 
Once the gels had set, they were fitted into the tank and the combs removed. Running buffer 
(0.3% Tris, 1.44% Glycine, 0.1% SDS in ddH2O) was poured in between the gels and outside 
the gel but without it touching to prevent a short circuit. The wells of the gel were rinsed to 
remove any gel debris or unpolymerised gel using a 1ml pipette and running buffer. Protein 
lysates were heated to 95°C or 5 minutes and then cooled on ice and spun at 13,000rpm for 
5 minutes in a bench top centrifuge before loading into the gels. Rainbow ladder (GE 
Healthcare) was also included in at least one well per gel to allow identification of protein 
size. The gel was then run for approximately 1 1⁄2 hours at 100V per gel until the dye front 
from the bromophenol blue in the loading buffer reached the bottom of the gel. The protein 
has a negative charge (from the SDS in the loading buffer), causing the protein to migrate 
from negative charge towards positive charge when the electrical current is run through the 
tank. 
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Transfer 
 
Transfer of the proteins from the gel onto a nitrocellulose membrane was then carried out. 
Blotting paper, sponge pads and a piece of nitrocellulose membrane were soaked in transfer 
buffer (0.3% Tris, 1.44% Glycine, 20% methanol in ddH2O). A cassette was then used to 
sandwich a sponge pad, two pieces of blotting paper, the gel, the nitrocellulose membrane, 
two pieces of blotting paper and another sponge pad taking care to avoid air bubbles. Again, 
the negatively charged protein migrates from negative charge towards positive charge when 
the electrical current is run through the tank. The gel was therefore placed towards the 
negative side of the tank and the membrane at the positive side. Once the sandwich was 
made, the cassette was placed in the tank with transfer buffer and an ice pack to prevent 
overheating. A current of 350 mA for 2 1⁄2 hours transfer. 
 
Blocking 
 
Once the transfer was complete, the nitrocellulose membranes were blocked in 5% skimmed 
milk in TBS-Tween (0.1%), which per litre comprises: 2.423 g Trizma HCl, 8.006 g NaCl and 
1ml Tween20 in ddH2O. The pH is adjusted to pH7.6 in the 10X stock solution 
 
Antibody Incubation and development.  
 
Primary antibodies were optimized with either 5% skimmed milk, 5% BSA or TBS-Tween 
depending on the efficacy of the antibody and manufacturers instructions.  The membrane 
was incubated overnight at 4C and then washed 3 times for 5-10 minutes each in TBS-T 
before addition of a secondary antibody.  The secondary antibodies used were either Goat 
anti-Rabbit or Goat anti-mouse (horse-radish peroxidase conjugated ) (Dako Ely 
Cambridgeshire UK) at a dilution of 1:5000. Membranes were incubated in secondary 
antibody for 1 hour at room temperature. This was followed by 3 x 5-10 minute washes in 
TBS-T and visualized using ECL and developed in a dark room using x-ray film and an 
automated developing system.  
 
Cells were washed in PBS and then lysed using lysis buffer (1M Tris, 2.5M NaCl, 10% Glycerol, 
0.5M Glycerophosphate, 1% Tween-20, 0.5% Nonidet P40, 1×EDTA-free Complete Protease 
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Inhibitor tablet (Roche) for 15 minutes on ice. Extracts were separated on SDS 12% 
polyacrylamide gels and transferred to a nitrocellulose transfer membrane. The blots were 
incubated with specific antibodies and developed according to the manufacturer’s 
instructions (ECL Immobilon, Millipore) 
 
2.6 Immunostaining and Image Processing 
 
Cells plated on cover slips or 5µm tissue sections were fixed with either 4% 
paraformaldehyde (PFA) in PBS for 10 minutes at room temperature, or in ice cold Methanol-
Acetone (50:50 mixture) at -20°C for 10 minutes depending on the optimal method for 
detection of the primary antibodies. The following steps were all carried out at room 
temperature. Cells were permeabilised with 0.1% Triton X-100 for 10 minutes if PFA fixation 
was used, then blocked with 5% Goat Serum for 1 hour. Cells or tissue sections were 
incubated with primary antibody diluted in 5% goat serum overnight at 4°C.  
 
The following day, fixed cells or tissue sections were washed in 3 x 5 minutes in PBS, then 
incubated with the appropriate Alexa Fluor (Life Technologies) fluorescent secondary 
antibody for one hour at room temperature. The secondary antibody was diluted 1:800 in 
5% goat serum. Cells or tissue sections were washed twice 3 x 5 minutes in PBS, then 
incubated in DAPI nuclear stain (1:10,000), then washed twice for 10 minutes each and finally 
mounted onto slides and imaged using the Zeiss 710 confocal microscope (Carl Zeiss).  
 
The quantification of perinuclear localization of K16 filaments was based on the method 
previously described by Feng & Coloumbe (Feng & Coulombe., 2015). CTRL and TOC cells 
were quantified in ImageJ by drawing a line from the nuclear envelope across the plasma 
membrane using the freehand tool and plotting the K16-associated fluorescence signal along 
this line.  K16 filament arrangements were classified as ‘perinuclear’ when all of the positive 
filament signals (>50% relative signal intensity, normalized to the maximum fluorescence of 
the specific cell) were found within 3um from the nuclear membrane. Images were selected 
randomly and blindly subjected to this quantification. For the final bar graph depicting the 
percentage of perinuclear cells, 90 images for each of CTRL and TOC from three independent 
experiments each were quantified. Statistical analysis was performed using the unpaired 
students t-test. 
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2.7 Generation of 3D Human Skin Equivalents 
 
Human dermal fibroblasts were embedded in 4 mg/ml collagen 1 matrices at a concentration 
of 250,000 cells/ml to produce dermal equivalents. After culturing these dermal equivalents 
for 24H, keratinocytes were seeded on top (30,000 cells/cm2) and kept in submerged culture 
for a further 24H. Afterwards, the human skin equivalents were lifted to the air-liquid 
interface and cultured until day 14 with alternate daily media change, before being PFA-fixed 
and paraffin-embedded for processing. 
 
2.8 Transfection of Cell Lines with Overexpression DNA 
constructs 
 
RHBDF2 constructs were prepared by subcloning wildtype RHBDF2 cDNA from Origene clone 
#SC122961 (Origene) into vector pEGFP-N3. Mutant RHBDF2 constructs were prepared using 
the QuikChange II site-directed mutagenesis kit (Agilent). 
 
N-terminus RHBDF2 construct was prepared by cloning wildtype RHBDF2- N-terminal 
domain into vector pEGFP-N3. The plasmid was prepared using In-Fusion HD Cloning kit 
(Clontech Laboratories, Takara). N-terminus RHBDF2 constructs were a generous gift from 
Prof M. Freeman (Oxford, UK) 
 
HaCaT cells were grown on coverslips and plated at a density of 2x105 cells per well of a 6 
well plate. Transfection was carried out after 24 hours using. Fugene 6 (Roche). The cell-
culture medium was changed the next day. Cells were fixed and immunostained 48 hours 
following transfection. 
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2.9 Co-Immunoprecipitation 
 
Cells were grown to confluence in 10 cm plates. Plates were washed twice on ice in ice-cold 
PBS and then lysis buffer was added with a protease inhibitor cocktail (Roche). Lysates 
collected after 10 minutes and pre-cleared by centrifugation at 13,000 G for 10 minutes at 
4°C. The supernatant was removed from the debris pellet and transferred to a clean tube. 
Protein concentration was calculated using the Bradford Protein Assay system (Bio-Rad). 
50 l Dynabeads (Thermo) were prepared according to manufacturers instructions. 
Antibodies (2-4g) were bound to the beads by incubation at room temperature with rotation 
for 30 minutes. Species matched IgG (Rabbit IgG sc-2027, Mouse IgG sc-2025, Santa Cruz) 
were bound to beads as a control. 2mg of protein lysate was added to beads and incubated 
overnight at 4°C with rotation. The following day beads were washed three times for 5 
minutes on ice in 700 l NP-40 wash buffer (50mM Tris pH 8.0, 150mM NaCl, 1mM EDTA, 1% 
NP40) containing protease and phosphatase inhibitors (Roche) followed by separation on a 
magnet. Beads were separated from antibody-protein complexes by boiling for 5 minutes in 
2x Laemelli buffer and the eluate separated by a magnet loaded onto a gel for SDS-PAGE 
electrophoresis. The lysate was run alongside as an input for the IP. 
 
2.10 Flexcell Mechanical Stress Assay 
 
The Flexcell FX-4000 Tension System (Flexcell International Corporation), a computer-
regulated bioreactor that uses vacuum pressure to apply cyclic or static strain to cells 
cultured on flexible-bottomed culture plates. It was used to subject a cell monolayer to 
mechanical stress. HaCaT cells were grown to a near confluence on BioFlex 6-well plates 
coated with pronectin (Flexcell International Corporation) which contain a flexible 
membrane in each 35-mm well. Each plate was placed over the loading station containing 6 
planar faced posts. Cells were subject to cyclic mechanical stretch with a frequency of 5 Hz 
and an elongation of amplitude ranging from 10 to 13%. Cells were stretched for 0 hours 
(unstretched control) and 4 hours, and then prepared for immunocytochemistry as 
described above. 
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2.11 Proximity Ligation Assay 
 
PLA was performed using the Duolink in-situ kit (Sigma) according to manufacturers 
instructions. Cells were plated on coverslips or Bioflex 6 well plates for cell stretching assay 
(above) and fixed with Methanol Acetone or PFA as described previously. Following fixation, 
cells were incubated in Duolink blocking solution for 30 minutes at 37°C. Previously 
optimized primary antibodies were diluted in Duolink Antibody diluent and added to cells, 
which were incubated overnight at 4°C. The following day the cells were washed in Duolink 
Wash buffer A 2 x 5mins. The PLA plus and minus probes were diluted 1:5 in antibody diluent 
and added to the cells which was incubated for 1hr at 37°C. The cells were washed in Duolink 
Wash buffer A 2 x 5mins. The Ligation-Ligase was prepared according to instructions and 
applied to cells for 30mins at 37°C. The cells were washed 2 x 2mins in Duolink wash buffer 
A and the Duolink Amplification-Polymerase solution added and incubated for 100min at 
37°C. The cells were washed in Duolink wash buffer B for 2 x 10mins and then mounted with 
Duolink in situ mounting medium with DAPI beforevisualization with a Zeiss Confocal 710 
microscope (Carl Zeiss). As a negative control, no primary antibodies were applied. A further 
negative control was the use of iRHOM1 instead of iRHOM2 primary antibody As a positive 
control, known binding partners (such as Keratin 6 and Keratin 16) primary antibodies were 
applied. Quantification was performed using ImageJ software analysis programme and 
analysed by students paired t-test using GraphPad Prism (Graphpad). 
 
2.12 Sh RNA Lentiviral Particle Transduction 
 
shRNA lentiviral particle transduction was used to silence RHBDF2 gene expression in human 
keratinocyte cell lines. 
 
Lentiviral particles were purchased from Santa Cruz biotechnology (Santa Cruz). The product 
is a pool of concentrated transduction ready viral particles containing 3 target-specific 
constructs which encode 19-25 nucleotide (plus hairpin) shRNA designed to knock down 
gene expression. 
 
Cells were plated at 2 x105 per well of a 6 well plate, which would resulted in 50-60% 
confluence after 24 hours. Cells were treated with Polybrene (Santa Cruz), a cation polymer 
used to increase the efficiency of infection of cells with the retrovirus. Polybrene was added 
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to the cells and incubated at 37°C for 20 minutes. The Polybrene media was then removed 
and to this the lentiviral particles (either RHBDF2 or negative scrambled shRNA sequence 
control) were added. This was optimized using different concentrations of particles. The cells 
were inclubated overnight at 37°C in complete media. In order to select stably transfected 
cells, Puromycin selection media was used. Cell lysates were obtained as previously 
described and analysed using SDS PAGE Electrophoresis and western blotting for iRHOM2 to 
determine gene silencing.  
 
2.13 Proliferation Assay 
 
Cells were plated at a seeding density of 1x104 per well and harvested at 24 and 72 hours 
and cell counts were performed using the Nucleocounter/Nucleocasette system 
(ChemoMetec, Denmark). 
2.14 Cell Migration Scratch Assay 
 
Cells were seeded at equal density on a 6 well plate and grown for 24-48 hrs in complete 
media (as described above) until a confluent monolayer was achieved. Cells were treated 
with Mitomycin C (400ng/ml) to prevent proliferation. A vertical scratch was performed 
using a 200 L Gilson pipette tip. Cultures were washed three times in PBS and incubated in 
media. Photographs were taken at 0, 18 and 24 hours. Wounded areas were measured using 
Image J software analysis. Results were analysed by students paired t-test using Graphpad 
Prism (Graphpad, San Diego, USA). 
 
2.15 PMA Treatment and ELISA 
 
Cells were plated at equal density (3x105 per well) on 6 well plates and grown for 24 hours 
in complete media. Cells were subsequently treated with 250ng/ml PMA. Media was 
collected at time points (4h, 24h) for ELISA. Collected medium specimens were analysed for 
the TNFα using the DuoSet ELISA kit (R&D systems, Abingdon, UK) and compared with 
untreated controls. In all cases data are presented as mean +/- SEM. Data shown represents 
the mean of at least three separate experiments for each cell lines. Results were analysed by 
students paired t-test using GraphPad Prism (Graphpad, San Diego, USA). 
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2.16 Okadaic Acid Treatment 
 
CTRL and TOC keratinocytes were seeded on coverslips in 12 well plates. After reaching the 
desired confluence, cells were incubated in media containing 1μM Okadaic Acid (Sigma) for 
1H. The media was replaced without Okadaic Acid and cells were fixed for immunostaining 
as described above at time points following the treatment (0H, 4H, 24H). 
 
2.17 Mouse Tissue 
 
All experiments involving mice followed the UK Animal Welfare Act guidelines and approval 
of the UK Home Office. irhom2 -/- mice were generated as previously described (Adrain et al., 
2012). All experiments were performed using age and sex matched littermates. 
 
The fore and hind-paw footpad epidermis from 20-week-old gender-matched irhom2 - /- and 
irhom2 +/+ mice (n=4 per genotype) were dissected and fixed in OCT on dry ice. 5µm sections 
were cut and mounted on slides. For histopathological analyses, sections were fixed in 4% 
PFA and stained with hematoxylin/eosin according to standard protocols. Epidermal 
thickness was measured using Image J software and analysed by students paired t-test (n=4) 
using GraphPad Prism (Graphpad, San Diego, CA, USA). 
 
Immunohistochemical staining was performed as previously described and visualised using 
the Zeiss 710 Confocal Microscope (Carl Zeiss, Germany)
2.18 DNA and RNA methods 
 
2.18.1 Patient samples 
 
All patient samples included in the work presented here were collected in accordance with 
the Declaration of Helsinki and approval of the East London and City Ethics committee. All 
informed patients provided written consent.  
2.18.2 Extraction of DNA from blood and skin 
 
DNA was extracted from whole blood samples using the QIAamp DNA blood midi/maxi kit 
(QIAGEN) following the manufacturer’s specifications 200 μl proteinase K was mixed with 1-
2 ml whole blood. 2.4 ml buffer AL were added and mixed by inversion of the tube, followed 
by incubation for 2 min. The tubes were incubated at 700C for 10 min, and mixed by inversion 
10 times with 2 ml 96-100% ethanol. This mixture was added onto the QIAamp Midi column 
placed in a 15 ml centrifuge tube and spun at 3000 rpm for 3 min. Firstly the column was 
washed with 2 ml of buffer AW1 followed by 2 ml buffer AW2 and spun between washes at 
5000 rpm for 1 min after the AW1 buffer and 15 min after the AW2 buffer. 300 μl buffer AE 
were added onto the membrane of the Midi column and incubated at room temperature for 
5 min followed by centrifugation at 5000 rpm for 2 min. DNA was resuspended in 200-300 μl 
distilled water by centrifugation at 5000 rpm for 3 min. 
 
Skin biopsy samples were obtained with written informed consent from patients with ARVC. 
In each patient, a 5mm punch biopsy was taken from unaffected skin from the left forearm. 
The fresh tissue was snap frozen on dry ice. 10*10 µm skin cryosections were used for DNA 
and RNA extractions with the QIAamp DNA and RNeasy mini kits (Qiagen, Hilden, Germany), 
following the instructions of the manufacturer. RNA was reverse transcribed into cDNA using 
SuperScript II (Invitrogen, Carlsbad, CA, USA).  
 
2.18.3 Nucleic acid quantification 
 
Nucleic acid concentration was measured using the NanoDrop ND-1000 Spectrophotometer 
(Thermo Fisher Scientific, Waltham, MA), according to the manufacturer’s specifications.  
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2.18.4 Polymerase Chain Reaction (PCR) 
 
Primer Design and Mutation Screening 
 
All primers were purchased from Sigma-Aldrich and specific primer pairs were designed  
using Primer3 software (v.0.4.0). The annealing temperature (AT) for each primer pair was 
optimised using a gradient PCR with temperatures varying between 55-65C PCRs for the 
screening of all mutations described in this report were performed using either the GoTaq 
DNA Polimerase (Promega, UK) or the BioTaq PCR Kit(Bioline, UK). 25 μl PCR reaction 
comprised: 5 μl of 5x (2.5 μl of 10x) reaction buffer, 1.5 μl of 25 mM (0.75 μl of 50 mM) 
MgCl2, 0.25 μl of 5 U/μl of Taq enzyme; 200 μM of each nucleotide (Bioline, UK); 1 μM of 
each primer and 20-30 ng of template DNA. Reactions were incubated on a DNA engine 
Tetrad 2 Peltier Thermocycler (MJ Research) and the cycling conditions consisted of 95°C for 
5 min,followed by 35 cycles of 95C for 30 s, optimised primer annealing temperature for 30 
s and 72°C for 30 s, with a final extension step at 72°C for 10 min and incubationat 40C for 
10 min. In addition to patient DNA, control DNA was used to amplify desired sequences. 
Resulting PCR products were resolved on a DNA agarose gel electrophoresis or digested with 
restriction digest enzymes  
 
Reverse Transcription-PCR (RT-PCR) 
 
Extracted RNA was used to make cDNA by RT-PCR. Briefly, 50 ng of RNA were added to 0.64 
μl random hexamers (200 μM), 1μl dNTPs (10 mM) made up to 12 μl final volume with dH2O. 
The reactions were incubated at 65C for 5 min, chilled on ice and 4 μl of 5x first strand buffer, 
2 μl of 0.1 M DTT and 1 μl RNase OUT (all Invitrogen, California, USA) were added to the 
reaction. The mixtures were then incubated at 25°C for 2 min before 1 μl (200 units) of 
superscript II reverse transcriptase (RT) (Invitrogen) was added. A negative control was 
simultaneously prepared using RNase free water instead of the enzyme. Samples were 
incubated at 42°C for 50 min, then by heat inactivation at 70°C for 15 min. 1 μl of cDNA was 
then added to a standard PCR.  
 
Agarose gels were then used to identify and separate PCR products and restriction digest 
fragments. To separate fragments shorter than 800 bp, 1.5% (w/v) agarose (Bioline, London, 
UK) gels were prepared.  Agarose was melted in the required volume of Tris-Borate-EDTA 
buffer and 0.5 μg/ml of ethidium bromide or 10 μl of 10,000x PAGE GelGreen (Biotium) were 
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then added to the solution. The mixture was poured into a gel tray with a comb to form the 
sample wells, and allowed left to solidify. The gel was flooded with TBE in an electrophoresis 
tank. For fragments longer than 800 bp, 1% (w/v) agarose gels were prepared. DNA samples 
were mixed with 6 x Orange G DNA loading buffer and loaded on the gel alongside a 1 Kb 
Plus DNA ladder (10% (v/v) (Invitrogen), 16% (v/v) loading buffer). Samples were 
electrophoresed at a voltage of 80-120V. DNA could be visualised and photographed under 
UV transillumination (MultiImage Light Cabinet, Alpha Innotech Corporation; pictures 
printed on Sony P-D890). 
 
Sanger Sequencing 
 
Sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, Foster City, CA). The optimal amount of PCR product (0.5-3 μl) was incubated 
with 6 μl ExoSAP-IT (Affymetrix) at 37°C for 45 min followed by 80°C for 15 min and 40°C for 
5 min; this enzymatic reaction removed any unincorporated primers and dNTPs. The Clean 
sequences were then added to a reaction containing 1 μl of BigDye® Terminator Master mix 
v3.1, 3 μl of better buffer (Microzone, Ottawa, Canada), 1 μl of 10 μM specific forward or 
reverse primer and ddH2O, to a final volume of 11.5 μl. Cycling conditions were as follows; 
25 cycles at 96°C for 30 s, 58°C for 15 s, 60°C for 1 min, followed by a final incubation at 40°C 
for 10 min. These reaction products were then precipitated with ethanol and EDTA. This 
mixture was centrifuged at 4000 rpm at 40C for 20 min and the pellet was washed with 125 
μl 70% ethanol and incubated on ice for a further 2 min, then centrifuged for 5 min at 4000 
rpm. Precipitated DNA was then air dried at room temperature. Precipitated products were 
resuspended in 10 μl HiDi formamide (Sigma-Aldrich, UK), incubated at 95°C for 3 min and 
on ice for 3 min, centrifuged for 2 min to remove air bubbles and loaded on the ABI Prism 
3130xl Genetic Analyser (Applied Biosystems, Life Technologies, USA). Traces were visualised 
using the Chromas LITE v 2.01 software (Free software from Technelysium Pty Ltd).  
 
Capture array 
 
Whole-exome capture performed using SeqCap EZ Human Exome Library v2.0 (Roche 
NimbleGen, Madison, WI) and sequenced with 100 bp paired-end reads on the HiSeq 2000 
platform (Illumina, San Diego, CA). Resulting reads were mapped to the hg18 human 
reference genome using the Novoalign alignment tool (Novocraft Technologies Sdn Bhd, 
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Selangor, Malaysia). Sequence variants were called with SAMtools and annotated with 
ANNOVAR (Wang et al., 2010). variants were filtered for homozygous changes shared by the 
two affected individuals, of which, 83 homozygous variants reported either as novel, or with 
an Exome Variant Server (NHLBI GO Exome Sequencing Project (ESP), Seattle, WA) estimated 
frequency of less than 0.01, were selected as potential candidates. 
 
2.19 Clinical Evaluation of Cardiac Patients for ARVC Project 
 
The project involved 6 families with a history of AC, specifically focusing on a cohort 
harbouring heterozygous N-terminal loss of function (nonsense/frameshift) mutations of 
DSP. The patients were recruited at the Heart Hospital, University College London Hospitals 
NHS Trust (UCLH), London, UK. Patients were diagnosed with AC according to the revised 
Task Force Criteria. Individuals were examined from cardiac and cutaneous perspectives. 
Systematic evaluation of first and second degree family members was performed in whom 
mutation-carrier status was verified. In total, personal history of cutaneous features was 
collected from 58 family members, 38 mutation carriers, including five deceased members, 
and 20 non-carrier healthy family members. All 33 living mutation carriers were recruited for 
detailed phenotyping, while 8 of them had 3mm punch biopsies of non-lesional skin of the 
lower forearm collected for molecular characterisation. Personal history of cutaneous 
features was collected, and detailed clinical examination of the skin and hair phenotype was 
carried out by a dermatologist (TM). Cardiac phenotyping was performed according to the 
protocol described in 30 family members (3 of the 33 carriers resided abroad and were 
therefore unavailable to participate in cardiac phenotyping). Arrhythmic characterization 
included arrhythmia recorded during 24 hour ambulatory ECG monitoring and/or exercise 
testing, cardiac arrest (CA), implantable cardioverter defibrillator (ICD) appropriate 
discharges. Patients with atypical chest pain, palpitations and/or syncope suggestive of vaso-
vagal origin were considered asymptomatic. All patients provided written informed consent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
iRHOM2 Regulates Cytoskeletal Stress-
Associated Keratin 16 
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3.1 Identifying Novel Interacting Binding Partners of iRHOM2 – 
Yeast 2 Hybrid Screen 
 
The Yeast 2 Hybrid screen which was performed in a 3-D human skin library (composed of 
proteins extracted from the Episkin library) to assess for novel protein-protein interactions, 
yielded 15 potential novel interacting binding partners with the N-terminus (aa1-403) of 
iRHOM2.  Each protein interaction was assigned a confidence score from A to E to rank the 
plausibility of the interaction. The score is derived from the Hybrigenics database and 
number of independent prey fragments identified by the screen (Figure 3.1).  Scores 
between A and C are suggestive of a genuine interaction. 112x104 potential preys were 
screened and 22 positive results were obtained. Of these, 9 positive preys were Type I 
keratins, each receiving the highest attributable confidence scores (A or B). These three 
keratins were K10, K14 and K16. All three are highly expressed in mammalian epithelia in a 
site and situation specific manner.  
 
Bait Prey 
clone 
library 
His+/Ade+/Laz+ 
prey clones 
True 
prey 
clones 
K10 
fragment 
prey 
clones 
K14 
fragment 
prey 
clones 
K16 
fragment 
prey 
clones 
Human 
RHBDF2 
N-
Terminus 
(aa1-403) 
112 x 
106 
28 22 3 4 2 
Figure 3.1 Table illustrating the positive prey clones identified by the Yeast 2 Hybrid screen.  
9 of the 22 prey clones identified are Type I keratins. The remaining clones scored less than 
C and are therefore less likely to represent a genuine interaction.  
 
3.2 Identification of Potential Binding Domain  
 
The Yeast 2 Hybrid screen identified a positive interaction between iRHOM2 and multiple 
fragments of each of the three keratins K10, 14 and 16. In order to identify a potential 
interacting domain, the overlapping regions of the positive prey fragments were compared. 
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The overlapping fragments from the two K16 prey fragments were located in their protein 
maps (www.uniprot.com), and found to correspond to the Coil 1B domain of the keratin 
filament. This was confirmed using the prey fragments for the two other Keratins identified 
by the screen (Figure 3.2 and 3.3).  
 
The amino acid sequence of the Coil 1B domain for each of the three keratins was inserted 
into the Clustal Sequence Alignment tool and sequence homology for this region was 
determined as 86.67% between the three keratins (Figure 3.4). This fell to 60% homology 
when type II keratins such as K1 were included suggesting that the conserved Coil 1B domain 
of the keratins 10, 14 and 16 is the region likely to be interacting with N-Terminus iRHOM2. 
The high degree of conservation also points to an important role for this region, which will 
be discussed later in the chapter.  
 
 
Figure 3.2 K16 prey fragments identified by the Yeast 2 Hybrid screen, both of which span 
the Coil 1B domain of K16. Below, K16 amino acid sequence. Bold letters refer to identified 
prey region starting form amino acids 167-310, underlined letters correspond to the Coil 1B 
domain.   
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Figure 3.3. Clustal sequence alignment demonstrating sequence homology between the 
amino acid sequence of K10, K14 and K16 (ordered from highest to lowest line) in a region 
corresponding to the the Coil 1B Domain (red box). 
 
 
 
K16 K10 K14 
K16 100 81.67 86.87 
K10 81.67 100 86.67 
K14 86.67 86.67 100 
 
Figure 3.4 Table shows Clustal sequence alignment homology score (%) between the K10, 14 
and K16 for the Coil 1B domain.  
 
The interaction between iRHOM2 and Keratin 16 was the focus of further study presented 
in this chapter. The rationale for this is that Keratin 16 is known to be a wound healing 
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keratin, and TOC is associated with several features of aberrant wound healing and, patients 
with TOC show phenotypic features restricted to sites known to express Keratin 16; palms, 
soles, perifollicular area, oral mucosa and in squamous cell carcinoma of the 
oesophagus(Brooke et al., 2014, Ellis et al., 2015).  Furthermore, Keratin 16 is a known 
tumour marker in head and neck and oesophageal cancer(Villaret et al., 2000).  
 
 
3.3 Confirmation of Interaction between iRHOM2 & Keratin 
16. 
 
3.3.1 Co-Immunoprecipitation 
 
Co-immunoprecipitation (Co-IP) was used to confirm that iRHOM2 and Keratin 16 form a 
complex. Initially, the technique was optimized at length with known binding partners, 
ADAM17 and iRHOM2 (outlined in Materials and Methods).  Binding between endogenous 
ADAM17 and iRHOM2 was confirmed in several cell lines including K17, TYLK1 and TYLK2 
(Figure 3.5).  
 
Figure 3.5. Endogenous Co-IP performed in Control and TOC keratinocytes (TYLK1 and TYLK2) 
using iRHOM2 to pull down ADAM17.  Antibodies used: Rabbit anti-RHBDFR (HPA018080 
Sigma) and Rabbit anti-ADAM17 (Ab2051, Abcam) 
 
Further Co-IPs were performed using endogenous proteins in HaCaT keratinocytes. This 
demonstrated that K16 was able to pull-down iRHOM2. Furthermore, iRHOM2 was able to 
pull down K16. iRHOM1 and iRHOM2 are family members which share the ability to bind 
ADAM17, therefore it was assessed whether iRHOM1 was able to interact with K16. 
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However, this pull down experiment was negative, suggesting that the interaction between 
iRHOM2 and K16 is exclusive (Figure 3.6A). 
 
To further validate the results of the yeast 2 hybrid screen, which used the N-Terminus of 
iRHOM2 as bait, the N-Terminus of iRHOM2, tagged with GFP, was overexpressed in HaCaT 
keratinocytes. Co-immunoprecipitation was performed using K16 to pull down GFP, and this 
confirmed that the N-Terminus region alone is able to bind K16 (Figure 3.6B). Using a 
construct lacking the N-Terminus of iRHOM2 (DNT-iRHOM2) tagged to HA, it was also 
confirmed that iRHOM2 lacking the N-Terminus domain was unable to bind K16 (Figure 
3.6C).  These constructs were a kind gift from the Freeman Laboratory.  
 
Figure 3.6 (A) Co-immunoprecipitation performed in HaCaT keratinocytes showing pulldown 
of iRHOM2 by K16. K16 does not pull down iRHOM1 (B) cell extracts from CTRL keratinocytes 
transfected with a vector expressing HA-tagged iRHOM2 lacking its N-Terminus (iRHOM2-
∆NT-HA) were immunoprecipitated with anti-K16 antibody and analyzed by western blot 
with anti-HA and anti-K16 antibodies. (C) Cell extracts from Control keratinocytes 
transfected with a vector expressing NT-iRHOM2-GFP were immunoprecipitated with anti-
K16 antibody and analyzed by western blot with anti-GFP and anti-K16 antibodies. 
 
 
3.3.2 Co-localisation Immunohistochemistry 
 
In cells, iRHOM2 is expressed predominantly in the cytoplasm (particularly endoplasmic 
reticulum) and at the cell surface memrane. WT-iRHOM2-GFP was overexpressed in HaCaT 
keratinocytes and co-staining with K16 was performed. Regions of yellow in the merged 
image suggest that both proteins are present in the same place, at the same time. This can 
be seen more clearly in the subtraction PDM (Pseudocoloured product of the differences of 
the mean) images which highlight areas of co-localisation in orange. In addition to diffuse 
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perinuclear co-localisation, there are also more discrete punctate areas of co-localisation 
throughout the cytoplasm. Co-localisation was not observed at the cell surface membrane 
which is likely to be because K16 localisation is predominantly cytoplasmic. 
 
 
Figure 3.7 Confocal microscopy analysis of GFP-tagged iRHOM2 overexpressed in HaCaT 
keratinocytes showing co-localisation with endogenous K16 (red). In the merged image, 
yellow regions are suggestive of co-localisation. Pseudocolored ‘product of the differences 
from the mean’ (PDM) image visually quantifies co-localisation, in which each pixel is equal 
to the PDM value at that location, are shown with a PDM scale. Scale Bar:20 μm. 
 
3.3.3 Proximity Ligation Assay 
 
Proximity ligation assay (PLA) is a technique used to identify protein-protein interactions 
where each red fluorescent dot suggests a discrete protein-protein interaction.  In HaCaT 
keratinocytes, PLA was used to demonstrate close proximity of endogenous K16 and 
iRHOM2.  In cells, K16 usually exists as a heterodimer with its known Type 1 Keratin binding 
partner K6 (Moll, 1998), and this interaction was used as a positive control for this 
experiment. PLA confirmed a positive interaction between iRHOM2 and K16, with red 
fluorescent signals distributed predominantly within the cytoplasm (Figure 3.8).   
 
iRHOM2-GFP Keratin 16 
Merge PDM 
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Figure 3.8. PLA in HaCaT keratinocytes shows red fluorescent signals (red dot) in the positive 
control (K6 and K16) and K16-iRHOM2. Each red dot signifies a single protein-protein 
interaction. The nucleus is counterstained with DAPI. Negative control performed in the 
absence of primary antibodies. The left panel is a positive control demonstrating a protein-
protein interaction between K6 and K16. The middle panel demonstrates cytoplasmic red 
fluorescent signals suggesting interaction between iRHOM2 and K16 in HaCaT keratinocytes.  
 
Considered with the binding studies above, these data support a genuine and novel 
interaction between iRHOM2 and K16. 
 
 
3.4 iRHOM2-Keratin 16 interaction in TOC 
 
3.4.1 Phenotypic Similarity between TOC and Pachyoncyhia Congenita Type I 
 
TOC bears several phenotypic similarities to  Pachyonychia Congenita Type I (PC-1) caused 
by autosomal dominantly inherited mutations in either K16 or K6A. These include the 
presence of a focal, non-epidermolytic palmoplantar keratoderma (FNEPPK), perifollicular 
hyperkeratosis, oral leukokeratoses in addition to the presence of multiple steatocystomas 
(Figure 3.9).  However, the presence of oesophageal SCC is unique to TOC, despite this, the 
marked clinical similarity between the two inherited diseases supports a shared 
pathophysiological mechanism.  Mutations in K16 associated with PC-1 occur in the 1A and 
2B domains and are thought to exert a dominant-negative effect on the wild-type protein 
(Liao et al., 2007) Over-expression of PC-associated mutant K16 in keratinocytes results 
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nuclear reorganization of the K16 filament network and some collapse of the endogenous 
cytoskeletal network (Smith et al., 2000).  It is thought that this collapse of the keratin 
filament network contributes to the clinical phenotype.   
 
 
Figure 3.9 Clinical similarities between TOC and PC-1: Yellow, hyperkeratotic thickening of 
the soles bilaterally at sites of pressure (focal non-epidermolytic PPK), Leukokeratoses of the 
mouth and tongue (oral mucosal hyperkeratosis), Steatocystomas (sebum-containing dermal 
cysts) and perfollicular hyperkeratosis (accumulation of scale around the hair follicle) 
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3.4.2 The Role of K16 in TOC 
 
Tylosis Keratinocytes (TOC) have been derived from patients harboring gain of function 
mutations in iRHOM2 and were use to gain insight into the functional relevance of the 
interaction between iRHOM2 and K16. Following informed consent, biopsies were harvested 
from interfollicular affected skin (papules) from a male and female Tylosis patient. As a 
normal control, breast skin from a 31 year old healthy female and leg skin from a 45 year old 
healthy female (K1 and K17 control cell lines) were also collected.  Cells were immortalized 
with HPV16(E6/E7) as described previously (Rheinwald & Green, 1975) and experiments 
were carried out on cells that had been passaged between 10 and 40 times.  
 
Firstly, western blotting demonstrates that K16 levels are increased in TOC keratinocytes 
compared with controls (Figure 3.10A). This was confirmed by Immunohistochemistry which 
showed strikingly increased K16 in lesional TOC skin biopsy compared with control 
interfollicular skin. In TOC, the epidermis also appears to be slightly thickened compared with 
normal control skin (Figure 3.10B). TOC keratinocytes have previously been shown to be 
hyperproliferative and this could explain the presence of a thickened epidermis (Blaydon et 
al., 2012). K16 is not usually expressed in the normal interfollicular epidermis, however its 
expression can occur in response to injury and in disease states such as psoriasis and 
squamous cell carcinomas (Bernot et al., 2002)  
 
Further confirmation of these findings was sought from 3D organotypic human skin 
equivalents derived from Control (CTRL) and TOC keratinocytes (organotypic culture 
performed by Benjamin Fell). Like Tylotic skin, the TOC organotypics were thickened and also 
showed upregulation of K16 throughout the epidermis compared with Control Organotypics 
(Figure 3.10C). iRHOM2 immunostaining is not shown here but has previously been shown 
to be comparable between TOC and control skin, with slightly increased cytoplasmic staining 
in TOC (PhD Thesis, Sarah Etheridge).  
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Figure 3.10 (A) Western blotting of cell extracts from Control and TOC keratinocytes 
immunoblotted for K16 (54KDa) showing upregulation of K16 in TOC. (B) 
Immunohistochemical staining of K16 (green) in normal and TOC skin. (C) 
Immunohistochemical staining of K16 (red) in 3 Dimensional Organotypics derived from 
control or TOC keratinocytes. Scale bars  20μm. Negative controls Appendix Figure B.1. 
 
 
To determine whether the N-Terminus mutation in iRHOM2 could affect its interaction with 
K16, Co-IP pull down assays were performed using control and TOC cell lysates, normalized 
for protein content using a Bradford Assay. This IP confirmed increased interaction between 
iRHOM2 and Keratin 16 in TOC keratinocytes compared with controls (Fig 3.11A). The extent 
of binding was quantified by performing densitometry on the IP western blotting bands in 
control and TOC from three independent experiments and normalized for input. The bar 
graph demonstrates this quantification, showing that there is a significantly increased 
iRHOM2-K16 pull-down in TOC compared with control keratinocytes (Figure 3.11B).  
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Figure 3.11 (A) CTRL and TOC keratinocyte lysates were immunoprecipitated with anti-K16 
antibody and analyzed by western blotting with anti-iRHOM1 and anti-iRHOM2 antibody. (B) 
Graph depicting fold change of iRHOM2 pull-down by K16 in TOC cells compared to CTRL 
(n=3), error bars denote SD, *P<0.05 
 
As a negative control, iRHOM1 was shown not to pull down K16 in both control and TOC cells 
however it could bind to its known partner ADAM17 in the same experiment (3.12A).  As a 
negative control, iRHOM2 was shown not to bind to another intermediate filament (Vinculin) 
(3.12B). 
 
A      B  
 
Figure 3.12(A) CTRL and TOC keratinocyte lysates were immunoprecipitated with anti-
iRHOM1 antibody and analyzed by western blotting with anti-K16, anti-ADAM17 and anti-
iRHOM1 antibody. (B) CTRL and TOC keratinocyte lysates were immunoprecipitated with 
anti-iRHOM2 antibody and analyzed by western blotting with anti-K16, anti-iRHOM2 and 
anti-Vinculin antibody.  
 
PLA was used to assess the apparent increased interaction between iRHOM2 and K16 in TOC 
compared with control keratinocytes. Increased signal intensity was observed in TOC 
compared with control (Figure 3.13A). Quantification of the signal intensity was performed, 
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relative to the DAPI to normalize for cell number. In total, 36 images were examined from 
three independent experiments for each cell type. The data are depicted in the bar graph 
(Figure 3.13B). Statistical analysis using the unpaired student’s t test confirmed a significantly 
increased interaction between iRHOM2 and K16 in TOC.  
 
Figure 3.13 (A) Proximity ligation assay (PLA) between iRHOM2 and K16 analyzed by confocal 
microscopy in CTRL and TOC keratinocytes. (B) Graph represents quantification of red 
fluorescent PLA signals relative to DAPI. (blue) Mean of 3 experiments, each experiment 
comprising 12 separate images. Error bars denote SD. *P<0.05.  
 
These findings suggest that the iRHOM2 N-Terminus gain-of-function mutations in TOC are 
associated with increased interaction with K16.   
 
3.4.3 iRHOM2 regulates the reorganisation of K16 filaments 
 
In humans, TOC manifests itself initially as hyperkeratotic thickening of the plantar and to a 
less extent palmar epidermis. K16 is one of only three keratins known to be consitutively 
expressed in the palmoplantar epidermis. Taking this into consideration, and in light of the 
findings presented so far, it suggests that iRHOM2 may play a role in the epidermal response 
to physical stress.  
 
In order to recapitulate mechanical footpad stress in vitro, CTRL and TOC keratinocytes were 
cultured in monolayer on flexible membranes and subjected to 4 hours of oscillating 
mechanical stress using the FlexcellTM system. The time-point of four hours was selected 
because K16 has been shown to be rapidly induced in injured epithelia within 4 hours of 
injury (Paladini et al., 1996) . Both CTRL and TOC cells showed upregulation of K16 and a 
perinuclear distribution of the filament network (Figure 3.14), which was more pronounced 
in TOC cells. Although keratins are key scaffolding proteins in epithelia, they are highly 
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dynamic structures and are able to rearrange themselves in response to specific stimuli to 
permit alterations in cell size and shape (Windoffer et al.,2011) 
 
 
Figure 3.14. CTRL and TOC keratinocytes were subjected to cyclical mechanical stretch at a 
frequency of 5hz and amplitude 10-13% using Flexcell FX-4000 Tension system for 0h and 
4hrs respectively. Stretched cells were immunostained for K16 and and analyzed by confocal 
microscopy. White arrowheads indicate perinuclear K16 filaments reorganization. Scale Bar: 
20μm 
 
In fact, TOC cells demonstrated increased perinuclear localisation of K16 even prior to stress, 
which is seen more clearly in greyscale images (Figure 3.15A). The percentage of cells with a 
perinuclear keratin network was quantified using a new methodology previously described 
by Feng and Coulombe (Feng and Coulombe, 2015).  This quantification showed a 
significantly higher percentage of cells with a perinuclear K16 keratin network in TOC 
keratinocytes compared with controls (Figure 3.15B) 
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Figure 3.15 (A) 16-bit greyscale images of K16 immuostaining in Control and TOC 
keratinocytes more clearly reveals the perinuclear arrangement of K16 in TOC cells. (B) 
Quantification of the perinuclear localization of K16 filaments in CTRL and TOC cells. Data 
represent the mean of 3 independent experiments, each experiment comprising 30 images 
per cell line. Error bars denote SD. **P<0.01 
 
To more clearly delineate the role of iRHOM2 in perinuclear reorganization of the K16 
network, Wild-Type (WT) or TOC iRHOM2-GFP constructs (made by Diana Blaydon) were 
overexpressed in HaCaT keratinocytes. Immunostaining for K16 was performed and confocal 
microscopy showed that the K16 filament network was relatively unchanged in cells 
transfected with WT-iRHOM2-GFP. However, in cells overexpressing TOC mutant-iRHOM2 
GFP, K16 showed a perinuclear redistribution.  Following mechanical stretching, both WT 
and Mutant transfected cells showed a striking perinculear relocalisation of the K16 filament 
network (Figure 3.16).  
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Figure 3.16. HaCaT keratinocytes were transfected with either Wild-type or TOC mutant 
iRHOM2-GFP and subjected to 4 hours of cyclical mechanical stretching using the Flexcell FX-
4000 tension system for 0h and 4 hours respectively. Cells were immunostained for 
endogenous K16 and analysed by confocal microscopy. 
 
In situ PLA was performed using probes for iRHOM2-GFP and K16 to determine whether the 
reorganization of K16 in stretched cells was linked to interaction between iRHOM2-GFP and 
K16. This showed an intense aggregation of peri-nuclear signal intensity, implying that peri-
nuclear reorganization of the K16 filament network is associated with iRHOM2-K16 
interaction. 
 
Figure 3.17 PLA of GFP (green) and K6 (red) in cells overexpressing either WT-iRHOM2-GFP 
or TOC-mutant-iRHOM2-GFP following 4H cyclical stretching. Images analysed by confocal 
microscopy.  
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This data suggests that iRHOM2, particularly the TOC-mutant form, plays a role in regulating 
K16 in response to mechanical stress, specifically, it appears to regulate perinuclear 
reorganization of the K16 filament network.  
 
3.4.4 K16 and K6 are differentially regulated in TOC 
 
K16 is a type I keratin that forms heterodimers with its type II binding partner K6. To assess 
the specificity of the effect of TOC on K16, western blotting was also performed for K6. 
Unexpectedly, levels of K6 were reduced in TOC cell extracts (Figure 3.18A). In addition, 
immunohistochemistry of TOC skin showed almost absent K6 despite the presence of 
abundant K16. Confocal analysis of TOC cells showed poorly formed K6 filaments that were 
reduced to cytoplasmic aggregates compared with the branch like filament network 
observed in CTRL keratinocytes, whereas K16 had previously been shown to be present in 
both cell lines (Figure 3.18B).  
 
 
Figure 3.18 (A) Western blot analysis of endogenous expression of K16 and K6 in CTRL and 
TOC keratinocytes. GAPDH was used as a loading control. (B) Confocal analysis showing 
reduced K6 expression in TOC keratinocytes. Scale Bar: 20μm Negative control Appendix 
Figure B.2 
 
PLA was performed in control and TOC keratinocytes to assess the extent of interaction 
between K6 and K16 in the two cell types. This showed significantly reduced interaction 
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between K6 and K16 in TOC (Figure 3.19), the same cells which had previously shown 
increased interaction between iRHOM2 and K16 (Figure 3.12), suggesting a switch in the 
binding partner of K16 in TOC.  
 
Figure 3.19 PLA between K6 and K16 analyzed by confocal microscopy. The graph shows 
quantification of red fluorescent PLA signals relative to DAPI. Mean of 3 experiments, each 
experiment comprising 12 separate images. Error bars denote SD.*P<0.05. Scale Bar: 20μm 
 
Overexpression of both WT and Mutant iRHOM2-GFP in HaCaT Keratinocytes also results in 
reduced K6. Immunohistochemistry of transfected cells shows reduction of K6 in cells 
showing GFP signal, and on closer examination, K6 appears distributed as cytoplasmic dots 
in transfected cells, similar to its appearance in TOC cells (Figure 3.18B) supporting the 
hypothesis that increased iRHOM2 activity is associated with reduced K6 however the 
mechanism remains undetermined.  
 
 
Figure 3.20 CTRL keratinocytes were transfected with either WT-iRHOM2-GFP or TOC 
Mutant-iRHOM2-GFP and immunostained for endogenous K6 and analyzed by confocal 
microscopy. K6 expression is reduced in transfected cells (white arrowhead) Scale Bar: 20μm. 
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In contrast, shRNA knock-down of iRHOM2 in TOC cells resulted in restoration of K6 levels 
comparable to control keratinocytes (Fig. 3.21A).  Re-expression of K6 was also shown to 
occur in 3-D organotypics derived from sh-iRHOM2 TOC cells (Fig. 3.21B), in contrast to 
reduced K6 expression in Control 3D cultures, whereas K16 was reduced in both sh-iRHOM2 
cell lines (Fig 3d).  
 
 
 
Figure 3.21 (A) Western blot analysis showing that IRHOM2 depletion by ShRNA reduces the 
expression of K16 in CTRL and TOC keratinocytes while it restores expression of K6 in TOC 
keratinocytes. GAPDH was used as a loading control (B) Confocal analysis showing the 
reduction of K16 expression but upregulation of K6 in Sh-iRHOM2 TOC 3D human skin 
equivalents. Scale bars: 20μm. Negative control Appendix Figure B.3 
 
Intriguingly, qPCR (by Matthew Brooke) showed that K6 mRNA levels were significantly 
reduced in TOC cells, where K16 mRNA levels were increased, suggesting that the regulation 
of these two keratins also occurs at transcriptional level (Figure 3.22).  
 
 
 
 
TOC B 
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Figure 3.22 Graphs depicting fold change of mRNA expression of K16 and K6 in CTRL and TOC 
keratinocytes measured by qPCR. (n=3) error bars denote SD, *P<0.05 
 
These data imply that the gain-of-function mutant form of iRHOM2 in TOC, is associated with 
increased interaction with K16 and reduced levels of K6 at both mRNA and protein level, 
suggesting a reciprocal regulation of K6 and K16. A potential mechanism for this comes from 
the results of the Yeast-2 Hybrid screen.  The two prey clone K16 fragments found to interact 
with the iRHOM2 N-Terminus bait, share a 143 amino acid overlapping region which 
corresponds to Coil 1B of K16 (Figure 3.2). Keratins are composed of head and tail domains 
well as central helical coiled-coiled domains (Coil 1A, 1B 2A and 2B) each with specific 
functions (Steinert et al., 1994). The Coil 1B domain plays a role in heterodimerisation 
between type I and II keratins (Bernot et al., 2005) . Increased binding of iRHOM2 to the coil 
1B domain of K16 in TOC could therefore physically impair dimerization with its binding 
partner K6 and potentially contribute to its downregulation and/or degradation. This data 
implies that differential modulation of K16 and K6 expression is likely to be iRHOM2-
dependent. 
 
 
3.4.5 iRHOM2 regulates the dynamicity of K16 filaments 
 
Keratin filament cycling plays a key role epithelial migration and proliferation particularly in 
response to injury. Retraction of rigid keratin filaments from the cell periphery results in 
cytoplasmic softening, facilitating the changes in cell size and shape required for motility and 
cell division (Beil et al., 2003) .  
 
In TOC, both migration and proliferation rates are increased compared with control 
keratinocytes and reportedly similar to those observed in wound-edge keratinocytes 
KRT6AKRT16
*
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(Blaydon et al., 2012). Therefore, we sought to assess whether the interaction between 
iRHOM2 and K16 could alter filament cycling.  
 
Okadaic Acid (OA) is a protein phosphatase inhibitor derived originally derived from shellfish 
and is widely used in Keratin studies to induce hyperphosphorylation of the keratin filaments 
which then aggregate into cytoplasmic “dots” (Busch et al., 2012). Control and TOC 
keratinocytes were treated with OA for 1 hour, which disassembled keratin filaments into 
cytoplasmic aggregates.  To determine whether filament cycling was altered in TOC, OA-
treated cells were monitored at time-points following treatment to observe how rapidly the 
K16 cytoskeletal architecture was able to recover (Figure 3.23).  
 
Figure 3.23. Confocal analysis of CTRL and TOC keratinocytes treated with 1μM Okadaic Acid 
for 1 hour, then fixed at 4H and 24H timepoints following treatment and immunostained for 
K16. White arrowheads represent aggregated K16 filaments. Scale Bar: 20μm 
 
4 hours following treatment, CTRL cells show limiting recovery, with few filaments reformed.  
In TOC cells however, there is partial recovery.  24 hours following treatment with OA, TOC 
cells show almost complete normalisation of K16 filaments however, in CTRL cells, K16 
filaments remain partially aggregated in the cytoplasm. These data qualitatively suggest that 
K16 turnover is more dynamic in TOC keratinocytes because the filaments returned to their 
normal pattern more rapidly following treatment, and this phenomenon could be related to 
upregulated iRHOM2 activity.  
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3.5 The role of iRHOM2 in Migration, Proliferation and 
Inflammation 
 
As discussed previously, TOC is characterized by features of “constitutive” wound healing, 
namely, upregulated migration, proliferation and inflammation compared with control 
keratinocytes.  To validate these observations, iRHOM2 was depleted from Control and TOC 
keratinocytes using shRNA iRHOM2 lentiviral particles. Sh Scramble was used as a control in 
both cell lines. The efficacy of knock down was checked at mRNA level by qPCR and at protein 
level by western blotting, both of which showed a robust reduction in the expression of 
iRHOM2 (Fig 3.24A and B).  Western blotting showed reduced K16 in both control and TOC 
shiRHOM2 cells, with almost complete loss of K16 in control keratinocytes, supporting a link 
between the expression pattern of the two proteins. 
 
 
A     B 
 
 
 
Figure 3.24 (A) Western blotting of iRHOM2 in control and TOC cell lysates, GAPDH used as 
a loading control.(B) qPCR for iRHOM2 in HaCaT or T2 cells treated with either scramble (SB) 
or iRHOM2 ShRNA.  
 
   
K16 is highly expressed at the wound edge and also in several epithelial cancers (Moll et al., 
1982). TOC Keratinocytes exhibit increased migration and proliferation rates, similar to that 
observed in wound edge keratinocytes and epithelial cancers (Blaydon et al., 2012).  We 
therefore hypothesised that the interaction between iRHOM2 and K16 could play a role in 
these cellular events. A proliferation assay was performed using shiRHOM2 CTRL and TOC 
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keratinocytes, measuring cell counts at 48 and 72 hours after plating.  This showed a 
reduction in proliferation rates in both cell lines in the absence of iRHOM2 (non significant).  
In fact, knock-down of iRHOM2 returns the proliferation rates of TOC cells to a level 
comparable to CTRL keratinocytes, thereby “normalising” their behaviour (Figure 3.25) 
.   
 
       24h             72h 
Figure 3.25. Proliferation assay performed in Growth curves of cultured cells for Sh-Scr, Sh-
IRHOM2 in CTRL and TOC keratinocytes showing slower growth rates for Sh-iRHOM2 cells in 
both cell lines. (Mean of 3 experiments ±SD) 
 
shiRHOM2 Control and TOC cells were also used to generate 3-Dimensional organotypics 
(Benjamin Fell). Immunostaining of these organotypics demonstrated reduced expression of 
K16 throughout the organotypic “epidermis” (Figure 3.26).   
 
 
Figure 3.26. Confocal analysis of 3D organotypics derived from shScr or ShiRHOM2 Control 
and TOC keratinocytes demonstrating reduction of K16 throughout the epidermis when 
iRHOM2 is depleted. Scale bars: 20μm 
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Figure 3.27. Confocal analysis showing the reduction of the proliferation marker Ki67 
expression in ShIRHOM2 TOC 3D human skin equivalents. Scale bars: 20μm. Negative control 
Appendix Figure B.4 
 
 
The proliferation marker, Ki67 was also reduced throughout the epidermis of shiRHOM2 TOC 
organotypics (Figure 3.27). Taken together, these observations suggest that depletion of 
iRHOM2 is associated with reduced K16 and impaired proliferation in control and TOC 
keratinocytes.  
 
 
Scratch-wound assays can be used to demonstrate cell migration in monolayer and migration 
is a key event not only in wound-healing but also tumourigenesis, contributing to metastasis.  
We performed scratch-wound assays using shiRHOM2 CTRL and TOC cells cultured in a 
confluent monolayer. These cells were pre-treated with Mitomycin C, a proliferation 
inhibitor to ensure that closure of the “wound” was not due to cell proliferation. Previously, 
our group has shown that TOC cells can close a scratch wound rapidly, within 4 hours. 
However, when iRHOM2 is depleted, migration is significantly abrogated, and as such the 
scratch remains open even after 24 hours in TOC shiRHOM2 cells (Figure 3.28A).  
Quantification of the percentage wound closure after 24 hours was performed an confirmed 
a significant reduction in wound closure in both Control and TOC shiRHOM2 cells, however 
shiRHOM2TOC cells were still able to migrate slightly faster than shiRHOM2 control cells 
(21.3% vs 4.9%)(Figure 3.23B). These findings suggest that iRHOM2 contributes to migration 
in both control and TOC keratinocytes (Figure 3.28B). 
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Figure 3.28 (A) Light-microscopy images of CTRL and TOC keratinocyte monolayers 0H and 
24H after scratch-wounding. (B)Graph shows quantification of wound closure as a 
percentage, mean of 3 experiments. Error bars denote SD *P<0.05, ***P<0.001  
 
iRHOM2 regulates the trafficking and maturation of ADAM17, a pivotal membrane bound 
sheddase which cleaves a number of substrates by ectodomain shedding, notably TNFα. 
Processing of ADAM17 by iRHOM2 results in cleavage of its prodomain, resulting in an active 
“mature” form (Adrain et al., 2012).  Both control and TOC cells depleted of iRHOM2 show 
decreased levels of mature ADAM17 (Figure 3.29A). Mature ADAM17 is required for TNFα 
shedding from the cell surface membrane. To test whether depletion of iRHOM2 also results 
in dampened TNFα release from cells, control and TOC shiRHOM2 keratinocytes were 
treated with PMA or a vehicle control (DMSO). PMA is known to increase TNFα release from 
keratinocytes by activating ADAM17. However, in shIRHOM2 cells, TNFα release is 
significantly reduced at both 4h and 24h timepoints in resonse to PMA (ELISA by Paul 
Delaney), presumably due to impaired maturation of ADAM17 (Figure 3.29B).  
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Figure 3.29 (A)Western blot analysis showing the modulation of ADAM17 in normal (K17) 
and TOC shiRHOM2 keratinocytes. GAPDH is used as a loading control. (B) Reduced shedding 
of ADAM17 substrate TNFα measured by ELISA in CTRL and TOC keratinocytes depleted of 
iRHOM2 (shiRHOM2) after stimulation with 250ng/ml PMA for 0, 4 and 24 hours. (n=3) Error 
bars denote SD *P<0.05. 
 
Although K16 is known to play a pivotal role in both migration and proliferation, substrates 
of ADAM17, activated by iRHOM2, can also contribute, particularly TNFα.  It is therefore 
possible that reduced ADAM17 maturation and therefore substrate shedding could also 
cause the changes in cell behavior resulting from iRHOM2 depletion.   
 
3.6 Examination of IRHOM2 KO mice paws reveal a thinner 
epidermis  
 
To validate the in vitro observations, we collaborated with Prof Matthew Freeman’s group 
at the University of Oxford, who provided us with access to irhom2 knockout (irhom2 KO) 
mice. These mice have been reported to be physically similar to irhom2 WT mice (McIlwain 
et al., 2012, Adrain et al., 2012) however, when they were re-examined, a striking difference 
in the paws of 20 week old adult mice was observed.  In all mice examined, the forepaws and 
hindpaws revealed diminution of the stress-bearing footpads.  The footpad skin also 
appeared pale and translucent when compared with their wild-type littermates who 
displayed hyperpigmentation and hyperkeratosis typical for their age (Figure 3.30A).  The 
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forepaw and hindpaw footpads of 4 WT and 4 KO littermates were excised. Multiple tissue 
sections were stained with haematoxylin and eosin and thickness of the epidermis was 
measured using Image J (Figure 3.30B). Measurements were taken through the thickest part 
of the footpad epidermis. 10 measurements were taken from each 5 separate sections from 
each mouse (n=4) and statistically analysed using the unpaired students t test.  This data is 
presented as a bar graph. In keeping with the examination findings, there was a significant 
reduction in footpad thickness in irhom2 KO mice (Figure 3.30C). However, there was no 
significant difference in the thickness of their back skin. Interestingly, the back skin does not 
constitutively express K16 and nor is it subjected to physical stress like the footpads.  
 
Immunohistochemical staining of the paws was performed for K16 and revealed diminished 
expression throughout the footpad epidermis in irhom2 KO mice compared with wild-types 
(Figure 3.30D).  As a control, the expression of the palmoplantar specific Type 1 Keratin, K9, 
was also assessed. K9 was not identified by the original Yeast-2-Hybrid screen as a potential 
interacting binding partner with irhom2. Levels of K9 in the irhom2 KO mice were 
comparable to WT mice (Figure 3.30E).  
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Figure 3.30 (A) The hind paws of 16-week-old irhom2 KO and irhom2 WT littermates (n=4 
per genotype) were photographed, revealing pallor and diminution of the major stress-
bearing paw footpads calluses (black arrowhead) in adult irhom2 KO mice.(B) Haematoxylin 
and eosin-stained cross-sections of hind-paw footpads showed a reduction in thickness of 
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the epidermis (black line) in irhom2 KO mice. Scale bars 50 μm (C) Graph depicts the mean 
thickness of the epidermis of hind paw and back skin from irhom2 WT and irhom2 KO mice 
calculated from 10 individual measurements in 5 separate cross sections from each genotype 
(n=3) error bars denote SD, *P<0.05. (D) Immunohistochemistry demonstrating reduction of 
K16 expression in paw skin sections. Scale bars: 20 μm.(E) Immunohistochemistry showing 
similar K9 expression in paw skin sections. Scale bars: 20 μm. Negative control Appendix 
Figure B.5. 
 
In cells, iRHOM2 depletion by shRNA results in impaired proliferation and reduced Ki67 
expression in 3D organotypics derived from these cells. In keeping with this, Ki67 was also 
reduced in the irhom2 KO mouse footpad epidermis (3.31A). In keeping with the in vitro 
findings of a reciprocal relationship between K16 and K6 in TOC, the footpad of irhom2 KO 
mice shows upregulation of K6 throughout the epidermis (3.31B). Reduced proliferation and 
K16 expression could result in a thinner epidermis in the knockout mice.  
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Figure 3.31(A) Confocal analysis confirming the reduction of Ki67 expression in the forepaw 
epidermis of irhom2 KO mice. Scale bars: 20μm. (B) Immunohistochemistry showing 
upregulation of K6 expression in the front paw and epidermis of irhom2 KO mice compared 
with irhom2 WT Scale bars: 20μm. 
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3.7 Results Summary 
 
1. Identification of a novel interaction between iRHOM2 and K16 
2. The interaction between iRHOM2 and K16 is increased in TOC, where K16 is 
upregulated 
3. K16 demonstrates a perinuclear localization in TOC kerationcytes which is increased 
upon mechanical stress 
4. K16 and its partner K6 are differentially regulated in TOC 
5. TOC is associated with increased dynamicity of K16 filaments 
6. iRHOM2 depletion is associated with reduced proliferation, migration and 
inflammation 
7. iRHOM2 KO mice display a significantly thinned footpad epidermis with reduced 
expression of K16. 
 
3.8 Discussion 
 
3.8.1 Introduction 
 
To date, very little is known about the substrates which iRHOM2 binds. Initial studies 
performed in drosophila and mice found that iRHOMs target EGF for ERAD (Zettl et al. 2001) 
and have been shown to regulate the substrate selectivity of protease substrates such as 
AREG and TGFa (N Nakagawa et al 2005, Maretzky et al 2012; Hosur et al 2014). Regulation 
of substrate selectivity was shown to be dependent on the N-terminal domain of iRhom2 
(Maretzky et al 2012).  More recently, two independent groups reported the critical role for 
iRHOM2 in the maturation and processing of ADAM17 in mice embryonic fibroblasts (MEFs) 
(Adrain et al., 2012, McIlwain et al., 2012). Both groups showed that in irhom2 KO mice, 
there was failure of maturation of ADAM17 and as a result stimulation with LPS failed to 
cause in shedding of TNFα.  Beyond EGF and ADAM17 in humans, no further studies have 
yet shed light on novel binding partners for iRHOM2. The identification of K16 (and 
potentially other Type 1 keratins) as targets of iRHOM2 therefore represents a novel finding 
in the field.  
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3.8.2 Interaction between iRHOM2 and K16 
 
Keratin 16 is a cytoskeletal protein with unique attributes contributing to its expression in 
specific pathological and physiological situations. It combines the distinct properties of 
mechanoresilience, flexibility and dynamic turnover, which are necessary in the 
hyperproliferative “stressed” stratified epithelia where it is expressed including the 
palmoplantar epidermis (Paladini and Coulombe, 1998, Paladini et al., 1996). Unlike inter-
follicular skin, the ridged skin of the palmoplantar epidermis is characterized by the 
constitutive expression of Keratins 6, 16, 17 and uniquely, Keratin 9 (K9). In addition to its 
high expression in the palmoplantar epidermis, K16 can be induced in hyperproliferative 
states such as wounded epithelia(Paladini et al., 1996, McGowan and Coulombe, 1998) and 
inflammatory skin diseases(Leigh et al., 1995). Upon regeneration, wound edge epithelial 
cells deviate from their normal expression pattern of K10 and induce K16 within 6 hours of 
injury(McGowan and Coulombe, 1998, Paladini et al., 1996). K16 is also a biomarker of 
several cancers particularly squamous cell carcinomas (SCCs), including those originating 
from cervical, oesophageal and nasopharyngeal epithelia(Karantza, 2011, Moll et al., 1982, 
Moll, 1998). The tightly restricted expression pattern of K16 supports the notion that this 
particular keratin bears unique properties, however, how the dynamic regulation of K16 
occurs in response to physiological and cellular stress remains poorly understood.  
 
In this report, using human and mouse models, iRHOM2 is shown to be a novel and 
unexpected regulator of the cytoskeletal response to physical stress through its interaction 
with K16.  Evidence for direct interaction between iRHOM2 and K16 comes firstly from a 
Yeast-2-Hybrid screen, in which K16 preys were 2 of only 22 positive interactors from a 
library of over 112 x 106 potential preys.  Secondly from co-immunoprecipitation 
experiments performed using endogenous proteins, thirdly from PLA studies (which confirm 
that the two proteins are within 40nm of one another) and finally from co-localisation 
immunohistochemistry.  The N-terminus of iRHOM2 appears to be functionally important, 
not only is it the site of all reported TOC-causing mutations in 5 separate large pedigrees, but 
it is also the domain which interacts with K16. In the absence of the N-terminus, iRHOM2 is 
no longer able to bind K16. Maretzky et al 2012 also showed similarly that regulation of the 
substrate selectivity of EGFR in mice is dependent on the N-terminus of iRHOM2.   
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The positive keratin prey fragments highlighted by the Yeast-2-hybrid screen were used to 
ascertain a potential site of interaction between iRHOM2 and K16.  All 9 prey fragments from 
K10, K14 and K16 showed sequence overlap directly corresponding to their highly 
homologous Coil 1B domain. Interestingly, disease-causing mutations in the Coil 1B domain 
have not been reported to date although several mutations have been ascribed to the other 
coiled domains including Coil 1A, 2A and 2B, hinting at a functionally important role for this 
particular region.  Within the field of keratin biology, several papers have highlighted the 
central role for Coil 1B in heterodimerisation between Type I and Type II keratins(Bernot et 
al., 2005, Wawersik et al., 1997, Wu et al., 2000).  In vivo, keratin polymerisation is initiated 
through the formation of heterodimers involving Type I and II intermediate filament 
proteins. A small hydrophobic “stripe” located within the Coil 1B domain appears to be key 
in mediating heterodimerisation (Bernot et al., 2005). Hydrophobic patches on the surface 
of proteins are thermodynamically unfavourable in aqueous environments and their 
presence often indicates a region of protein-protein or protein-lipid interaction, making this 
domain effectively a “docking-site” for interacting proteins (Bernot er al., 2005).  
Additionally, the Keratin Coil 1B domain displays a 13-residue trigger motif required for 
stability of their heterodimers. Side directed mutagenesis of critical residues within this 
trigger motif has been shown to cause near total collapse of the keratin filament network 
around the nucleus and a reduced ability to form heterodimers (Wu et al., 2000). In TOC we 
see increased interaction between iRHOM2 and K16 compared with control keratinocytes in 
co-immunoprecipitation experiments, further quantified by PLA. The increased interaction 
beween K16 and iRHOM2, likely to be through the coil 1B domain, appears to occur at the 
expense of binding with its known partner, K6. PLA between K6 and K16 is significantly 
downregulated in TOC keratinocytes.  It is tempting to speculate that greater binding 
between iRHOM2 and K16 in TOC keratinocytes could physically impair K16 interacting with 
its partner, K6. This points to an unusual reciprocal regulation between K16 and K6 in TOC. 
In support of this, shiRHOM2 in TOC keratinocytes results in restoration of K6 expression 
demonstrated by western blots and 3D organotypic cultures.  This occurs despite a reduction 
in K16, providing further evidence for an “uncoupling” between K6 and K16 in TOC K6 
expression appears to be globally reduced in TOC keratinocytes, both at protein level 
(western blotting and immunohistochemistry) and also at mRNA level (qPCR). It is possible 
that K6 is less stable as a monomer and may therefore be targeted for degradation. 
Presumably, a negative feedback loop exists when K6 does not bind to K16, to prevent 
unstable K6 monomer accumulation in the cytoplasm, however how this occurs this remains 
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to be explored. Uncoupling of K16 and K6 expression is highly unusual and challenges 
conventional dogma. Although rarely reported, one circumstance in which K16 is expressed 
without K6 is in the palmoplantar epidermis.  Here, K16 is prominently expressed in the basal 
layer whereas K6 expression is more restricted, and more similar in distribution to K17 
(Swensson et al., 1998).  Similarly, transgenic mice lacking K9 develop marked hyperkeratotic 
thickening and callus formation of their paws in which K16 is highly upregulated in the 
footpad and interfootpad skin whereas K6 upregulation was restricted to the footpads alone 
(Fu et al., 2014). Suggesting that surprisingly, differential regulation of K16 and K6 may be 
more prevalent than previously considered.  It may be that in TOC, the interfollicular and 
potentially oesophageal epithelium adopts a more “palmoplantar” keratin signature, which 
in turn favours hyperproliferation.  
 
3.8.3 Perinculear Reorganisation of K16 Filaments 
 
Wound edge keratinocytes are poised to undergo proliferation and migration and thus allow 
tissue regeneration. K16 is rapidly expressed in response to tissue injury and, 
ultrastructurally, has been shown to adopt a perinuclear arrangement of filaments which 
proceeds the onset of migratory behaviour (Paladini et al.,1996).  Further studies have shown 
that this delocalization is linked to fragmentation of rigid keratin filaments from the cell 
periphery, resulting in cytoplasmic “softening”, thereby increasing cell plasticity, 
subsequently facilitating proliferation, migration (Beil et al., 2003, Busch et al., 2012, Rolli et 
al., 2010).  The improved viscoelastic properties resulting from keratin filament 
reorganisation have also been linked to increased invasion in cancer cells. In particular, 
Sphingosylphosphorylcholine (SPC), a naturally occurring bioactive lipid present in high 
density lipoprotein particles found in the blood and malignant ascites of patients with 
ovarian cancer has been shown to induce perinuclear reorganisation of keratin 8-18 filament 
networks.  Consequently, SPC stimulates migration of cells through pores of limited side and 
the authors conclude that the metastasis-inducing properties of SPC could result from the 
high degree of elasticity it causes, enabling cells to squeeze through membranous pores 
during metastasis (Beil et al., 2003). Intriguingly, iRHOM2 has also been linked to ovarian 
cancer (Wojnarowicz et al., 2012), however this may be due to loss of heterozygosity at the 
17q25 locus.  In TOC not only is K16 upregulated, but the filament network itself appears to 
adopt a different pattern. TOC cells more frequently display a perinculear localisation of K16, 
even in the absence of mechanical stress. This pattern is further enhanced by subjecting TOC 
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cells to mechanical stress for four hours.  Overexpression of either WT or TOC-mutant 
iRHOM2 has a similar effect on unstretched control keratinocytes, and results in striking 
perinculear filament reorganisation following mechanical stress. PLA also confirms binding 
between iRHOM2-GFP and K16 in the perinculear regions, suggesting that K16 filament 
reorganisation is mediated by interaction with iRHOM2. How does iRHOM2 cause K16 
filament reorganisation? Although this question remains to be answered fully, it is possible 
to hypothesise that reduced binding between K16 and K6 could be explanatory.  As 
heterodimers, K6 “anchors” K16 to desmosomal cell-cell adhesion structures, stabilising the 
intermediate filament network which has a branch-like appearance (Kouklis et al., 1994). By 
contrast, when K6 is down regulated in TOC, K16 is effectively “released” from its tether, and 
can reorganise itself around the nucleus.   Our group have previously shown that 
desmosomes in TOC skin have an “immature” appearance, lacking the characteristic electron 
dense midline seen in normal skin (Brooke et al., 2014). In light of the findings presented 
here, it is possible that this could partly be due to alterations in the dynamics between 
desmosomes and the keratin intermediate filament network.   
 
3.8.4 iRHOM2 and K16 Filament Dynamicity 
 
Keratin filaments are highly dynamic structures and cycle through stages of assembly and 
disassembly in a context specific manner. Filament remodelling and turnover are key factors 
which determine cell growth and turnover (Windoffer et al., 2011, Kolsch et al., 2010). 
Interference with Keratin filament dynamics in human disease and transgenic mice leads to 
reduced resilience of epithelia to mechanical and other challenges. One dramatic example is 
mutation in K5 or K14 underlying Epidermolyis Bullosa which results in severe tissue fragility 
from birth (Ishida-Yamamoto et al., 1991).   
 
In TOC, we observe enhanced filament turnover demonstrated by rapid recovery from 
treatment with Okadaic acid. K16 filaments in TOC cells reform within 4 hours after 
treatment whereas control keratinocytes still show only partial recovery 24 hours following 
treatment.  It is pertinent to note that K16 turnover has been shown to almost double in the 
absence of K6 (Bernot et al., 2005) and this could explain K16 filament dynamicity in TOC. In 
conjunction with perinuclear localisation of K16 in TOC, enhanced filament dynamicity would 
favour the upregulated proliferation and migration observed in TOC keratinocytes compared 
with controls.  By contrast, shiRHOM2 impairs proliferation and migration in both control 
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and TOC keratinocytes.  This could partly be because shiRHOM2 results in reduced K16 in 
both cell lines.  After scratch wounding, abundant keratin filament precursors align at the 
leading edge of migrating cells, thereby extending the intermediate filament cytoskeleton 
towards the “wound”.  Keratin filament particles reorganise and elongate to facilitate 
changes in cell shape required for motility(Windoffer et al., 2011). It is therefore conceivable 
that, when K16, the major wound-induced keratin is downregulated, cell migration is 
impaired.  
 
3.8.5 A Novel Cutaneous Phenotype in irhom2 KO Mice 
 
The irhom2 KO mice displays a clinical phenotype which has not been previously reported in 
the literature. The presence of “thinned” footpads is somewhat unusual.  It would be 
reasonable to suggest that the “thinned” footpad skin occurs as a result of reduced 
proliferation and K16 expression throughout the epidermis in the absence of iRhom2. Quite 
remarkably, K16 KO mice display and altogether opposing phenotype. By 8 weeks of age, 
K16-KO mice are disabled by painful callous development and palmoplantar hyperkeratosis 
which demonstrates several hallmarks of inflammatory activation. Inflammatory cytokines, 
“DAMPs” and “alarmins” are all activated and histologically, there is an influx of 
inflammatory cells particularly macrophages.  The pain resulting from the inflammatory PPK 
is so severe that mice limp and their mobility is restricted (Lessard et al., 2012).  Irhom2 KO 
mice show no such features, there is no evidence of inflammation clinically or histologically 
and quite the opposite of PPK, their footpads are thinner than WT littermates.  How can 
these two phenotypes both linked to reduced K16 expression be reconciled? The answer 
could lie in ADAM17, the most well-established target of iRHOM2 whose major function is 
the shedding of inflammatory cytokines. ADAM17 activity is reduced in irhom2 KO mice and 
thus there is impaired shedding of inflammatory cytokines including TNFα, Amphiregulin and 
IL6. In this report, shiRHOM2 in both control and TOC human keratinocytes reduces ADAM17 
activity and significantly hinders TNFα shedding in response to PMA stimulation.  Impaired 
ADAM17 activity in the irhom2 KO mouse footpad epidermis could exert a protective effect, 
preventing inflammation and hyperkeratosis in response to physical stress.  Potentially, this 
observation could be significant as therapeutic options in the treatment of PPKs are 
extremely limited. PPK’s can have a profound impact on patients’ quality of life, rendering 
them immobile due to severe pain. Topically formulated specific iRhom2 inhibitors or more 
specific tissue silencing using intralesional siRNA may be future therapeutic options. 
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ADAM17 inhibitors have been in development for many years, however concerns about side-
effects have been the primary issue, due to widespread tissue expression. Oral or injectable 
therapies targeting iRhom2 may be a more appealing alternative, as it is more likely to be a 
skin-specific therapy.  Therefore, although the wider role for ADAM17 in inflammatory PPK’s 
remains to be explored, it is likely that further study in this area could prove insightful.   
 
The TOC phenotype in humans diametrically opposes that observed in irhom2 KO mice.  It is 
likely that The combination of high K16 expression in response to mechanical stress and 
increased cell turnover in the presence of upregulated iRHOM2 activity provide a possible 
explanation for the presence of palmoplantar keratoderma in TOC. This model could also 
explain the diminished K16 expression and thinner footpads in irhom2 KO mice. Taken 
together, the evidence suggests that iRHOM2 and its regulation of K16 play a key role in the 
dynamic response of the footpad in humans and mice to physical stress.  
 
3.8.6 TOC and PC-1 
Looking at the remarkable clinical overlap between the phenotypes of TOC and PC-1 caused 
by K16 mutation, this functional relationship is in some ways unsurprising.  Both conditions 
are inherited as autosomal dominant traits with high penetrance.  They similarly present with 
marked hyperkeratosis of the plantar, and to a lesser extent, palmar epidermis following 
weightbearing, I,e. when children begin walking. Typically in TOC this is in early childhood 
however it can manifest earlier in PC-1.  Anecdotally both groups of patients report a marked 
improvement in their keratoderma following extended periods of rest when walking is 
restricted e.g. following surgery/childbirth.  This implies that the presence of the 
keratoderma is linked to physical “stress”. Both groups can also develop follicular occlusion 
resulting in steatocystomas (sebum containing dermal cysts) which may be because K16 
(amongst other keratins) are expressed within the lumen of sebaceous glands and increased 
K16 could result in occlusion.  Oral leukokeratosis is present in both conditions and is 
hypothesized to occur as a result of repeated oral trauma due to eating.  However, PC-1 has 
never been linked to oesophageal cancer unlike TOC and this is the key difference between 
the two conditions.   
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3.8.7 iRHOM2-K16 Interaction and Disease 
 
In addition to its established role in wound-healing K16 is pathologically expressed in a 
variety of disease states including squamous cell carcinomas, irrespective of their site of 
origin and including those arising from the oesophagus, nasopharynx and cervix (Pan X et al, 
2013, Karantza et al., 2011).  As such it is often referred to as “biomarker” of SCC. In the skin, 
K16 expression is also used to delineate tumour islands in cutaneous squamous cell 
carcinomas(Lai et al., 2016).  Its expression has also been linked to inflammatory dermatoses, 
particularly Psoriasis (Leigh et al., 1995).  With this in mind, it is possible that there may be a 
broader significance for the role of iRHOM2 in the pathophysiology of these disorders which 
remains to be explored.  
In TOC, the contribution of iRHOM2-K16 to the development of oesophageal cancer has yet 
to be studied however, it is the focus of ongoing investigation within the group. The 
upregulated shedding of proinflammatory and pro-proliferative cytokines by the iRHOM2-
ADAM17 pathway is likely to be the major contributor to the development of neoplasia. 
However, preliminary data points to increased K16 expression in precursor oesophageal 
lesions in TOC (personal communication: Lisa McGinty, Kelsell Group).  This is an area that 
warrants further study as it could yield insight into the mechanism underlying both TOC and 
sporadic OSCC.  
 
3.8.8 Conclusions 
 
The data presented here point to a novel and hitherto unidentified role for iRHOM2 in 
regulating the wound-healing and disease associated keratin, K16. The findings demonstrate 
direct interaction between iRHOM2 and K16 and show synchronicity between the expression 
pattern of these two proteins; shRNA mediated knock-down of iRHOM2 in human 
keratinocytes or irhom2 -/- in mouse paw skin is associated with depleted K16, and 
reciprocally, high iRHOM2 activity in TOC is associated with increased K16.   
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By orchestrating the remodelling and turnover of K16, and uncoupling it from its binding 
partner K6, iRHOM2 acts as a key regulator of the epithelial response to physical stress. 
These findings contribute to our understanding of the molecular mechanisms underlying 
hyperproliferation of the palmoplantar epidermis at sites of high physical stress in both 
physiological and disease states and how this “stress” keratin, implicated in wound healing, 
inflammation and cancer, is regulated Thus, pharmacological modulation of iRHOM2 by 
targeting two stress-response proteins, K16 and ADAM17, could provide a specific 
therapeutic strategy in the treatment of PPK’s, inflammatory epithelial disease and 
neoplasia.   
 
3.8.9 Further work 
 
The focus of the work presented in this report is the interaction between iRHOM2 and K16, 
however, the yeast 2 hybrid screen highlighted two additional keratins, K10 and K14 as 
potential binding partners. K10 and K14 are highly expressed in the interfollicular epidermis 
and the relevance of this potential interaction would be interesting to study further.  Co-
immunoprecipitation, colocalisation, and PLA studies could be performed to confirm 
interactions between iRHOM2 and K10/K14. Immunostaining of TOC and normal skin could 
also be performed. Furthermore, their binding partners including K1 and K5 should also be 
assessed. It might be that the effect of iRHOM2 on these keratins differs from K16. K10 is 
downregulated following injury, where there is a switch from K1/10 to K6/K16. Possibly, 
iRHOM2 may somehow be regulating this switch.  In vivo validation could be performed on 
irhom2 KO mice. It may also be interesting to examine the expression and activity of iRHOM2 
in EBS caused by mutations in K14 or K5 to see if it plays a role in the development of tissue 
fragility.  Immunohistochemical staining and PCR of EBS skin could be performed. The impact 
of EBS-causing mutations on iRHOM2 binding could also be assessed using Co-
immunoprecipitation and Proximity Ligation assay experiments.  
 
More detailed study could be undertaken to further characterise the interaction between 
iRHOM2 and K16. These could include site-directed mutagenesis and subsequent Co-IP of 
tagged fragments of irhom2 and K16 to locate the precise binding domain.  Live cell imaging 
of TOC and control keratinocytes could also be performed to more formally quantify the rate 
of filament turnover.  The qPCR findings showing reduced K6 expression in TOC also warrants 
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further study. Perhaps examining transcription factors known to regulate keratin gene 
expression including c-Jun and fos could be performed.   
 
As TOC and PC-1 share several phenotypic similarities, iRHOM2 expression at protein and 
mRNA level in skin samples from PC-1 patients could be performed.  It may be that increased 
iRHOM2 plays a role in the hyperkeratotic skin phenotype observed in these patients. In a 
similar vein, the broader role of iRHOM2 in other PPK’s such as diffuse NEPPK due to 
Aquaporin 5 mutations, striate PPK’s due to desmoplakin mutations and DNEPPK due to K9 
mutations could also be studied. It is possible that upregulated iRHOM2 activity is a common 
feature in the skin of other PPK’s.  Skin biopsies obtained from patients could be 
immunostained for iRHOM2 and protein extracted for western blotting. qPCR of mRNA could 
also be performed. Upregulated iRHOM2, K16 and ADAM17 activity could point to a shared 
pathophysiolocal mechanism in the formation of PPK. 
 
 As K16 has an established role in Psoriasis, this could potentially be an exciting area for 
further study. The psoriatic epidermis shares similarities with TOC skin, namely 
hyperproliferation, upregulated inflammation, increased immune cell infiltrate and high K16 
expression.  Like TOC, psoriasis is also considered similar to exaggerated wound healing. 
Preliminary data from our group has shown increased expression of iRHOM2, ADAM17 and 
K16 in Psoriasis RNA sequencing data sets (Matthew Brooke/Professor Nick Reynolds). More 
detailed study using psoriasis cell lines and patient skin biopsies would be necessary to 
properly evaluate the contribution of iRHOM2 to the hyperproliferative inflammatory 
phenotype.  
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Chapter 4 
 
Loss of function Desmoplakin I and II 
mutations underlie dominant 
Arrhythmogenic Cardiomyopathy with a 
hair and skin phenotype 
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4.1 Background 
 
4.1.1 Clinical and Genetic Heterogeneity of Arrhythmogenic Cardiomyopathy (AC) 
due to DSP mutations 
 
Recessively or dominantly inherited mutations in Desmoplakin (DSP) are associated with 
considerable phenotypic variability. Some mutations result in cardiocutaneous syndromes, 
others in non-syndromic skin-limited involvement and some forms show cardiac features 
only.  Although this mostly due to the precise location of the mutation, there can also be 
quite marked variability between individuals from the same family, carrying the same 
mutation (Sen-Chowdhury et al., 2005, Brooke et al., 2012).   
 
4.1.2 Skin Phenotypes Linked to DSP 
 
Armstrong et al. (Armstrong et al., 1999), reported a large kindred in whom multiple 
members developed a striate PPK phenotype in the first or early second decade of life 
revealed a missense mutation in the N-terminal region of DSP resulting in a premature stop 
codon. 
Affected individuals presented with linear thickening along the flexor aspects of the fingers 
and pressure bearing areas of the soles, exacerbated by use.  Hair abnormalities were not 
detected. This paper did not outline whether cardiac investigations were undertaken, 
however they do not mention the co-existence of AC and suggest a skin-restricted 
phenotype.  Histologically, the epidermis showed widened intracellular spaces and clumping 
of the keratin filaments, with loss of connection to the desmosomes. However, it remains a 
possibility that, as this paper was published before DSP was linked to AC and 
cardiocutaneous disease (Norgett et al., 2000), that specific diagnostic investigations for AC 
were not undertaken.   
 
Lethal acantholytic epidermolysis bullosa has been reported in a neonate presenting as 
complete alopecia, neonatal teeth, nail loss, extensive skin erosion and neonatal death.  The 
infant had compound heterozygosity for a recessive nonsense and frameshift DSP mutation. 
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which resulted in near total deletion of the intermediate filament binding sites in the DSP 
tail domain (Jonkman et al., 2005).   
 
More recently, a recessively inherited missense mutation in DSP was linked to “SAM 
Syndrome” (Severe dermatitis, multiple allergies and metabolic wasting)(McAleer et al., 
2015).  The resulting amino acid substitution (His586Pro) contributes to the histological 
features of widened intercellular spaces and defective skin barrier formation, with marked 
attenuation of cornified envelopes, a virtual absence of corneodesmosomes and 
abnormalities of the post-secretory maturation and organisation of secreted lamellar body 
contents.  Impaired barrier function would contribute to the formation of severe dermatitis, 
similar to the pathophysiology of atopic eczema. Interestingly, cardiac involvement was not 
a reported feature in this patient.   
 
A novel Erythrokeratodermia associated with cardiomyopathy syndrome has also been 
linked to DSP mutations in 3 children (Boyden et al., 2016).  The affected individuals were 
noted to have sparse coarse hair at birth and a persistent pruritic erythrokeratodermia, 
unreponsive to topical or systemic immunomodulatory agents. The children also 
demonstrated failure to thrive and marked onychodystrophy.  Exome sequencing located 
three novel, tightly clustered, de novo missense mutations in DSP as the underlying cause of 
this syndrome.   The resulting substitution with a proline was suggested to disrupt the 
conserved a-helical structure of the spectrin-repeat (SR6) at this position.  The mutation 
results in mis-localisation of DSP at the intercellular junction, with formation of focal 
aggregates.  Overexpression of the disease causing mutation in primary human keratinocytes 
allowed the quanitifcation of Cx43 localisation, which was found to be reduced by 80% at 
the cell surface membrane (Gutstein et al., 2001).   
 
 
 
 
 
 
117 
4.2 RESULTS 
 
4.2.1 Deep Clinical Phenotype of DSP Mutation Carriers and Their Families 
 
Due to the specialist nature of monitoring and treatment, patients with AC are managed at 
tertiary referral centres with specific expertise. The patients who participated in this study 
were recruited from a cohort at the The Heart Hospital (originally at UCLH, later, The Heart 
Hospital at Bart’s and the London). At the Heart Hospital, a cardiomyopathy clinic runs 
weekly, some of the patients who attend this clinic have a confirmed diagnosis of AC. For the 
purpose of this study, patients with clinically confirmed AC, with autosomal dominantly 
inherited mutations in the gene encoding DSP were selected from this clinic for further 
evaluation. 6 families (38 patients) were included in the study and underwent cardiac and 
cutaneous evaluation as well as a skin biopsy (Figure 4.1). Patients were invited to participate 
in the research project with informed written consent. Clinical photographs were 
documented. Patients were selected to participate in the study if they had a frameshift or 
truncating mutation in DSP as the impact of the functional effect of missense mutations is 
considered more complex to determine.  
 
 
 
Figure 4.1 Project plan; ARVC/AC Patients with dominantly inherited mutations in DSP were 
selected for deep clinical and genetic phenotyping as well as a skin biopsy from non-
lesional skin.  
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4.2.2. Cutaneous Phenotyping 
Family 1 Q273.fs 
 
The 52 year old proband of this particular family presented with Ventricular Fibrillation at 
rest, in fact, whilst watching television. Following this near-fatal event, clinical evaluation 
and genetic screening  of known ARVC genes identified the presence of a frameshift mutation 
at p.Q273fs. This mutation is the most proximal of all the patients included in this study. 
Clinical examination of the patient revealed wavy/kinky hair and linear hyperkeratosis of the 
forefoot, most prominent between the great toe and second toe.  The patient was a 
physiotherapist and commented that she had suffered from severe dryness of her hands 
which required regular use of emollients during the winter months due to cracking and 
fissuring. She also developed marked thickening and hyperkeratosis affecting the heels 
which developed in adulthood, bilaterally which she scraped and moisturized to keep under 
control. The patient had an ICD in situ following the VF episode and had received shocks from 
the device.  Her cardiac echo showed a mildly dilated left ventricle, with ejection fraction of 
45% and an aneurysmal left apex.  After the proband’s initial diagnosis, genetic family 
screening was performed which highlighted 7 further DSP mutation carriers including the 
patients son (3-II) (Figure 4.2) . Clinical examination of the patient’s mother (1-II) showed 
soft curly hair as well as a prominent striate and focal keratoderma (Figure 4.2), with gross 
thickening and fissuring affecting the heels bilaterally. This individual commented that her 
feet had caused her “years of trouble” including numerous visits to the GP for topical 
treatment to relieve the cracking and fissuring. Both mother(1-II) and daughter(2-II) 
commented that they had “ugly feet”.  The proband’s brother(2-V) was also examined, 
although he now keeps his hair short, he had wavy hair as a child. Examination of his skin 
revealed milder linear thickening between the great toe and second toe and to a lesser 
extent, hyperkeratosis at sites of friction and pressure over the lateral aspects of the 
forefoot.  Clinically, his keratoderma was less marked than in the other two mutations 
carriers examined.  Unfortunately, the sister of the proband (2-III) could not be examined as 
she now lives in Canada, however through email contact, it was possible to ascertain that 
she had very curly hair until the menopause, however it was much less curly now.  The 
proband had two children, one of which also carried the mutation (3-II). The affected son 
also had kinky/wavy hair, whereas the unaffected daughter(3-I) had straight hair. The 
patients husband(2-I) had straight hair.  Patient 2-III’s children were both found to be 
mutation carriers and both have very curly/frizzy hair, however, it is important to note that 
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the children’s father, of Italian descent, also has curly hair.  2-III and both her children (3-III 
and 3-IV) also have/had moderate eczema requiring the care of a dermatologist during 
childhood.  Patient 2-V has one child who carries the mutation, who also has curly hair, 
however his unaffected son does not.  His partner has straight hair.  In summary, in this 
particular family, 5/8 mutation carriers have curly hair, the remaining 3/8 carriers have 
wavy/kinky hair.  The unaffected offspring (2/2) have straight hair. Overall it appears that 
there is segregation of the curly/wavy hair phenotype with mutation carrier status in this 
family.   
 
 
 
 
 
Figure 4.2 Pedigree and clinical photographs of Family 1 (p.Q273.fs). Symbols: circle – 
female; square – male; Black – mutation carrier, wavy line – curly hair; diagonal line – 
deceased. Co-segregation of the hair phenotype with the genotype can be observed in all 
members of this family. Patient 1-II demonstrates the typical curly hair phenotype. White 
arrowheads mark plantar focal keratoderma with hyperkeratosis and callous formation 
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120 
 
Family 2 p.L585fs 
 
The proband in this family (2a-I) died of Sudden Cardiac Death (SCD) aged 22 whilst playing 
sport.  His brother (2a-II) presented on two occasions to A&E at the age of 18 years old with 
Ventricular Tachycardia whilst playing football that required cardioversion.  Following this, 
and the death of his brother, a diagnosis of AC was made and he was identified to have a 
causative frameshift mutation in DSP at position L585, on screening of a known panel ARVC 
genes.  The family tree from this pedigree is somewhat unclear, and the three families who 
participated in this project are not known to each other but were located through extensive 
family screening and as such can be considered distant relatives (Figure 4.3). The full details 
of the original family trees were no longer available in the current records at the time of 
writing.   
 
Patient 2a-II was examined during a routine clinic appointment for AC follow up.  On 
examination, the patient had curly and slightly frizzy hair. Examination of the palms was 
unremarkable, however his feet had caused him trouble for many years. Although previously 
undiagnosed, examination findings were in keeping with a striate keratoderma affecting the 
soles of both feet. His heels also showed hyperkeratosis and thickening (Figure 4.3).  His 
keratoderma required him to regularly shave hard skin from his soles.  On further 
questioning he also explained that his brother, the index case, also had very thick hard skin 
on both feet. Their mother, also a DSP mutation carrier, had curly hair but he was unaware 
of whether her feet were similarly affected. She died of breast cancer in her 50’s. 2a-II has a 
daughter who has undergone genetic screening and was found not to carry the mutation, 
she was described as having straight hair like her mother.  Within this large pedigree was 
another family who participated in this research through phone consultation. Both 
mutations carriers, 1b-II (72 years old) and 2a-I (43 years old) had been identified through 
family screening. Both mother and son had rough curly hair that they commented grew 
slowly.  2a-I also had suffered from a marked keratoderma for several years that had 
required specialist care by Dermatology.  His mother did not have similar keratoderma of her 
hands and feet but did have dry skin. His sister (2b-II) had straight silky hair.  
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Figure 4.3 Pedigree and clinical photographs of family, black circles/squares with wavy lines 
indicate curly haired mutation carriers 2 L.585fs. Co-segregation of the hair phenotype with 
the genotype can be observed in all members of this family. Patient 2a-II demonstrates the 
curly hair phenotype, heel hyperkeratosis and fissuring and a focal and striate keratoderma 
(white arrowheads) Patients 1b-II and 2b-I also had tightly curled hair.  
 
Another nuclear family within this pedigree also showed similar segregation of the curly hair 
phenotype with mutation carrier status. 1c-I, a 62 year old female also had very curly hair 
and clinical features of a mild striate keratoderma.  Her daughter, also a mutation carrier had 
similar curly hair but lacked palmoplantar involvement.  Her brother, who had also been 
L.585fs
1a)I 1b)I1a)II 1c)I 1c)II1b)II
2a)I
2c)I2b)II2b)I2a)III2a)II
3a)I
2c)II
2a#II
1b#II 2b#I
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tested for the mutation had straight hair that differed markedly from the two mutation 
carriers.   
 
In these 7 DSP mutation carriers, we observe the curly hair phenotype shows 100% 
segregation with disease.  
 
 
Family 3 p.T922s.fs 
This patient is the index case in her family and presented with recurrent palpitations and pre-
syncopal episodes. Her hair was tightly curled (Figure 4.4) and she had a striate keratoderma 
affecting both her feet. Her sister (non-mutation carrier) was unaffected. The parents of this 
patient lived in New Zealand and had not undergone genetic testing. 
 
Figure 4.4: The proband in this family had tightly curled hair. 
 
Family 4 p.s1015fs 
The index case in this large pedigree died of sudden cardiac death in her early 20’s whilst 
playing badminton. Prior to this she had not exhibited any features of AC. Subsequent family 
screening found 7 further patients who carried the disease-causing mutation p.S1015fs 
(Figure 4.5).  Two sisters 2-II (56yrs) and 2-IV (53yrs) carry the mutation and have tightly 
curled frizzy hair. None of their other siblings had similar hair. In fact, the sisters had already 
remarked how those family members who carried the mutation also all had curly hair.  Both 
sisters suffered from painful thickened skin affecting both feet and clinical examination 
revealed hyperkeratosis and fissuring of the heels bilaterally. 2-IV was a podiatrist and had 
always been aware that the thickening affecting her feet was unusual, differing from most 
of the patients she saw. On examination she also had eczematous patches on her upper arm 
and back which she explained typically developed exacerbated after immersion in water 
(swimming, baths). She also had to be cautious not to take prolonged showers as this could 
cause similar lesions, particularly on the upper back.   3-II (31yrs) also had remarkably curly 
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and frizzy hair whilst his two siblings who did not carry the mutation had straight hair.  Clinical 
examination of a male cousin of the index case (2X, 61 yrs) who also displayed the striking 
curly phenotype did not show clear evidence of a palmoplantar keratoderma. The patients 
son (3-VIII) who also carried the mutation had frizzy hair whilst his unaffected siblings did 
not. In this family we also observe complete segregation of the curly/frizzy hair phenotype 
with mutation carrier status. Non-carrier offspring do not have curly/frizzy or wavy hair in 
this family. 2-II and 2-IV also displayed signs of a keratoderma.  
 
 
 
Figure 4.5 Pedigree and clinical phenotype of Family 4 p.1015fs All 8 mutations carriers in 
this family presented with a curly hair phenotype.  Clinical photographs of DSP mutation 
carrying family members exhibit the characteristic tight curls. Patient 3-II has a strikingly 
different hair phenotype to his two unaffected siblings (3-I and 3-III) 
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3"I 3"II 3"III
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Family 5 p.R1113X 
 
The index case in this family, 2-II died of sudden cardiac death in her early 30’s. A stop 
mutation pR1113X was identified on screening a panel of known ARVC genes.  Following her 
death her family was screened for the causative stop mutation.  Her two sons, 3-I and 3-II 
were found to carry the mutation. Examination of 3-II, a 24 year old male, showed extremely 
curly, frizzy hair which he confirmed was similar to his mothers hair.  He had recently begun 
working in a warehouse which involved heavy lifting and had since developed subtle linear 
hyperkeratosis along the palmar aspect of his fingers. He also had focal hyperkeratosis on his 
toes, which is an unusual site to occur and is suggestive of a pathological keratoderma (Figure 
4.6).  Although his brother (3-I) was not examined, he was contacted by phone and sent 
photographs of his hair, which was less curly than his brothers but still showed a similar 
phenotypic appearance. Images of his feet were not obtained.  Their sister (3-III), who did 
not carry the mutation, had straight hair.  The father and both sisters of the index case all 
shared the same curly/frizzy hair phenotype.  Both sisters also showed features of a striate 
keratoderma and thickened fissure heels (Figure 4.6), as did their father to a lesser extent. 
Both of the mutation carrier daughters of 2V, shared the curly hair phenotype, and one of 
them also had gross thickening between the great and second toe (3-VI) whereas their non-
carrier cousins 3-IV and 3-V did not.  In this family, 8 of the affected mutation carriers had 
curly/frizzy hairs whereas all non-carrier offspring do not.  Furthermore, five of the carriers 
showed overt features of a palmoplantar keratoderma.  It is pertinent to note that the 
palmar keratoderma in patient 3-II was brought on by increased activity – since he had 
started lifting heavy boxes, supporting the hypothesis that “stress” is an important 
aetiological factor in the presence of skin involvement.   
 
 
 
 
125 
 
 
  
 
Figure 4.6. Pedigree and clinical photographs of Family 5 p.R1113X. All mutation carriers 
exhibit the curly hair phenotype. They also demonstrate hyperkeratosis and fissuring of the 
heels.  
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Family 6 p.E1493X 
 
The index case in this family (1-V) died in his 40’s from sudden cardiac death, which 
prompted further family screening. The actual pedigree is in fact much larger than that 
shown here, however these family members were not examined as part of this study as they 
do not attend the clinic at the Heart Hospital.  The 64 year old brother of the index case (1-
II) was examined for cutaneous signs. This individual had soft curly hair and a focal plantar 
keratoderma on clinical examination. He worked as a joiner and his hands were dry and 
fissured (Figure 4.7).  His two affected children, 2-II and 2-IV however did not have curly or 
even wavy hair, in fact, both had straight hair, as did both of their unaffected siblings. Their 
cousin, 2-VI was also examined. She had straight hair and no evidence of a keratoderma 
Further questioning revealed that in this family, 6 of the 7 mutation carriers had straight hair 
and also did not have skin involvement.  The correlation of hair and cutaneous phenotype 
with mutation-carrier status in this family appears to differ markedly from the other 5 
families examined in this study.   
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Figure 4.7 Pedigree and clinical photographs of family 6 p.E1493X. Square with wavy lines 
indicates curly haired carrier, Square or circle with straight lines indicates straight haired 
carrier. Unlike the other pedigrees examined in this study, only 1 of the 7 mutation carriers 
exhibited a curly hair, hyperkeratotic skin phenotype. Other mutation carriers such as 2-III 
and 2-VI had straight hair. 
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4.2.3 Summary of Hair Findings 
 
In summary, 6 families in which members carried DSP gene mutations were phenotyped with 
respect to their skin and hair.  Of the 39 mutation carriers in the families examined, 29 
(74.4%) had curly hair, a further 4 (10.2%) had wavy hair and  6 (15.4%) had straight hair.   
 
Intriguingly, none of the non-carrier offspring showed the curly hair phenotype in these 
families.  All the families who participated in this study were Caucasian.  In the European 
population, the incidence of curly has been estimated at 15%, which is significantly lower 
than in the DSP mutant cohort studied here (P=0.0012)(Figure 4.8).   
 
 
DSP$
mutation
Carriers Curly Wavy Straight Non4
Carriers
Curly
p.Q273fs 8 5/8 3/8 0 0/2
p.H586fs 7 7/7 0 0 0/3
P.922fs 1 1/1 0 0 0/1
p.1015fs 8 7/8 1/8 0 0/11
p.R1113X 8 8/8 0 0 0/3
p.E1493X 7 1/7 0 6/7 0/3
Total 39 29+
(74%)
4+(10%) 6+(15%) 0+(0%)
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Figure 4.8 Table summarizing hair phenotype in the 6 pedigrees examined in this study. Bar 
chart showing that 74% of DSP mutation carriers exhibited a curly hair phenotype, 
significantly higher than observed in the general population. 
 
 
Family 6 does not fit the phenotype inheritance pattern clearly observed in the other 5 
families, with 6/7 members having straight hair and also lacking a skin phenotype.  Initially 
this was felt to be rather unusual, however further examination of the location of the 
disease-causing mutation provided potential insight into the underlying mechanism.  The 
mutation site in this family, a stop mutation at p.1493, occurs in the DSP I isoform specific 
region of the protein (Figure 4.9).  As previously discussed in the introduction, DSP undergoes 
alternative splicing to yield two isoforms, DSP I being the full-length form and DSP-II lacking 
approximately two thirds of the residues within the rod domain. The p.1493 mutation would 
therefore only affect DSPI, and should not affect DSPII. DSPII is thought to be the major 
functional isoform in the skin and hair (Cabral et al., 2012),  it could be “protective” in these 
individuals and preclude the presence of a skin/hair phenotype.   
 
 
Figure 4.9 Schematic representation of DSP I and II isoforms. The mutations of the pedigrees 
in this study are predominantly located in the N-Terminus of both DSP I and II. However, the 
causative mutation in Family 6 (red) lies within the DSP I specific region. 
 
Despite this, it is evident from the patients examined in this study that there is a high degree 
of segregation between the curly hair phenotype with DSP mutation carrier status in the 
families examined. Looking at the 24 mutation-carrying offspring of curly haired patients 
with AC due to DSP mutation, 22 of these (92%) also carried the mutation. Suggesting that, 
the presence of curly hair in a family member in which the proband has curly hair is highly 
suggestive of mutation carriage in that family member.  This novel phenotypic finding may 
be useful in highlighting family members for genetic screening.  
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The curly hair in this patient cohort has an unusual texture and also tends to be frizzy, with 
a coarse “wire wool” texture in several of the individuals examined. Some patients 
commented that the texture was rough and required careful styling as it became knotted 
easily. Several members of independent families also commented that their hair grew slowly, 
or was difficult to grow longer. However, they did not describe hair breakage, fragility or 
excessive thinning of the hair.  Interestingly, the curly hair phenotype could vary between 
individuals within the same family, carrying the same mutation suggesting additional factor.  
For example, in family 5, R1113X, although 3-I and 3-II both have curly hair, the appearance 
of their hair differs, the curl is looser in 3-II, whereas in 3-II its appearance is more typical of 
the “woolly” hair described associated with Naxos or Carvajal disease.  Other patients 
described their hair becoming less curly with time (e.g. 2-III and 2-IV). We were unable to 
obtain scalp biopsies for further evaluation and no hair microscopy was performed. Overall, 
the hair phenotype in the curly-haired DSP-mutation carriers appeared to be less striking 
than that observed in Naxos or Carvajal disease but still present. Nevertheless, these finding 
suggest a marked clustering of the curly hair phenotype with mutation carrier status with 
the exception of Family 6.  The variability in the hair phenotype in members of the same 
family could be attributed to genetic or epigenetic modifiers for example by DNA 
methylation or histone modification.  
 
 
4.2.4 Summary of Skin Findings 
 
Unlike the hair phenotype, the skin finding, although present in several patients, were 
altogether subtler.  Some patients had evidence of a striate PPK with linear hyperkeratosis 
affecting the feet and/or palms.  Patients showed variable hyperkeratosis, particularly 
between the great toe and second toe or painful hyperkeratotic fissuring of the heels.  
Several patients also described marked dryness of the skin, particularly the hands, and some 
had even developed clinical features similar to eczema.  Another important factor to consider 
was that the skin phenotype in many families appeared to become more prominent in later 
life.  For example, in Family 5. Although in this family, the skin features were less clearly 
defined than the hair phenotype, the youngest family members, aged 15 and 19 showed very 
little thickening of the plantar skin however their mother, aunts and grandfather all had more 
overt features of plantar keratoderma. Although the skin findings were more variable, there 
was a correlation between their presence and skin “stress”. For example, several individuals 
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mentioned that their keratoderma deteriorated following walking/exercise and their hands 
became very dry when washed frequently or in the winter months.  Others also mentioned 
that exposure to water, such as swimming, bathing or long showers, exacerbated the 
formation of eczematous patches on the interfollicular skin.  Although the skin features were 
somewhat less striking than the hair phenotype, they were nonetheless present. Simply 
asking the question of whether the patient had ever had problems with their hands and feet 
often led to an animated discussion with several replying “how did you know” or “you don’t 
want to see my feet they have always been so ugly” etc. This response was not generally 
observed in unaffected carriers or the partners of mutation carriers.  Several patients 
described time-consuming foot-care regiments, for example shaving or scraping hard skin, 
foot soaks and regular application of emollients.    Although patients were aware that little 
could be done therapeutically for their keratoderma, there was some sense of relief to them 
that it was in fact due to their underlying DSP mutation.   
 
  
4.2.5 Mechanism of Disease – Haploinsufficiency 
 
How these autosomal dominantly inherited mutations in DSP actually cause disease has 
remains somewhat controversial.  To address this question, it was important to determine 
whether the mutant allele was being expressed at the mRNA and protein level.  The following 
experiments were carried out by Dr Anna Posafalvi (Kelsell Group). Skin biopsies were taken 
from non-lesional skin on the patients forearm with written informed consent.  cDNA and 
mRNA were extracted from patient and control skin. Specific primers were designed 
targeting either wild-type DSP or the particular mutant sequence. Sanger Sequencing 
revealed that in all six samples analyzed, the mutant allele was present only the genomic 
DNA but not in the mRNA, where only the wild-type allele transcript was detected (Figure 
4.10). Physiological mechanisms exist to prevent the transcription/translation of mutant 
mRNA, and it is likely that if the mutant mRNA is transcribed, it undergoes nonsense-
mediated decay to prevent it being translated and producing an aberrant protein product.  
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Figure 4.10 Sanger Sequencing traces showing that the causative mutation is present in 
genomic DNA (upper panel) but absent from mRNA from each patient using specifically 
designed primers, where only the wild-type allele was detected. This suggests that the 
mutant allele is not being transcribed/translated and that the downstream effects are due 
to haploinsufficiency. 
 
4.2.6 Immunohistochemical Staining of Patient Skin Biopsies 
 
Towards understanding how the disease-causing mutations could contribute to the skin 
phenotypes observed linked to AC, immunohistochemical staining was performed of the 
patient skin biopsy samples. (Dr Anna Posafalvi performed the immunohistochemical 
staining and the confocal imaging was performed by myself) 
 
DSP and PG 
 
In normal control skin, DSP staining (using an antibody directed at the N Terminus of both 
isoforms I and II -Materials and Methods) and PG (PG)  show a predominantly membranous 
staining pattern throughout the epidermis, including the basal layers.  However, in mutant 
Q273fs skin, DSP is mislocalised (Appendix Figure C.1), forming intercellular aggregates in the 
basal layers extending to the mid-epidermis. Also, cytoplasmic localisation of DSP seen here, 
which is less evident in control skin, also suggesting mislocalisation. PG expression appears 
to be fainter in patient skin than control, with the formation of intercellular aggregates in 
the basal layers. There is also both cytoplasmic and membranous localization in the 
suprabasal epidermis. The size and shape of the cells does not appear to be altered and there 
c.1755dupA; 
p.H586fs  
c.3045delG; p.R1015fs  
Patient 
Genomic 
DNA 
Patient 
mRNA 
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is no evidence of clefting or widened intercellular spaces. Immunostaining for Connexin 43 
(Cx43) was also performed, as this Gap Junction protein is also essential for 
electromechanical conduction in cardiac myocytes. Improperly located Cx43 in has been 
shown to occur in cardiac biopsies from patients with AC.  In control skin, Cx43 is located at 
the intercellular membrane in the basal and spinous layers. In Q273fs however, it is almost 
entirely absent from the basal layers and instead, is irregularly accumulated in the upper 
epidermis. All three junctional proteins fail to localize correctly in the basal and suprabasal 
layers of the skin from patients with this particular mutation.   
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Figure 4.11. Immunohistochemical staining of patient and control skin. DSP immunostaining 
shows a granular membranous distribution in the basal and mid-epidermis.  PG 
immunostaining appears faint and speckled in the basal layers of patient skin. Cx43 
immunostaining is virtually absent in the basal layers of patient skin. Scale bars marked on 
individual images. Negative control Appendix Figure C.4. 
 
 
 
Patient H586fs shows impressive mislocalisation of DSP in the epidermis. Rather than a 
continuous membrane localization, It forms irregularly distributed dense intercellular 
aggregates which occur more extensively than in Q273fs, extending to the superficial 
epidermis (Figure 4.11).  PG staining is also markedly different from control skin. In the 
patient skin, its expression appears diminished however, where it is present, it forms 
aggregates and accumulates abnormally in the cytoplasm. By contrast, the signal intensity in 
the upper epidermis appears more intense than control skin, possibly suggesting that there 
may be increased expression of PG in the upper layers to compensate for reduced DSP.  Cx43 
immunostaining reflects the distribution of both PG and DSP, its expression is reduced in the 
basal and suprabasal layers and restricted to the upper stratum spinosum.    
 
In both Q273fs and H584fs, the overall levels of DSP appear to be qualitatively somewhat 
reduced, although more striking in H585fs.  By contrast, T922fs shows robust downregulation 
of DSP throughout the epidermis compared with control skin.  Very faint intercellular staining 
is observed in the mid-epidermal layers, predominantly as aggregates (Figure 4.11).  It is 
possible that this particular mutation results in addition to haploinsufficiency, a dominant-
negative effect of the mutant allele on the wild-type.  With regards to PG in T922fs, the 
immunostaining is much less prominent than in control skin, and appears slightly irregularly 
distributed compared with control skin (Appendix Figure C.2).  Cx43 staining is also unusual.  
It appears upregulated in the upper spinous layers and stratum granulosum but almost 
completely absent from the basal and suprabasal layers (Appendix Figure C.3).   
 
R1015fs shows a similar staining pattern for DSP as Q273fs and H585fs, with intercellular 
aggregates of DSP seen in the basal and suprabasal layers (Appendix Figure C.1).  Although 
this is less apparent in the superficial epidermis, there is also a slight reduction of the overall 
intensity of the green signal in this staining. PG staining was distributed in a similar fashion 
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to DSP in this patient’s skin, also showing reduced intercellular deposition in the basal layers, 
and the formation of faint intercellular aggregates.  Cx43 immunostaining differed markedly 
from control skin. The intensity of staining appeared reduced and formed ill-defined “dots” 
or diffuse cytoplasmic staining in the lower epidermis (Appendix Figure C.3).   
 
The immunohistochemical staining pattern of the three proteins, DSP, PG and Cx 43 are also 
abnormal in skin from R1113X (Figure 4.11 and Appendix Figures C.1-C.3).  DSP is abnormally 
distributed in the basal and suprabasal epidermis, where it is present in the cytoplasm and 
forms discrete foci at the intercellular membrane.  The PG signal shows reduced intensity in 
the basal layers and Cx43 is almost entirely absent in the basal and suprabasal layers, save 
for a few speckles.  This differs significantly from its expression pattern in normal skin.  
Where it is located throughout the epidermis.   
 
E1493X 
In the skin biopsies taken from family members carrying this mutation, the localization of 
DSP in the skin actually appeared unchanged compared with control skin. It is correctly 
localized intercellularly without cytoplasmic distribution and minimal formation of 
intercellular aggregates in the basal layers. PG staining was also preserved compared with 
control skin. Cx43 immunostaining appeared comparable with control skin (Figure 4.12). 
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Figure 4.12 Immunohistochemical staining of control and patient (p.E1493X) skin. The 
distribution of DSP, PG, and Cx43 is comparable between patient and control skin. Scale bar 
20µm. Negative control Appendix Figure C.4 
 
It has been previously shown by selectively depleting HaCaT keratinocytes of either DSP-I or 
DSP-II by siRNA, that DSP-II is the key isoform mediating intercellular adhesion in response 
to mechanical stress (Flexcell stretch assay)(Cabral et al., 2012). A Dispase assay was 
performed to assess the role of each isoform in desmosomal adhesion. This showed that 
siDSP-I did not result in a significant increase in the number of fragments produced upon 
agitation, whereas siDSP-II did.  This suggests that DSP-II is able to compensate for DSP-I 
function with respect to intercellular adhesion in keratinocytes.  Therefore, it is relatively 
unsurprising that the DSP-I specific mutation, Q1493fs does not result in a cutaneous 
phenotype, as cutaneous mechanoresilience is predominantly maintained DSP-II (Cabral et 
al. 2012). Furthermore, PG and Cx43 localization is also preserved in this patient, further 
emphasizing that heterozygous loss of DSP-I can be compensated in the skin.   
Control p.E1493X
DAPI Cx43 Cx43 Cx43DAPI Cx43
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4.2.7 Summary of Immunohistochemical Findings  
 
Reviewing the results of the immunohistochemical findings, some consistent trends are 
observed.  In skin from Q273fs, H585fs, T922fs, R1015fs and R1113X, DSP immunostaining 
was reduced in the basal and suprabasal layers and, where present, it appeared to form 
intercellular aggregates and speckles.  PG immunostaining was also reduced in the basal and 
suprabasal layers in these samples and importantly, Cx43 immunostaining revealed a similar 
expression pattern.  Suggesting that, these mutations in DSP result in mislocalisation of the 
three proteins and in some cases reduced expression in the basal layers.  It is particularly 
interesting that these changes are observed in skin biopsies taken from clinically normal 
appearing skin in all five families.  In cardiac tissue from patients with AC, it has been shown 
that PG immunostaining at the intercalate disc is consistently reduced (Asamaki et al., 2009).  
This includes archival autopsy cardiac tissue from the index patient carrying the mutation 
R1113X, whose sister and son donated skin biopsies used for the immunostaining shown 
here. Furthermore, mislocalised Cx43 is also observed in AC. Taken together, these 
observations suggest that clinically unaffected skin from patients with AC can show 
mislocalisation of desmosomal and gap junction proteins that are also found in the heart. It 
is possible to therefore extrapolate that perhaps, the skin in these patients reflects their 
heart.  Interestingly, the changes observed in the skin are predominantly confined to the 
basal and suprabasal epidermis whereas the upper epidermis appears relatively unaffected 
with regards to distribution of DSP, PG and Cx43.  The desmosomal components present in 
the basal layer of the skin are highly similar to those present in the cardiac intercalate disc, 
however their composition differs in the upper stratum spinosum and stratum granulosum.  
Importantly, in addition to DSP and PG, the desmosomal proteins DSC2, DSG2 and PKP2 are 
all preferentially expressed in the basal and suprabasal epidermis and also the intercalate 
disc but not in stratified epithelia. Therefore, the basal and suprabasal epidermis could 
histologically provide a “mirror” for the cardiac intercalate disc. Clinically this could be very 
useful as obtaining a cardiac biopsy is difficult and carries risks during the procedure 
including aneurysm formation and haemorrhage.  Obtaining a skin biopsy is markedly easier, 
particularly from clinically unaffected skin.   
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4.2.8 Correlation of Cardiac and Cutaneous Phenotypes 
 
There can be marked clinical heterogeneity in the cardiac phenotype in patients with AC, 
even amongst individuals within the same family, carrying the same disease-causing 
mutations. To examine the cardiac phenotype of mutation carriers included in this data set, 
retrospective analysis of clinical data from patients was performed.  The patients 
demographics and clinical features, according to the most recent AC Task Force Criteria were 
ascertained from their electronic records by Dr Silvia Castelletti.  The data examined include 
age, sex, family history, symptoms, echo findings, the presence of T-wave inversion, signal 
averaged ecg (SAECG), presence of arrhythmia on 24 hour tape, the presence of an ICD, 
whether the ICD had emitted shocks, and whether the patient fulfilled criteria for a diagnosis 
of AC based on the task force guidance.  The clinical characteristics of patients who fulfilled 
or borderline fulfilled the criteria for AC are shown summarized in Table 1.  
 
 
 
 Variant Patient DSP 
mutation 
carrier 
Age/ 
sex 
Major 
Criteria 
Minor 
Criteri
a 
Curly/
wavy 
hair 
Skin 
 pQ273fs        
1  2-II y 53 F c, e a, d yes yes 
2  1-II y 71 F f a, d yes yes 
3  3-V y 17 F f  yes No 
4  3-II y 17 M f  yes yes 
5  2-V y 46 M f d yes no 
6  2-III y 54F N/A N/A yes no 
7  3-III y 18F N/A N/A Yes No 
8  3-IV y 17M N/A N/A yes No 
9  3-I n 26 M   no no 
10  3-VI n 16 M   no N/A 
         
         
         
 pH586fs        
8  2a-I y 55 M *  yes N/A 
9  2a-II y 50 M a, e, f d yes yes 
10  1c-II y 61 F a, c, f d, e yes yes 
11  2c-II y 36 F e, f d yes yes 
12  2b-I y 42 M e, f a yes yes 
13  1a-II y 71 F f   yes N/A 
14  1b-II y 76 F e, f d yes yes 
 
139 
15  3a-I n 20 F   no no 
16  2c-I n 42 M   no no 
17  2b-II n 39 F   no N/A 
         
 pT922fs        
18  1-I y 30 F b, e c, d yes yes 
19  1-II n 28 F   no no 
         
 pR1015fs        
20  2-V y 26 F *  yes N/A 
21  2-II y 53 F a, b, e, f d yes yes 
22  2-IV y 56 F a, e, f d yes yes 
23  2-X y 61 M c, e, f a, d yes no 
24  3-II y 31 M f a yes yes 
25  3-VIII y 18 M f  yes no 
26  3-I n 30 F   no No 
27  3-III n 27 F   no no 
28  3-IV n 16 F   no No 
29  3-V n 17 M   no no 
30  3-VI n 33 M   no N/A 
31  3-VII n 32 F   no N/A 
32  3-XII n 64 F   no N/A 
33  3-XIII n 52 F   no N/A 
         
 pR1113x        
  2-II y 30 F *ʇ  Yes N/A 
34  1-I y 84 M f d, e yes yes 
35  2-III y 54 F c, f a, d yes yes 
36  2-V y 50 F c, f a, d yes yes 
37  3-I y 26 M f  yes yes 
38  3-II y 24 M f  yes yes 
39  3-VI y 20 F f  yes Yes 
40  3-VII y 15 F f  yes no 
41  3-V n 23 M   no No 
42  3-IV n 25 F   no no 
43  3-III n 22 F   no no 
         
 pE1493x        
  1-V y 38 M * ʇ    
44  1-II y 64 M f a, c, d yes yes 
45  1-III y 59 M a, f d yes no 
46  2-IV y 34 M f d no no 
47  2-VI y 32 F f a, d no yes 
48  2-VIII y 31 F f  no no 
49  2-III y 36 F f d no no 
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Table 4.1. Cardiac and cutaneous phenotype in DSP mutation carriers and non-carrier 
family members 
Categories of fulfilled diagnostic criteria are reported.  
*index case: died suddenly ʇ post-mortem diagnosis 
a, global or regional dysfunction and structural alterations; b, tissue characterization of wall; 
c, repolarization abnormalities; d, depolarization abnormalities; e, arrhythmias; f, family 
history.  
 
 
Among all patients, 12/30 (40%) fulfilled the 2010 Task Force Criteria for AC diagnosis. The 
fulfilment of the diagnostic criteria is presented in Table 4.1. Ten patients (33%) had history 
of arrhythmic symptoms, inverted T waves on electrocardiogram (ECG) were present in 9 
(30%) patients whilst signal-averaged ECG (SA-ECG) was positive in 12 (40%) mutation 
carriers. Ejection fraction was impaired in 9 (30%) patients at echocardiogram. During 24 
hour ambulatory ECG monitoring, >500 ventricular ectopics were noted in 13 (43%) mutation 
carriers, in particular, in 7 of these a non-sustained ventricular tachycardia (NSVT) was 
recorded. Cardiac Magnetic Resonance (CMR) showed fibrofatty infiltration in 10 patients 
(33%) and 11 (37%) patients had an ICD implanted, two of these for secondary prevention. 
A representative cardiac MRI is shown below (Figure 4.13). 72% of patients were found to 
have a skin phenotype.  As desmoplakin is a critical component of the intercalate disc, 
mutations in DSP impair conduction as well as cell-cell adhesion, resulting in fibrofatty 
infiltration and arrhythmia.  
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Figure 4.13. A representative cardiac MRI image from patient II:10 in Family 4. It shows 2 
chambers and short-axis LV turbo spin echo images with and without fat saturation and late 
gadolinium enhancement image on the same slice of a AC patient positive for a mutation in 
DSP. Arrows indicate some areas of fat infiltration (A, B, D, E) and fibrosis (C, F). 
 
 
The exact mechanisms underlying the development of a striate keratoderma remain largely 
unknown however, it is thought that it arises because the footpad epidermis is not able to 
adequately withstand mechanical stress and therefore develops compensatory thickening as 
a “stress response”.  This may be akin to fibrosis seen in the hearts of patients with AC, 
essentially also an impaired response to physical stress. As the histological findings observed 
in patients skin (mislocalised and/or downregulated desmosomal proteins DSP, JUP and 
Cx43) are similar to the typical features observed in myocardial biopsies from patients with 
AC, it suggests therefore that the desmosome dysfunction in the skin could reflect a similar 
occurrence the heart.  Extrapolating this hypothesis further, we questioned whether the 
presence of skin involvement could therefore confer a poorer outcome for patients with AC 
or be linked to disease severity.  Although there is relatively little data available for risk 
stratification in patients with AC, there is a broad agreement that ICD implantation is 
recommended in patients with documented sustained ventricular arrhythmias due to the 
high incidence of arrhythmia recurrence (Brugada et al., 2012) but also those presenting with 
high risk symptoms such as syncope and NSVT.  ICD therapy occurs in approximately 10% of 
p.R1015Sfsp.R1015fs 
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AC patients per year, with an estimated survival benefit of around 25-30% at 3 years (Carrado 
et al., 2003).  Therefore the placement of an ICD is suggestive of a more severe disease 
phenotype.  In this cohort, 12 of the 18 patients (67%) had an ICD in place at the time of 
writing.  All of these patients had clinical evidence of a striate keratoderma. Anecdotally, 
within the same family (p.S1015.fs) two sisters with marked skin involvement of their plantar 
epidermis (2-II and 2-IV) required ICD placement, whereas their cousin (2-X), who did not 
have involvement of the plantar epidermis, does not require an ICD.  These findings could 
suggest that the presence of cutaneous involvement may be associated with a more severe 
cardiac phenotype. Functionally, this would be logical as both skin and cardiac involvement 
indicates defective desmosomal dysfunction and an impaired cutaneous and myocardial 
response to physical strain would therefore be seen in both tissues.  Interestingly, all four 
patients carrying the DSP-1 specific mutation p.E1493X appear to have a milder cardiac 
phenotype than the other families, all family members have normal echocardiograms and 
do not have TWI in V1-V3. Nor do any of the members of this family have an ICD. It has 
previously been shown that DSP-I is the predominant isoform in the heart, with DSP-II 
expression found only in small amounts in the left atrium and ventricle (Ucuzmu et al., 2006). 
However, the seemingly milder cardiac phenotype in this family would suggest otherwise, 
and raises the possibility that in fact, DSP-II could be compensating for DSP-I 
haploinsufficiency in the heart, perhaps in response to stress.  Interestingly, the skin from 
these patients also shows relatively normal expression of PG and Cx43 despite reduced levels 
of DSP-I throughout the epidermis.   
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4.3 Summary of Findings and Discussion 
 
1. Novel cutaneous phenotype in Dominantly Inherited AC 
2. Haploinsufficiency is the molecular mechanism in the skin 
3. Differential expression of DSP I and II isoforms in the skin.  
4. Correlation between cardiac and cutaneous phenotype 
 
The data presented above support a novel cutaneous phenotype in dominantly inherited AC 
caused by mutations in DSP, namely the presence of curly hair and PPK, including striate 
keratoderma, focal keratoderma, hyperkeratosis and fissuring of the heels.  The presence of 
curly hair is found in 76% of all mutation carriers, with a further 10% having wavy hair, 
significantly higher than in the control Caucasian population (p=0.0012).  The curly hair 
phenotype is highly penetrant, such that 92% of offspring of curly-haired mutation carriers 
who also carry the mutation, will also have curly hair.  This phenotypic feature may prove to 
be useful in genetic screening of susceptible family members.  Furthermore, it could also aid 
the timely diagnosis of AC, which as previously eluded to, can be complex due to the vast 
heterogeneity of the clinical presentation.  A proportion of the mutation carriers also had 
evidence of a striate keratoderma and/or hyperkeratosis and fissuring of the heels. This 
could manifest initially as linear thickening between the great toe and the second toe in 
several of the patients examined.  The striate keratoderma in the mutation carriers is a much 
milder phenotype than that observed due to homozygous mutations in DSP (Armstrong et 
al., 1999, Norgett et al., 2000) and appears to become more prominent with age, suggesting 
exposure to mechanical force may be a contributory factor. Some patients also described 
developing very dry hands, particularly in winter, which could manifest as fissures and 
hyperkeratosis along the fingers.  Recently, a homozygous missense mutation in the N-
terminus region of DSP has been linked to “SAM” syndrome (McAleer et al., 2015). 
Ultrastructural analysis of patient skin revealed marked attenuation of cornified envelopes 
and a virtual absence of corneodesmosomes, pointing to a defective skin barrier in the 
pathophysiology of the disease.  It is possible that a similar defect could exists in our cohort 
and contribute to a compromised skin barrier, which would explain the presence of dry, 
cracked fissuring skin, worsened by exposure to cold weather and water.   
 
By extracting mRNA and protein from patient skin biopsies, experiments performed by Dr 
Posafalvi confirmed that haploinsufficiency is the likely underlying molecular mechanism in 
the skin of these patients. The mutant allele does not appear to be expressed at mRNA, and 
 
144 
therefore at protein level, there may be a reduced level of DSP in the skin which could explain 
mislocalisation of DSP, PG and Cx43 in the basal and suprabasal layers of the patients’ skin. 
Using a murine model with a conditional genetic deletion of one allele of DSP in the adult 
heart (DSP+/-), Gomes et al., (Gomes et al., 2012) demonstrated that haploinsufficiency of 
DSP could mimic the cardiac phenotype observed in AC. Furthermore, they also showed 
reduced DSP and PG at the intercalate disc and mislocalisation of Cx43.  These observations 
are similar to what was observed by immunohistochemical staining performed in the skin of 
patients with AC in this study.  However, it is pertinent to note that Armstrong et al., 
(Armstrong et al., 1999) identified a truncating mutation affecting the n-terminal region of 
DSP as the underlying cause of a striate keratoderma in a large pedigree who intriguingly did 
not have underlying ARVC, nor have they since developed it (personal communication), 
suggesting the role of DSP in the development of cardiac and cutaneous features of ARVC is 
complex and likely to be multifactorial.  
 
In the family carrying the mutation p.1493X however, the clinical and histological findings 
were significantly different to those observed in all 5 other families.  In this family, there was 
a notable absence of the curly hair phenotype, with 6/7 family members having straight hair. 
Furthermore, the same 6 family members also did not have features of a keratoderma or dry 
skin/xerosis.  As previously discussed, the location of the mutation is likely to explain the 
difference. The mutation occurs in the DSP-I specific region of the gene, which would 
effectively be “spliced out” in DSP-II.  The presence of “normal” DSP-II in the presence of 
DSP-I haploinsufficiency appears to rescue the clinical phenotype, such that hair 
development also occurs normally. PG, DSP (using DSP-I and II antibody) and Cx43 
immunostaining all appeared comparable between patient and control skin. This observation 
is consistent with previous studies which has confirmed that DSP-II is the isoform required 
for mechanoresilience in keratinocytes (Cabral et al., 2012).   
 
To gain further understanding into the correlation of cutaneous and cardiac findings in this 
cohort, detailed cardiac phenotypic analysis was performed for patients who 
fulfilled/borderline fulfilled the criteria for AC in this cohort.  78% of patients with AC criteria 
also had skin involvement. Of particular interest was that 100% of patients who required an 
ICD to manage their disease also had skin involvement. It is likely that the critical role of the 
desmosome in maintaining skin integrity and cardiac function reflects the shared phenotype 
in this cohort. The presence of skin involvement is suggestive of defective desmosome 
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function and could perhaps represent a surrogate marker for defective desmosome function 
in the heart. In fact, within the same family, the presence of skin involvement delineated two 
sisters who required an ICD from their cousin who did not, which is particularly unusual as 
all three members carry the same mutation. This points to additional factors (genetic or 
epigenetic modification) which could exacerbate both the cardiac and cutaneous 
phenotypes.  Moreover, the family carrying the DSP-I specific mutation p1493X, appeared to 
have a milder cardiac phenotype than the other families, none of these family members 
required an ICD and all had normal echocardiograms. From this it could be inferred that 
despite haploinsufficiency of DSP-I, DSP-II is able to compensate not only in the skin, but also 
in the heart.  A role for DSP-II in the heart has not yet been clearly elucidated and further 
work would be necessary to establish its function more clearly.   
 
In clinical practice, the presence of curly hair and keratoderma is likely to be a useful 
additional clinical identifier of AC patients. When incorporated into family screening for AC, 
it could be particularly useful in persuading individuals to partake in genetic screening 
programmes and identify high risk family members who warrant further diagnostic tests, 
lifestyle changes and participating in regular follow-up. This study did not include pedigrees 
with missense mutations in DSP, nor did it examine carriers of other desmosomal AC gene 
mutations.  All pedigrees included in this study happened to be of Caucasian origin, however 
it would be important to consider the significance of the cutaneous phenotype in other 
populations including those in which curly hair is known to be more highly prevalent. 
Although our study includes the largest number of DSP mutation carriers reported, and the 
first systematic approach of a well-defined mutation subtype cohort, larger-scale genotype-
phenotype correlation studies are necessary to confirm these dermatological findings. 
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Chapter 5  
 
Mutations in FAM83G Cause Autosomal 
Recessive Palmoplantar Keratoderma 
with Leukonychia and Abundant  
Curly Hair 
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5.1 Introduction  
5.1.1 FAM83 Family of Proteins 
 
The FAM83A-H (FAMily with sequence similarity 83) comprise a novel group of signalling 
proteins about which relatively little is known. They were Initially described as “hypothetical 
proteins”, however mass spectrometry has since confirmed the expression of all 8 proteins 
(Cipriano et al., 2013). FAM83A-H are highly conserved in jawed vertebrates, and are 
characterised by the presence of conserved N-Terminal “domain of unknown function”; DUF 
1669 (Figure 5.1). Within this region is a putative phospholipase D motif however it lacks the 
functionally important histidine residues required for enzymatic activity and its molecular 
role remains unknown.  
 
Sequence alignment of members of the FAM83 family show that there is between 32% and 
48% sequence homology within the DUF 1669 region however, outside of this domain 
(Cipriano et al., 2013), the proteins are divergent, sharing very little protein sequence 
similarity. Since their identification, the function of FAM proteins are slowly being 
uncovered, with a predominant focus on their potential role as oncogenes (Bartel et al., 
2016) however the role of the DUF1669 domain remains to be determined.  
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Figure 5.1 The eight FAM83 proteins (A-H) share a common N-terminal domain and Domain 
of Unknown Function (DUF1669) however differ considerably in their C-terminus region. The 
DUF1669 contains a putative phospholipase D motif (PLD). (Adapted from Bartel et al., 2016). 
 
Overexpressed or dysregulated FAM83 proteins have been identified as regulators of cell 
growth, proliferation and metastasis and can be markers of resistance to targeted therapies 
in breast cancer (Cipriano et al., 2014).  FAM83A, for example confers resistance to an EGFR 
tyrosine kinase inhibitor (TKI) in tumorigenic mammary epithelial cells (Lee S-Y et al., 2012).  
Subsequently, FAM83B was found in an independent mutagenesis screen at the Jackson Lab, 
to drive mammary epithelial cell transformation, in a fashion similar to active RAS (Cipriano 
et al., 2012). These data suggest that FAM83 A and B play a role in EGFR and RAS signalling 
pathways and could contribute to malignant transformation in breast tissue.  Further 
evidence for the role of FAM83 proteins in cancer comes from gene expression studies, 
which have shown that FAM83A, B, D and E are highly expressed in ovarian cancers, whereas 
A, C and D are increased in bladder cancer (Cipriano et al., 2014).  
 
Beyond malignancy, autosomal dominantly inherited mutations in FAM83H have been 
shown to underlie Amelogenesis Imperfecta (AI) (Kim et al., 2008, Lee et al., 2008). This rare 
disorder is characterised by impaired mineralisation of the tooth enamel, and as a result, the 
dental enamel of affected individuals is “cheesy soft” in consistency. FAM83H was the first 
non-extra cellular matrix protein found to cause Amelogenesis Imperfecta.  All reported 
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mutations introduce premature stop codons in exon 5 which results in deletion of part of the 
C terminal domain ranging from 503-880 amino acids in length. FAM83H has been shown to 
regulate the cytoplasmic localisation of Casein Kinase Ie by direct interaction. The C-terminal 
truncated protein occurring in AI is thought to have gain-of-function activity leading to 
mislocalised nuclear Casein Kinase Ie that is toxic to ameloblasts (Wang et al., 2016).  
Interestingly, AI-causing mutations in FAM83H have not been linked to malignancy although 
FAM83H is overexpressed in colon cancer where it disorganises the keratin cytoskeleton 
through its interaction with Casein Kinase 1e (Kuga et al., 2016).  As described in Chapter 1, 
keratin filament assembly/disassembly plays a key role in cell proliferation, invasion and 
migration and could explain the role of FAM83H in colon cancer invasion and metastasis.  In 
AI, disruption of the cytoskeleton by disease causing mutations in FAM83H also impairs the 
formation of desmosomes. Both keratins and desmosomes are required for the proper 
formation of dental enamel in ameloblastoma cells.   
Other members of the FAM83 family, FAM83C, E and F remain to be characterised and are 
yet to be linked to function or disease.  
 
 
5.1.2 FAM83G 
 
FAM83G is an 823 amino acid long protein encoded by the FAM83G gene located on 
chromosome 17p11.2. It is highly conserved in eutherians (placental mammals) however in 
more distantly related vertebrate species, the predicted FAM83G orthologs show reduced 
homology. RNA and protein expression studies reveal that FAM83G expression is highest in 
the skin, followed by the colon and oesophagus (www.proteinatlas.org).  FAM83G 
expression is specifically enriched (> five-fold) in the skin compared with 26 other tissue 
types (Edqvist et al., 2015). 
To date, it has been the subject of only four publications, three linking it to disease in animals 
(Radden et al., 2013, Drogemuller et al., 2014, Sayyab et al., 2016) and one functional study 
(Vogt et al., 2013).  Using a proteomic approach, Vogt et al. 2013, identified FAM83G as a 
novel Smad1-interacting protein, where it promotes smad4-independent signalling and 
transcription of non-BMP target genes NEDD9 and ASNS. 
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5.1.3 Recessively Inherited Mutations in FAM83G in Animal Models 
 
In 2013, the Jackson laboratory reported the identification of a spontaneously occurring 
phenotype in mouse with a woolly coat evident at 3-4 weeks of age and named it the “wly” 
mouse (Radden et al., 2013) (Figure 5.2). No other phenotypic abnormalities were seen and 
affected mice had a normal life expectancy.  
 
 
Figure 5.2 The wly mouse exhibits a striking, woolly coat. Histopathology of murine skin 
demonstrated “giant hair follicles in anagen” (adapted from Radden et al.,2013) 
 
A recessively inherited frameshift mutation resulting in a 995bp deletion in FAM83G was 
determined as the underlying cause of the wly mouse by exome sequencing. The authors 
suggested that this deletion is likely to result in a severely truncated non-functional protein 
product, at least partially removing the conserved DUF1669.  Although no functional work 
was carried out in this paper, a skin biopsy from an affected mouse revealed “giant” hair 
follicles with all hairs in the anagen phase of the hair cycle (Radden et al., 2013).  
 
Purebred dogs are particularly well suited to genetic analysis due to their limited population 
structure. In 2014, Drogemuller et al. (Drogemuller et al., 2014) used a genome wide 
association (GWAS) approach combined with whole genome sequencing (WGS) to identify 
missense mutations in FAM83G as the underlying cause of the recessively inherited disorder 
“Hereditary Footpad Hyperkeratosis” in Kromfohrlander and Irish Terrier dog breeds. The 
variant c.155G>C was predicted to change an evolutionarily conserved arginine into a proline 
(p.R52P) and occurs within the DUF1669.  Further genotyping confirmed that this variant was 
present in more than 500 HFH dogs. Like the “wly” mouse, the phenotype in affected dogs 
is a bushy coat presenting from a few weeks of age. In addition, the dogs also have 
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hyperkeratotic, fissured footpads and hard, rapidly growing nails that require frequent 
trimming (Figure 5.3). 
 
 
Figure 5.3 Hereditary Footpad hyperkeratosis in Irish Terrier dogs. (A) Marked 
hyperkeratosis and fissuring of the footpads as well has rapidly growing nails are observed 
in mutation carriers compared with normal controls (B). (C) Affected dogs are identifiable by 
the presence of a woolly, wavy coat (left) compared with normal control (right). Figure 
adapted from Drogemuller et al., 2014. 
 
 Although there is no reduction in life expectancy, pain and discomfort resulting from 
footpad thickening and superadded infection can contribute to lameness. Biopsies taken 
from the paw of an affected dog revealed marked hyperkeratosis and acanthosis of the 
epidermis (Drogemuller et al., 2014).  As a consequence of this discovery, dog breeders can 
now use commercially available genetic screens for variants in FAM83G to screen for HFH.   
 
As the reported deletion in mice results in a severely truncated and probably non-functional 
protein, it is likely that the mutation in dogs, with a similar clinical phenotype is also loss of 
function.  
 
In the Irish Terrier cohort with 10 cases and 21 controls, all
dogs had call rates .90%. We removed 5,723 markers with call
rates ,90% from the analysis. We also removed 89,179 markers
with MAF ,10% and 366 markers strongly deviating from
Hardy-Weinberg equilibrium in the controls (p,1025). The final
Irish Terrier dataset consisted of 31 dogs and 82,671 SNPs.
We performed an allelic association study and determined an
empirical significance threshold by performing 100,000 permuta-
tions of each dataset with arbitrarily assigned phenotypes.
As both datasets showed considerable population stratification,
we also analyzed the data using GenABEL and a mixed model
approach [27]. This procedure corrects for cryptic relatedness by
using the genomic kinship estimated from the marker data as
covariable in the model. In both cohorts the same markers showed
the highest association regardless whether the simple PLINK
analysis or the mixed model GenABEL analysis was performed.
With the correction for population stratification the genomic
inflation factors were reduced from 1.40 to 1.07 in Kromfohr-
länder and from 1.32 to 1.02 in Irish Terriers. The corrected p-
values (Pc1df) for the best associated markers were then 4.761028
in Kromfohrländer and 4.261026 in Irish Terriers.
We also used PLINK to search for extended intervals of homo-
zygosity with shared alleles. The final critical interval was defined
by visual inspection of all SNP chip genotypes on chromosome
5 for the 13 Kromfohrländer and 10 Irish Terrier cases in an
Excel-file.
Gene analysis
We used the dog CanFam 3.1 assembly for all analyses. All
numbering within the canine FAM83G gene corresponds to the
Figure 4. Clinical phenotype of digital hyperkeratosis. (A) Paw of a 1 year old affected Kromfohrländer. Note the cracked surface and deep
fissures of the foot pads. (B) Paw of a control Kromfohrländer. (C) Hair coat of the dogs shown in panels A and B. The affected dog (left) has a more
irregular coat appearance in comparison to the unaffected control dog (right). Both dogs are representatives of the wire-haired (‘‘rough-coated’’)
Kromfohrländer variety.
doi:10.1371/journal.pgen.1004370.g004
FAM83G in Footpad Hyperkeratosis
PLOS Genetics | www.plosgenetics.org 6 May 2014 | Volume 10 | Issue 5 | e1004370
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Tightly regulated homeostatic mechanisms determine the turnover of skin and hair and nail 
matrix cells to maintain stable epidermal thickness and rate of hair and nail growth The 
animal phenotypes reported, comprising bushy hair, rapid nail growth and footpad 
thickening suggest that loss of functional FAM83G results in an imbalance of epidermal 
homeostasis.  
 
 
5.1.4 Maintaining Epidermal Homeostasis – The Stem Cell 
 
Over the course of a human lifetime, the outer layers of the epidermis are replaced over a 
thousand times. Intricate regulatory mechanisms govern the balance between proliferation 
and differentiation of cells in the basal layer that give rise to distinct epidermal lineages.  Self-
renewing stem cells residing in the basal layer of the epidermis play a critical role in 
replenishing the epidermis during homeostasis and in response to injury (Solanas and 
Benitah 2013). The key defining characteristics of stem cells are as follows: 
1. It Is not itself terminally differentiated 
2. It can divide without limit 
3. Its daughters have the choice to either remain a stem cell or commit to terminal 
differentiation.   
To maintain a steady state within the epidermis, precisely 50% of the daughters of stem cells 
in each generation must remain as stem cells. Stem cells are also required for skin 
appendages such as the hair and nails. The nail matrix contains a small population of self-
renewing stem cells which sustain continuous growth of the nail. These cells can even 
orchestrate reconstruction of a partially amputated digit (Tekeo et al. 2013). Stem cells in 
the hair follicle have been intensively studied and will be discussed later in this chapter.  
 
5.1.5 Canonical Wnt Signaling Pathway 
 
Wnt signalling is a highly conserved pathway which is required for the maintenance of adult 
epithelial stem cells of various lineages.  They are well known to regulate stem cell 
pluripotency and regulate multiple processes during development, such as cell polarity and 
embryonic induction and the specification of cell fate.  Stem cell proliferation and malignant 
transformation are often considered “ two sides of the same coin” and as such, misregulation 
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of Wnt signalling is widely implicated in human cancer (Solanas et al., 2014). Several 
components of the pathway are known oncogenes or tumour suppressors and this is the 
focus of much investigation for therapeutic discovery. Although both canonical and non-
canonical Wnt signalling pathways exist, this chapter will focus on canoncical Wnt signalling 
which plays a key role in the skin and its appendages.  
 
Canonical Wnt signalling is mediated by its intracellular signal transducer protein, β-catenin.  
It is initiated by the binding of Wnt ligands to the extracellular binding domain of their 
corresponding 7 pass transmembrane G-coupled receptors (Frizzled, Fz) and the activation 
of Disheveled (Dvl). These receptors then form a complex with co-receptors LRP5/6 which 
results in their activation.  In the absence of Wnt signalling, β-catenin is sequestered and 
degraded at the cell surface membrane by a “destruction complex” comprising AXIN, APC, 
GSK3, Casein Kinase 1a and PP2A, which phosphorylate the amino terminal of β-catenin and 
leads to its recognition by E3 ubiquitin Ligase B-TrCP which targets it for proteosomal 
degradation (Stamos and Weis, 2013).  This continual degradation prevents β-catenin 
translocating to the nucleus.   
When Wnt is activated, the destruction complex is inhibited because Axin is recruited to the 
complex. β-catenin phosphorylation and degradation is reduced and it becomes stabilized, 
accumulating in the cytoplasm and subsequently translocating to the nucleus (Figure 5.4). 
Although nuclear β-catenin does not bind DNA itself, it does interact with the TCF/LEF family 
of transcription factors leading to transcription of pro-proliferative Wnt target genes such as 
c-myc and c-jun. The details of how β-catenin shuttles between the cytoplasm and nucleus 
remain largely unknown however, microtubules and active transport are thought to be 
involved (Sugioka et al., 2011).   
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Figure 5.4 Canonical Wnt signalling. (A) In the absence of Wnt signalling, phosphorylated Β 
Catenin is sequestered in its destruction complex in the cytoplasm. (B)When Wnt ligands 
bind to Frizzled/LRP complexes at the cell membrane, the destruction complex is recruited, 
releasing β-catenin, now in its dephosphorylated “activated” state. It can then translocate to 
the nucleus and activate transcription factors such as TCF/LEF1 leading to the transcription 
of Wnt target genes (yellow arrow)  
 
Constitutive activation of Wnt signalling has been linked to carcinogenesis. For example, 
autosomal dominantly inherited mutations in APC are linked with the familial cancer 
syndrome “Familial Adenomatosis Polyposis”. Mutant APC prevents inhibition of β-catenin 
and results in a high risk of developing colorectal carcinoma in affected individuals. 
Furthermore, global exome-sequencing has confirmed that the majority of colorectal 
cancers carry inactivating APC mutations (Wood et al., 2007).  Patients with hereditary Axin 
3 mutations also carry a predisposition to colon cancer and have tooth agenesis (Lammi et 
al.,2004). 
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5.1.6 R Spondins and LGRs 
 
The strength of Wnt signalling can be further fine-tuned in vertebrae by the R-spondin family 
of ligands and leucine rich repeat (LGR) G-coupled family of receptors (Clevers et al., 2014).  
R Spondins are ligands for LGR5, 5 and 6, a subgroup of the Rhodopsin family of GPCR’s (de 
Lau et al 2012) and act as secreted ligands of Wnt signalling. The important role that R-
Spondins play in embryogenesis has been shown by loss of function mutations in humans 
and mice.  Inactivation of the R-Spondin 2 gene results in a “foot-less” mouse (Nam et al., 
2007). R Spondin 1 mutations underlie gonadal development in XX individuals.  R Spondin 3 
regulates placenta development and causes embryonic death. Our group have previously 
found that loss of function mutations in R-Spondin 4 cause congential anonychia (absent or 
severely hypoplastic nails on fingers and toes) in humans (Blaydon et al. 2006).   
LGR4-6 bind R-spondins in response to canonical Wnt signalling, which results in 
phosphorylation of LRP 5/6 and stabilised β-catenin (de Lau et al 2011).   
LGR5 is a highly specific marker of actively proliferating stem cells in the intestine and hair 
stem cell bulge. They have been shown to mark long-lived yet slowly cycling cells in the hair 
stem cell bulge, which result in increased hair growth when transplanted into nude mice 
(Jaks et al., 2008).   
 
 
5.1.7 Wnt/ β-catenin Signaling in the Hair Follicle Stem Cell Niche 
 
The hair follicle has proved to be an ideal tissue in which to study stem cell behaviour due to 
its accessibility, and the well characterised anatomical nature of individual components of 
the hair stem cell niche. Wnt signalling is critical for hair follicle development and 
regeneration. When Wnt signalling is inhibited by ectopically expressed Dickkopf1 (DKK1), a 
secreted Wnt antagonist, in the skin of transgenic mice, there is complete failure of 
formation of the placode, the initial embryonic structure required for hair follicle 
development and this results in a hairless mouse (Andl et al. 2002).  By contrast, sustained 
Wnt activity and nuclear translocation of β-catenin has been shown to induce de novo hair 
follicles within the epidermis of transgenic mice (Lo Celso et al, 2004) by redirecting 
keratinocytes in the interfollicular epidermis and sebaceous glands to differentiate along the 
hair follicle lineage.  
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5.1.8 Anatomy and Function of the Hair Follicle 
 
Hair follicles are self-renewing structures containing distinct reservoirs of multipotent stem 
cells that are able to entirely regenerate the epithelium.  At the base of the hair follicle is a 
pocket of dermal cells known as the dermal papilla, from which signals arise instructing 
epithelial stem cells in the hair bulge to divide and migrate to the base of the hair follicle and, 
in response to further cues from the dermal papilla, differentiate to form the hair shaft 
(Alonso and Fuchs, 2006).  Hair does not grow continuously, but instead passes through 
sequential cycles of growth (Anagen), rest (Telogen) and shedding (Catagen). During each 
anagen phase, hair cycles are able to generate an entire hair shaft from root to tip. Cyclical 
growth and shedding of hair occurs throughout postnatal life and is influenced by hormonal 
changes, for example androgens in both men and women contribute to shortened anagen 
phase and miniaturisation of scalp hair follicles which cause androgenetic alopecia (AGA), a 
common form of hair loss.  By contrast, during pregnancy, high levels of oestrogen lengthen 
anagen and reduces hair shedding (Langan et al., 2010).   
 
Hair follicle cycling is governed by two opposing regulatory pathways – inhibitory Bone 
Morphogenic Protein (BMP) and activating Wnt signalling. During phases where BMP 
signalling predominates, hair enters the telogen (resting phase). Once Wnt signals surpass 
the threshold for activation, and β-catenin is translocated to the nucleus, the follicle is 
primed undergo telogen-anagen transition. Hair is then regenerated by stem cells located in 
the bulge, which migrate to the matrix at the tip of the hair bulb, and differentiate to form 
the multiple layers of the outgrowing hair shaft and inner root sheath. The rapidly dividing 
cells within the matrix elongate into the dermis by rapidly expanding during anagen (Alonso 
and Fuchs 2006).  Distinct markers define bulge stem cells, these include LGR5, CD34 and 
Keratin 15. The inductive properties of hair bulge stem cells has been shown in an elegant 
series of experiments by Jahoda et al. (Jahoda et al., 1984) who demonstrated by 
transplantation, that adult bulge stem cells can induce the growth of hair when transplanted 
into follicles which would otherwise not grow hair.  The regeneration of hair follicles requires 
activated β-catenin in dermal papilla cells (Enshell-Seijffers et al 2010). More recently, Zhou 
et al (Zhou et al. 2016) overexpressed a stabilised form of β-catenin in the dermal papilla 
which led to an accelerated rate of hair growth in mice by increased matrix cell proliferation 
and differentiation in hair follicles.   
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5.2 RESULTS 
 
5.2.1 Clinical Phenotype 
 
Two adult siblings from a Pakistani family with a history of parental relatedness presented 
with progressively deteriorating palmoplantar keratoderma. They reported marked 
thickening of the skin of the soles and to a lesser extent the palms since childhood.  They 
also had thick, bushy and curly scalp hair, noticeable since the age of 2-3 years old, which 
they both commented grew very quickly, requiring frequent haircuts. The female siblings’ 
hair could grow easily below her waist and was extremely thick.  Examination revealed severe 
diffuse, verrucous hyperkeratosis with deep fissuring affecting the soles (Figure 5.5) and to 
a lesser extent, the palms. The hyperkeratosis was more marked at pressure bearing sites. 
Some hyperkeratosis was also noted in the interdigital spaces.  There was no evidence of 
transgradiens. The toenails were dystrophic with onycholysis and leukonychia was also 
present, most evident in the finger nails. There was also some proximal nail fold erythema 
and periungual swelling.  Onychomycosis was excluded by negative fungal culture. No 
abnormalities of teeth or sweating were identified. Both siblings had abundant curly, dense 
scalp hair. The affected females’ hair had a matted appearance and was difficult to brush. 
There was no evidence of hair breakage and no scalp abnormalities were observed. Neither 
sibling described excessive hair growth elsewhere on the body and clinical examination did 
not reveal hirsutism. Both parents were examined and did not share any phenotypic 
similarity to their offspring. Neither sibling reported any further symptoms and a full skin 
examination did not reveal any additional phenotypic features. Both parents were examined 
and found to be unaffected and both had straight hair. Clinical photographs were taken with 
written patient consent.  
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Figure 5.5 (A) Two siblings presented with diffuse, gross palmoplantar keratoderma, 
displaying marked  hyperkeratosis and fissuring particularly affecting the soles and to a lesser 
extent the interdigital space (B). The toenails were dystrophic (C) and leukonychia was 
observed in the hands (D). The scalp hair was curly, thick, dense and had a matted 
appearance. The affected female could grow her hair beyond the waist (E and F). 
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5.2.2 Exome Sequencing 
 
Peripheral blood samples were collected for exome sequencing from all four family members 
after written informed consent in adherence with the Declaration of Helsinki Principles and 
approval of the East London and City Health Authority. Exomes were captured and enriched 
using SeqCap EZ Human Exome Library v3.0 (Roche NimbleGen, Madison, WI) and were 
sequenced on a Hiseq 2000 platform (Illumina, San Diego, CA) according to the 
manufacturer’s instructions. Sequence variants were filtered against public databases 
(dbSNP137, 1000 Genomes Project, HapMap8).  Given the history of parental relatedness of 
the family, the variants were filtered for homozygous changes shared by the two affected 
individuals, of which, 83 homozygous variants (i.e. variants identified in both chromosomes) 
were reported either as novel, or with an Exome Variant Server (NHLBI GO Exome 
Sequencing Project (ESP), Seattle, WA) estimated frequency of less than 0.01, were selected 
as potential candidates. These candidates included a homozygous C to A transversion, 
c.C101A, in exon 2 of FAM83G (NM_001039999) a gene reported to be mutated in 
Hereditary Footpad Hyperkeratosis (HFH) in Kromfohrländer and Irish terrier dog breeds, 
which presents with fissuring hyperkeratosis of the paws and a bushy coat (Drogemuller et 
al., 2014, Sayyab et al., 2016). Furthermore, the bushy hair phenotype of the “woolly” mice 
(wly mouse) has been linked to a 995bp deletion in fam83g (Radden et al., 2013). Therefore, 
the variant in FAM83G presented as an obvious candidate for further analysis. The 
homozygous c.C101A variant in FAM83G was confirmed by Sanger sequencing in both 
siblings and both parents were heterozygous carriers (Primer sequences: FAM83G-F: 
5’CCGGGCTCATCAGGTCTTT 3’ and FAM83G-2R: 5’ GAGCGGTCCGACTTCTGG 3’; Figure 5.6A 
and D.1). The c.101C>A mutation results in loss of a Cac8I restriction endonuclease 
consensus site and segregation of the mutation with the condition was confirmed by RFLP 
(restriction fragment length polymorphism) analysis (Figure 5.6B) which was performed by 
Dr Diana Blaydon (Kelsell Group). The mutation c.C101A is predicted to change an 
evolutionary conserved alanine to glutamate (p.A34E) in the protein FAM83G. This missense 
mutation was absent from dbSNP, ExAC, 1000 genomes, gnomAD and EVS. It is predicted to 
be deleterious to the protein structure (Polyphen2 score 1.00, SIFT score 0.00) as the 
resulting amino acid change is from a non-charged, non-polar residue to a charged polar 
residue. This particular residue is conserved across 29 vertebrate species examined, 5 of 
which are shown here (Figure 5.6C) as well as between members of the FAM83 family of 
 
160 
proteins. The FAM83A-H family are characterized by the presence of a conserved N-terminal 
domain of unknown function; DUFI 669. Like the missense variant, p.A34E, reported in this 
study, the missense variant, p.R52P, underlying HFH in dogs is also located in the DUF 1669 
domain (Figure 5.6D). FAM83G expression is specifically enriched (> five-fold) in the skin 
compared with 26 other tissue types (Edqvist et al., 2015). FAM83G has been implicated as 
a regulator of BMP signaling (Vogt et al., 2014) 
 
 
 
 
 
Figure 5.6 (A) Homozygous C to A mutation, c.101C>A, in FAM83G identified by exome 
sequencing was confirmed by Sanger sequencing (B) Segregation of the mutation within the 
family was confirmed by RFLP analysis (genotypes in red). (C) The mutation c.101A is 
predicted to result in the missense variant, p.A34E, in the FAM83G protein affecting an 
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alanine residue (indicated in red) that is evolutionary conserved across vertebrates. (D) The 
mutation occurs within the DUF1669 (red arrowhead) 
5.2.3 Histology and Immunohistochemistry 
 
With informed consent, a 5mm punch biopsy was taken from the right thigh of the affected 
male sibling. The skin at this site appeared clinically normal. Unfortunately, both siblings 
declined a biopsy being taken from the scalp, palms or soles.  H&E staining of the patients 
skin showed some evidence of an acanthosis, and thickening compared with site-matched 
normal skin.  There was no evidence of hyperkeratosis (Figure 5.7).  
 
 
Figure 5.7 H&E staining of patient skin reveals acanthosis compared with site matched 
control skin (Scale bar 50 μm) . 
 
Immunohistochemistry for FAM83G (Abcam ab121750, Cambridge, UK) revealed that its 
expression was diminished throughout the epidermis of the patients’ skin. In control skin, 
FAM83G was observed throughout the epidermis, more prominently in the basal layers in 
keeping with previous reports (Drogemuller et al., 2014 (Figure 5.8).  
 
As the H&E and the clinical phenotype were suggestive of a hyperproliferative aetiology, 
immunohistochemistry was performed for known proliferation markers; Ki67 (Abcam 
ab15580) and K14 (CRUK LL001). Both appeared upregulated in the patient skin compared 
with control. Interestingly, K14 immunostaining which is usually confined to the basal layer 
in the normal epidermis, extended to the suprabasal layers (Figure 5.8).  These observations 
support the hypothesis of increased keratinocyte proliferation in the patient skin.   
 
As epidermal homeostasis is a balance between proliferation and differentiation, 
immunohistochemistry for epidermal differentiation markers K10 (Ab9026, Abcam, UK), 
Control  Patient  
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Loricrin (Ab85679) and Filaggrin (Ab81468) were also performed (Figure 5.9).  Their 
distribution and expression appeared to be similar between control and patient skin. 
Suggesting that, at least in clinically normal-appearing skin, the missense mutation in 
FAM83G results in increased proliferation without altering differentiation.   
 
Figure 5.8 Patient epidermis displays reduced FAM83G expression.   Upregulation of Ki67 is 
observed in the basal layers. Keratin 14 expression appears increased and extends to 
suprabasal layers. Total β-catenin expression appears similar between patient and control 
skin, although some nuclear staining is seen in the upper layers. Active nuclear β-catenin 
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expression is markedly increased in patient skin compared to control and extends to the 
upper layers (white arrow) (Scale bars 50μm). Negative control Appendix Figure D.2. 
  
Figure 5.9 Immunohistochemical staining of differentiation markers K10, Loricrin and 
Filaggrin showed similar localisation and expression between patient and control skin. (Scale 
bars 50μm). Negative control Appendix Figure D.2 
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5..2.4 Confocal Hair Analysis 
 
As the hair phenotype in both affected siblings and the animal models appears to have a 
striking hair component, we performed confocal hair analysis in collaboration with the 
Maatta Lab (University of Dundee).  Hair samples from both parents and the affected son 
were sent for analysis.  Confocal imaging of hairs revealed membrane bound deposits on the 
outer cuticle of the hair shaft in 30% of the patients’ hairs (Figure 5.10 A arrowhead), which 
were absent in the parents’ hair shaft. This was confirmed by transmission electron 
microscopy (X4000) (5.10 B) and was felt to be consistent with poorly differentiated cuticle 
cells. It is possible that this could occur in the presence of increased proliferation within the 
hair follicle.  No other abnormalities of the hair shaft were identified. 
 
 
Figure 5.10 (A) Confocal imaging of the hair shaft from the affected sibling shows membrane 
bound deposits on the outer cuticle of the hair shaft (white arrowhead) (Scale bar 25µm). 
(B) TEM of a cross section of the affected siblings’ hair shaft show regions of poorly 
differentiated cuticle cells (black arrowhead)(Scale bar 4µm). 
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5.2.5 FAM83G expression profiling 
 
Publicly available large scale datasets can provide a useful tool in identifying the potential 
role for novel genes.  The Lifemap discovery website (www.discovery.lifemapsc.com) holds 
a repository of numerous microarray datasets derived from the literature.  A search for 
FAM83G in this repository highlighted that it was found in three individual microarray 
analyses of hair bulge stem cells. In one study by Greco et al. (Greco et al., 2009), FAM83G 
was one of 102 genes found to be differentially upregulated in hair bulge stem cells 
compared with dermal papilla cells in adult mice, with a 6.12 fold change observed. Although 
not conclusive, taken together with the strikingly similar clinical phenotypes in humans, dogs 
and mice, this could suggest a hitherto unidentified role for FAM83G in hair follicle stem 
cells.  
 
5.2.6 FAM83G and β-catenin 
 
The most striking and unifying feature of the three reported phenotypes in animals and 
humans is the presence of bushy, thick hair that is also longer than the hair of their wild type 
littermates.  Histological evaluation of the hair follicle of the wly mice has previously shown 
“giant” follicles all in anagen (Radden et al., 2013). The duration of anagen is the main 
determinant of hair length. This led us to hypothesise whether the mutation in FAM83G 
could result in increased Wnt activity, which could subsequently maintain hair in the anagen 
phase.  β-catenin is a critical signalling molecule at the centre of canonical Wnt signalling and 
plays a pivotal role in hair and nail growth and skin homeostasis.  We performed 
immunohistochemical staining with a total β-catenin antibody (BD Transduction Labs 
610153, Oxford, UK) (Figure 5.8) in the patients skin and observed that β-catenin expression 
appeared similar between patient and control skin cells but subtle nuclear localisation was 
evident in the upper layers in patient skin. Nuclear Β Catenin suggests its activation and 
propogation of downstream Wnt signaling. To confirm that β-catenin was indeed activated, 
immunohistochemical staining was performed with an active β-catenin antibody (Merck 
Millipore 05-655 Clone 8E7, Watford, UK) and this demonstrated rather strikingly, nuclear 
accumulation throughout the epidermis in patients’ skin compared with control skin where 
its expression was minimal (Figure 5.8).  Initial staining was performed by myself and 
repeated by Lisa McGinty (PhD student, Kelsell group) for the purposes of publication. 
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5.2.7 FAM83G Expression in Murine Hair Follicles 
 
To further explore the role of FAM83G in hair follicles, immunohistochemical staining was 
performed in hair follicles from the back skin of control mice in different phases of the hair 
cycle. FAM83G was found to be expressed during the anagen growth phase (P28) (Figure 
5.11 A) and exhibited high levels of staining intensity at the IRS as well as in the dermal 
papilla. The expression of FAM83G appeared to be maintained in catagen/early telogen 
(P42), within the IRS (Figure 5.11 B). As outlined previously, FAM83G has previously been 
identified as a differentially expressed gene in adult mouse hair bulge stem cells compared 
with dermal papilla cells during telogen (P56) (Greco et al., 2009).  
 
 
 
 
Figure 5.11 (A) FAM83G expression in the murine hair follicle during anagen (P28) is 
observed in the Inner Root Sheath (IRS), Dermal Papilla (DP) and sweat glands (SG). (B) 
FAM83G expression is observed in the IRS during catagen/early telogen (P42). Scale bar 
50µm. Negative control Appendix Figure D.2 
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5.2.8 FAM83G Knock-Down in HaCaT Keratinocytes 
 
HaCaT cell lysates in which FAM83G had been knocked-down by sh-RNA were received as 
kind gift from the Sapkota Lab (Dundee, UK) for this project.  These lysates were 
immunoblotted and probed for β-catenin and Active β-catenin (Anti-ABC Clone 8E7, Merck, 
Millipore, dephosphorylalted Ser37 or Thr41)). Western blotting of these lysates showed no 
differences in total β-catenin. However Active β-catenin appeared to be upregulated at 
protein level in FAM83G-KO cells (n=3).  Other downstream markers of Wnt signalling such 
as Axin, c-myc, TCF, R Spondin 1 and 4 were also assessed but differences were not observed 
(Figure 5.12) . It is important to note that this data is preliminary and at the time of writing, 
the role of FAM83G in Wnt signalling is unknown. This preliminary data suggests that there 
may be a relationship between FAM83G and active β-catenin however further investigation 
of downstream markers such as LEF1, Cyclin D1, c-myc and c-jun are necessary to 
characterise this relationship further.  
 
One hypothesis that could explain our findings is that FAM83G could be part of the β-catenin 
destruction complex. Unpublished work by Hans Clevers lab have identified FAM83G as a 
novel binding partner for AXIN2. A further potential area of study could be whether FAM83G 
interacts with keratins. FAM83H has been shown to regulate keratin filament spatial 
organisation by interaction with CK1a. It is possible that FAM83G, which also shares the same 
DUF region as FAM83H could also interact with the keratins but at present this remains 
speculative. Wnt signalling in humans is complex and affected by multiple converging 
signalling pathways, therefore although some novel findings are observed here, a great deal 
of further work is necessary to unravel the complexities of FAM83G in the skin. A more recent 
study has identified the DUF domain as a requirement for interaction with CK1a for the 
FAM83 family of proteins, highlighting their novel role of FAM83 proteins in Wnt signalling 
(Fulcher et al., 2018).  
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Figure 5.12 Immunoblotting of lysates extracted from FAM83G KO cells was performed and 
showed upregulation of active β-catenin but no clear differences in Axin, C-myc, TCF1, R 
spondins 1 and 4. GAPDH was used as a loading control. 
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5.3 Discussion 
 
5.3.1 A novel role for FAM83G in human skin, hair and nail homeostasis 
 
The predominant focus of this work is the novel identification of a disease-causing mutation 
in FAM83G in humans. The missense mutation identified is predicted to be damaging, 
suggesting a loss-of-function effect. This work presented here formed the basis of a paper 
published by Maruthappu et al., 2018.  The findings highlight a hitherto unidentified role for 
FAM83G in the homeostasis of the palmoplantar epidermis and hair follicle. Across all three 
species identified in this and previous publications, mutations in FAM83G affect the highly 
conserved DUF1669, and result in a similar clinical phenotype. We have highlighted a a role 
for this novel protein in skin, hair and nail homeostasis. A challenge faced during the 
publication of this work is that at the time of writing, very little was known about the function 
of FAM83G in human skin therefore it was possible only to speculate on its role.  
 
5.3.2 Mutations in FAM83G are associated with increased proliferation markers in 
the epidermis 
 
In patient skin, we have shown evidence for hyperproliferation, with increased K14 and ki67 
in the basal layers. This is particularly interesting because the site of the biopsy used for these 
studies was the patients’ thigh, and appeared phenotypically normal with no overt evidence 
of thickening of the epidermis. Differentiation markers, K10, Loricrin and Filaggrin all showed 
comparable immunostaining to control skin, suggesting that in patient skin, there is 
increased basal proliferation without overt changes in differentiation.  It is possible that 
these patients have increased turnover of clinically normal appearing skin.  
 
One interesting finding was the increased nuclear localization of β-catenin in patient skin 
compared with control skin. This was observed using an antibody for “active” Β Catenin 
(Merck, Millipore AE07). Total β-catenin however was comparable between the two 
samples.  Nuclear β-catenin was observed throughout the epidermis in patient skin. Nuclear 
β-catenin is rarely seen in the normal adult human epidermis but does occur in non-
melanoma skin cancers such as Basal cell carcinomas, Squamous cell carcinomas and 
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Pilomatrixomas (Doglioni et al., 2003). It has also been observed in the suprabasal layers of 
hyperproliferative psoriatic skin and in the wound healing state (H Clevers., 2006). Full skin 
examination of our patients have not revealed such tumours but they remain under regular 
surveillance. It is possible that upregulated β-catenin activity in the palmoplantar epidermis 
of affected patients skin and nails contributes to the development of the marked 
hyperproliferative palmoplantar keratoderma. Furthermore, recent research has linked a 
close family member FAM83H to upregulated Wnt/ β-catenin signaling and a similar 
mechanism is highly likely to contribute to the skin hair and nail phenotype observed (Yang 
et al., 2018). 
 
The findings above led us to consider whether FAM83G could in fact play a role in canonical 
Wnt signaling. Previous publications have shown that overexpression of active β-catenin in 
the murine epidermis increases the thickness (with increased density of hair follicles) and 
length of hair growth (Zhou et al., 2016), which bears similarity to the hair phenotype 
observed in our affected patients.   
 
5.3.3 Mutations in FAM83G result in a striking hair phenotype  
 
Our patients exhibited a striking exuberant curly/wavy hair phenotype, which is also 
observed in both animal models.  Anecdotally, our patients also reported rapid hair growth, 
with the affected male cutting his hair every month. The affected female could easily grow 
her hair beyond the waist. Neither parent exhibited a similar phenotype. Unfortunately, our 
patients declined a scalp biopsy, which could have shed further light on the role of FAM83G 
in the human hair follicle. However, confocal microscopy of the hair shaft of affected patients 
uncovered the presence of deposits on the cuticle in 30% of the patients’ hair samples, 
absent from both parents and control hair. Electron microscopy suggested that these were 
poorly differentiated cuticle cells. This could result from hyperproliferation within the hair 
follicle.  
 
Murine hair follicles undergo predictable cycling and therefore allow examination of the hair 
follicle at different phases of the hair growth cycle. Murine hair follicles in Anagen (P28) and 
Telogen (P42) were a kind gift from Dr Kristin Braun. Immunohistochemistry of FAM83G 
showed it localized to the inner root sheath and dermal papilla during anagen and in the 
inner root sheath during telogen.   
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The inner root sheath is composed of the inner root sheath cuticle, Henley’s and Huxley’s 
layers. BMP, Wnt/ β-catenin and Notch signaling are responsible for the normal 
differentiation of matrix cells into the hair shaft and IRS envelope. Mutations in genes such 
as Gata3, which is expressed in the IRS, can lead to alterations in the hair shaft (Kaufman et 
al., 2003). FAM83G also localized to the Dermal Papilla during anagen. Dermal papilla cells 
have been shown to instruct surrounding matrix cells to proliferate and move upwards 
subsequently differentiating into the various layers of the hair shaft and the inner root 
sheath (Millar et al., 2002).  Although several pathways have been implicated in the 
reciprocal signaling between the DP and matrix cells, Wnt signaling has emerged as dominant 
(Millar et al., 2002). Furthermore, inhibition of β-catenin signaling in the DP has been shown 
to induce catagen and prevent anagen induction (Enshell-Seijffers et al., 2010).  By contrast, 
Zhou et al., (2016) demonstrated that overexpression of a stabilized form of β-catenin 
(resistant to degradation as it lacks key ubiquitination sites) promoted hair follicle 
neogenesis and accelerated hair growth. Of note, the hair follicles were significantly denser 
and hair shafts were longer than in controls. They were also found to remain in anagen longer 
than in controls. It is interesting to consider these findings in light of the fact that 
histopathology from the wly mouse demonstrates “giant hair follicles in anagen” (Radden et 
al., 2013). 
What is particularly unusual is why increased body hair growth was not observed in either 
affected patient. It may be that FAM83G exerts specific actions within the scalp hair follicle 
or that the threshold for activation of hair growth differs between body hair and scalp hair.  
 
5.3.4 Recent insights into FAM83G  
 
Since the publication of this work (Maruthappu et al., 2018a), very recently published work 
by the Sapkota group (Dundee) have shed further light on the role of FAM83G through 
experiments performed in vitro and in Xenopus (Fulcher et al., 2018, Bozatzi et al., 2018)  
 
Although it was initially felt that the role of FAM83G was to interact with SMAD1 and 
subsequent regulation of BMP signaling, this group now feels that this is actually a more 
minor function, and the predominant role of FAM83G, and the FAM group of proteins is in 
interacting with casein kinase isoforms. They have identified that the DUF1669 domain is 
critical for this interaction to occur in FAM83A-H (Fulcher et al., 2018).  They also discovered 
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that mutations in the DUF1669 impaired the ability of FAM proteins to interact with CK1 
isoforms and interfered with its proper subcellular localization.  Furthermore, the group have 
shown that FAM83G does indeed regulate Wnt signaling at the level of the destruction 
complex. They show that overexpression of FAM83G mRNA results in complete axis 
duplication in Xenopus embryos, a feature of heightened Wnt signaling (Bozatsi et al., 2018).  
 
Although exciting, their findings appear to somewhat contradict what we have observed in 
our patients.  Patient skin carrying homozygous recessive mutations in FAM83G within the 
DUF1669, which are assumed to be loss-of-function because of the predicted effects on 
protein structure, show increased nuclear β-catenin, a feature of upregulated Wnt signaling. 
Furthermore, the clinical phenotype supports hyperproliferation in human skin, hair and 
nails. Although this appears to be in contrast with work from the Sapkota lab, it could 
potentially be reconciled if the mutant FAM83G in our patients, fails to sequester CK1a 
because it occurs within the DUF1669 domain, potentially resulting in relative 
overexpression of CK1 isoforms and subsequent propogation of Wnt signaling and associated 
nuclear translocation of β-catenin. Moreover, our studies were performed in humans, 
whereas these two publications primarily used human cell lines (U2OS bone cells) and 
Xenopus for their studies.  Intriguingly, immunoblotting of FAM83G KO U2OS lysates gifted 
from the Sapkota lab appeared to show increased active β-catenin (Figure 5.12) but not other 
downstream markers of Wnt activity. However, after discussion with Dr Sapkota, it was 
revealed that they have also observed increased β-catenin GS3KB phosphorylation sites 
(Ser37 and Thr 41) in this cell line, (which is in fact the target of the ABC antibody used in our 
experiments) at basal unstimulated conditions (Bozatzi et al., 2018 - Figure 9A.) However, 
following stimulation of Wnt and using a Wnt3A reporter assay, mRNA expression and cell 
fractionation, they were able to demonstrate reduced nuclear localisation of active β-
cateninin FAM83G KO cells (Bozatsi et al., 2018). An alternative hypothesis is that the 
mutation observed in our patients are not loss-of-function as originally hypothesized but 
gain-of-function.  One way to investigate this would be to clone the mutation in human 
keratinocytes and perform co-immunoprecipitation to determine its impact on CK1 binding. 
It would then also be possible to assess the downstream impact on Wnt signaling.  
 
5.3.5 Clinical Relevance 
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The data presented in this chapter provide for the first time, an introduction to the possible 
role of FAM83G in human skin, hair and nail growth. This is particularly interesting because 
despite an obvious hair skin and nail phenotype, these patients are otherwise healthy. If 
FAM83G does indeed play a role in the regulation of human scalp hair growth, resulting in 
increased density and length of hair growth, it may well be an attractive target for 
therapeutic development. Dampened Wnt/β-catenin signaling is a feature of several 
common forms of hair loss, including alopecia areata and androgenetic alopecia (Lim et al., 
2016).  Further studies of FAM83G, in particular regarding its role in hair biology and the hair 
cycle, may support targeting FAM83G and associated pathways in scalp hair disorders 
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Chapter 6 
 
Final Discussion & Future Work  
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6.1 Background 
 
At birth, the epidermal skin of our palms and soles has a similar thickness to the skin 
elsewhere such as the forearm. As we expose these areas to physical stresses such as 
gripping and walking, the skin adapts by thickening to protect it against substantial external 
forces. Abnormally thickened skin affecting the palms and soles occurs in the PPK’s. As 
described earlier, the PPK’s have an intriguingly diverse range of genetic and acquired causes 
(Blaydon and Kelsell, 2014, Maruthappu et al., 2014). A subset of PPKs are also associated 
with diverse syndromes linked to other cutaneous features (Betz et al., 2012) and also non-
cutaneous conditions such as hearing loss, cardiomyopathy and oesophageal cancer 
(Blaydon et al., 2012, Kelsell et al., 2001). The varied mechanisms underlying the 
development of keratodermas therefore lends itself more broadly to the exploration of the 
genetic basis of human disease. The focus of this thesis is the study of mutations underlying 
three distinct keratodermas, and how these mutations contribute to the development of the 
clinical phenotype observed, using three approaches: 
 
 
 
 
176 
 
 
 
 
 
 
6.2 iRHOM2 and K16 
 
Keratin 16 (K16) is a major cytoskeletal stress keratin, providing resilience at pressure-
bearing sites such as the human palms and soles and mammalian footpad.  It is also well 
established as a bio-marker, upregulated in hyperproliferative disorders including psoriasis 
and several cancers. Using in vivo and in vitro material from human and mouse, the work 
presented in this thesis identifies the inactive rhomboid protease iRHOM2 as a direct 
regulator of K16 (Maruthappu et al., 2017).  
 
Historically, it has been considered that the keratins were simply structural components 
within the cell, providing mechanoresiliance in a site and situation specific manner. However, 
more recent evidence points to a more dynamic role for these proteins within the cell. For 
example, K17 has been found to regulate expression of Aire (Autoimmune regulator) and 
does so by translocating to the nucleus (Hobbs et al., 2015). Downstream effects include the 
transcription of pro-inflammatory genes.  K16 has also been shown to regulate NRF2 and it 
is thought that oxidative stress resulting from hyperphosphorylated NRF2 in K16-/- mice 
contributes to the development of painful callouses and a Pachyonychia Congenita-like 
Rare%! CommonGene%! Function
Genotype%! Phenotype
FAM83G iRHOM2
DSP
PPK
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phenotype (Kerns et al., 2016). More recently, iRHOM2 has been shown to play a key role in 
the cellular response to oxidative stress through the master regulator p63 (Arciadicono P et 
al., 2018), providing a mechanistic understanding for the role of K16 in oxidative stress.   
 
K16 is highly upregulated at the wound edge, in specific carcinomas and in psoriasis. 
Previously, this has been attributed to the fact that K16 is highly dynamic and therefore 
expressed in hyperproliferative states. However, it would be interesting to determine 
whether in fact, the interaction between iRHOM2 and K16 influences its expression in these 
situations. iRHOM2 has been clearly implicated in the maturation of ADAM17 (TACE) and 
subsequent cleavage of TNFα (Adrain et al., 2012, McIlwain et al., 2012, Brook et al., 2014). 
As ADAM17 has also been implicated in wound healing, carcinomas and psoriasis (Gooz et 
al., 2010), it would be of interest to explore whether K16 plays an additional regulatory role 
in this interaction.   
 
The discoveries made during the course of this thesis with regards to iRHOM2 and its role in 
keratinocyte biology may also have wider implications, namely the role of iRHOM2-K16 in 
keratinocyte hyperproliferation in psoriasis.  Following on from this, studies are underway in 
the Kelsell group to investigate the role of iRHOM2 in psoriasis using iRHOM2 mice models 
in which a psoriatic phenotype has been induced. The aim of such studies is to determine 
whether irhom2KO can attenuate the development of psoriasis using the Imiquimod mouse 
model.  In addition, iRHOM2 expression in lesional, non lesional and normal skin will be 
compared by immunohistochemistry and PCR studies.    
  
6.3 FAM83G and its role in human skin and hair growth 
 
The data presented in Chapter 5 are based on the identification of the first reported human 
disease-causing mutation in FAM83G associated with striking hyperproliferative skin, hair 
and nail phenotypes. The findings are comparable the to two animal models (Drogemuller et 
al., 2014, Radden et al., 2013).  The involvement of skin, hair and nail phenotypes suggested 
a role for FAM83G in Wnt signalling.  More recent studies have now shown that FAM83G 
forms part of the β-catenin destruction complex and may therefore regulate Wnt signalling 
(Bozatzi et al., 2018).  Although aberrant Wnt signalling has strongly been implicated in 
oncogenesis, it is pertinent to note that the affected humans appear healthy, and all 
reported animal models have normal life expectancies.  Therefore, the precise role of 
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FAM83G in Wnt signalling remains a promising area for further investigation, and one which 
Dr Sapkota’s lab (MRC Protein Phosphorylation Unit, Dundee UK) continues to research.  
 
One of the most striking and unique features of the cutaneous phenotype in the affected 
patients was the presence of abundant curly hair. Anecdotally, both affected patients 
reported rapidly growing hair and the affected female could grow her hair well beyond her 
waist. β-catenin/Wnt signalling is critical to the development of hair follicles and therefore 
precisely how FAM83G regulates this pathway is intriguing. The work presented in this thesis 
suggests that loss of FAM83G function appears to promote hair growth via upregulated β-
catenin activity. Active β-catenin is located in the nucleus in patient skin, whereas it is 
expressed at low levels in control skin (Maruthappu et al., 2018a).  β-catenin/Wnt signalling 
pathways have been studied in great detail so it is relatively surprising that FAM83G has not 
previously been identified as a component of this pathway.  However, this study 
demonstrates how monogenic diseases can provide unique insights into the function of 
previously unknown genes.   
 
The potential clinical relevance of FAM83G is compelling. Hair loss remains a significant 
concern to patients and can cause genuine distress. As such, the value of the global hair loss 
treatment market is over $2.8 billion and few effective treatments are available. The most 
common cause of hair loss is androgenetic alopecia, and over 85% of males over the age of 
50 are affected, in addition to many women. Therefore, the discovery of a gene whose 
function is potentially linked to increased hair growth could benefit a large population. 
Androgenetic alopecia has been linked to dysregulated β-catenin/Wnt signalling via the 
androgen receptor (AR) (Kretzchumar et al. 2015).  The AR has been shown to negatively 
impact on β-catenin signalling in mouse hair follicle bulb cells through reciprocal regulation. 
Further work would be required to characterise the role of FAM83G in different phases of 
the human hair cycle and in pathological states such as androgenetic alopecia.  
 
6.4 Novel Cutaneous Phenotypes linked to Arrhythmogenic 
Cardiomyopathy 
 
AC is a highly heterogeneous disorder with an incidence ranging from 1:5000 to 1:1000 
depending on the population studied (Sen-Chowdhury et al., 2010). Due to the variability in 
presentation, the foremost clinical challenge in AC is making an accurate and timely 
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diagnosis.  This is complicated by the fact that clinical features may be subtle or absent, and 
mutations in desmosomal genes contribute only up to 50% of cases. Further investigations 
into additional candidate genes have implicated non-desmosomal proteins such as TGF-B3, 
and TMEM43 (Beffagna et al., 2005, Merner et al., 2008). In those patients who carry a 
desmosomal mutation, studies have shown that only 30-50% fulfill the AC Task Force Criteria 
(Towbin et al., 2008). One theory is that modifier genes may play a role in the variability of 
presentation particularly phenotypic differences within the same family.  Genetic diagnosis 
may also be in part hampered by the incomplete sensitivity of mutation screening techniques 
which may miss mutations such as deletions and insertions or regulatory non-coding 
variants. It is likely that the advent of whole genome sequencing in a timely and cost-
effective manner, will uncover hitherto unidentified causative genes in AC.   
 
The work presented in this thesis identifies a cutaneous phenotype in autosomal dominantly 
inherited AC caused by mutations in DSP. Haploinsufficiency is likely to be the mechanism 
underlying the development of curly hair and PPK in the cohort of patients examined 
(Maruthappu et al., 2018b). The presence of a readily recognisable phenotype could facilitate 
diagnosis in AC, and is currently being considered for inclusion in the revised AC Task Force 
Criteria. However, mutations in DSP underlie only 10-15% of AC cases.   
 
Mutations in PKP2 are most common, contributing to 40% of causative desmosomal 
mutations (Sen-Chowdhury et al., 2010). AC caused by PKP2 mutations appears to be non-
syndromic and cutaneous features have not been reported to date. PKP2 is the only isoform 
expressed in the heart, whereas in the skin, both PKP1 and PKP3 are also expressed, and may 
compensate for PKP2 deficiency. Mutations in DSG2 are responsible for 10-15% of 
desmosomal AC mutations.  Again, hair and skin features have not been reported in those 
carrying DSG2 mutations (Syrris et al., 2006, Awad et al., 2006).  Functional redundancy of 
DSG2 in the skin, rescued by the presence of DSG1 and DSG3, may explain the lack of 
skin/hair features in these patients.   
 
Despite this, it would be of interest to broaden the scope of the work presented here and 
undertake formal dermatological examination of patients with PK2P, JUP, DSG2 and DSC 
mutations to determine whether subtle hair and skin features are evident.  To date, these 
studies have not been performed involving a dermatologist. During the course of this study, 
one patient with a PKP2 mutation was reviewed, anecdotally he reported severe blistering 
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of both his feet after walking long distances. It may be that cutaneous features could become 
apparent under increased stress in such patients. It may also be fruitful to examine patients 
with AC in whom the genetic diagnosis remains unknown, to explore the presence of hair 
and skin features. It is plausible that even if the genetic causes is unknown, the similarities 
between the components of the intercalate disc and epidermis could result in a cutaneous 
phenotype 
 
Skin biopsies taken from unaffected sites of patients with AC could demonstrate 
mislocalisation of desmosomal proteins. If validated against cardiac biopsies from the same 
patients and normal controls, this could potentially be of diagnostic benefit. Cardiac biopsies 
are difficult to obtain and carry procedural risks including precipitating arrhythmias and 
cardiac haemorrhage. By contrast, skin biopsies are much more straightforward to obtain, 
and could hypothetically be used for screening and diagnostic purposes. Asimaki et al. 
(Asimaki et al., 2017) have demonstrated changes in the distribution of cell junction proteins 
in buccal mucosa cells from patients with ARVC, similar to those observed in their 
cardiomyocytes.  They propose that these cells could prove useful in studying disease 
mechanisms and potential therapies.  However, the very nature of buccal mucosal cells is 
that they are prone to shedding. Therefore, studying adhesion complexes in these cells is 
likely to be fraught with complexities and less likely to be a true representation of 
cardiomyocytes. By contrast, cell-cell adhesion in the skin is critical to its function and robust, 
similar to that required in cardiomyocytes. The skin, and in particular the basal layer of the 
epidermis is therefore more likely to authentically represent the cardiac intercalate disc. If 
the findings of this thesis were validated, it could be a potentially useful aide in the early 
diagnosis of AC, which at present, remains the foremost clinical challenge.  
 
6.5 Conclusions  
 
The development of PPK’s as a result of a diverse array of genetic mutations is a curious 
phenomenon. The palmoplantar skin is unique in its ability to withstand phenomenal 
physical stress. This remarkable adaptation may also be its vulnerability. Mutations in 
epidermal genes may be relatively compensated in the skin, but reveal themselves at 
stressed sites such as the palmoplantar epidermis. Consequently, of the known 
keratodermas, mutation carriers do not present with PPK at birth, but instead typically 
develop thickening of the palms and soles once they start walking or during times of 
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increased physical exertion. Mechanical stress in the skin can also act as a surrogate for 
“stress” elsewhere. For example, in TOC, we now know that epithelial “stress” caused by 
exposure to toxins e.g. alcohol and cigarette smoking, accelerates the development of 
oesophageal cancer. In AC, the presence of PPK is linked to impaired adhesion in 
cardiomyocytes and results in fibrofatty replacement in the myocardium. AC is exacerbated 
by “stress” and as such, patients are advised to limit strenuous activities.   
 
The PPK’s studied as part of this Thesis have provided a unique mechanistic insight into three 
diverse diseases. This adds to the significant body of work linking PPK’s to numerous systemic 
disorders and highlights this peculiar phenomenon as an abundant resource for investigating 
genotype-phenotype correlation.   
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Appendix A -  Buffers 
 
Buffer Reagents: 
 
RM+  
40μg/ml Hydrocortisone 
500μg/ml Insulin 
1μg/ml EGF 
10-8 (0.84 μg/ml) Cholera toxin 
500μg/ml Transferrin 
1.3μg/ml Lyothyronine (L4) 
 
Normal media (add to DMEM) 
10% (v/v) FBS 
2 mM L-glutamine 
100 U/ml Penicillin 
100 μg/ml Streptomycin 
1% RM+ 
 
TBE Buffer 9M Tris base 
9M Boric acid 
0.2M EDTA, pH 8.0 
 
DNA Loading Buffer 50% (v/v)  
Glycerol 0.2% (w/v) Orange G 
 
Western Blotting Polyacrylamide Running Gel (10%) in 5 ml 
1.7 ml of Acrylamide mix [Protogel 30% (w/v) 
acrylamide : 0.8% (w/v) Bis-acrylamide 
stock solution (37.5:1)] 
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1.9 ml of ddH2O 
1.3 ml of 1.5 M Tris, pH 8.8 
0.05 ml of 10% SDS 
0.05 ml of APS 
0.002 ml of TEMED 
 
Western Blotting Polyacrylamide Stacking Gel (5%) in 1 ml 
0.17 ml of Acrylamide mix [Protogel 30% (w/v) 
acrylamide : 0.8% (w/v) Bis-acrylamide 
stock solution (37.5:1)] 
0.68 ml of ddH2O 
0.13 ml of 1.0 M Tris, pH 6.8 
0.01 ml of 10% SDS 
0.01 ml of APS 
0.001 ml of TEMED 
 
 
 
 
 
 
SDS Protein Loading Buffer 
0.100 M Tris-HCl, pH 6.8 
4% SDS 
20% Glycerol 
0.001% Bromophenol Blue 
1.44 M Beta-mercaptoethanol (10%) 
 
Western Blotting 10x Running Buffer 
0.25M Tris base 
1.92M Glycine 
1% SDS 
 
Western Blotting 
10 x Transfer Buffer 
0.48M Tris base 
0.30M Glycine 
0.37% (w/v) SDS 
Add 20% (v/v) Methanol to 1 x Transfer Buffer 
 
10 x TBS 
0.5M Tris-HCl, pH 7.5 
1.5M NaCl 
 
1 x T-TBS 
(Tween 20-TBS) 
0.05M Tris-HCl, pH 7.5 
0.15M NaCl 
0.1% (v/v) Tween-20 
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Appendix B-  Results Chapter 3 - Negative Controls 
 
 
 
 
Figure B.1 Negative control for K16 in normal skin (left) and CTRL organotypic (right) 
staining Scale bar 20 µm 
 
 
 
 
Figure B.2 Negative control for K6 staining in CTRL keratinocytes.  
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Figure B.3 Negative control for K6 staining in CTRL organotypics. Scale bar 20 µm 
 
 
 
Figure B.4 Negative control for Ki67 staining in CTRL organotypics. Scale bar 20 µm 
 
Figure B.5 Negative control for mouse paw staining K16 (left) and K9 (right) Scale bar 20 
µm 
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Appendix C - Results Chapter 4 Additional immunostaining and 
negative controls. 
 
F 
Figure C.1 
Immunohistochemical staining of DSP in control and patient skin. Scale bar 20 µm 
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Figure C.2 
Immunohistochemical staining of JUP in control and patient skin. Scale bar 20 µm 
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Control*
skin
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Figure C.3 
Immunohistochemical staining of Connexin 43 in control and patient skin. Scale bar 20 µm 
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Figure C.4  Negative controls  performed with secondary antibody only, anti-rabbit (left) 
and anti-mouse (right). Scale bar 20 µm 
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Appendix D - Results Chapter 5 – Primer sequences and 
negative controls 
Primer Sequences – FAM83G 
 
FAM83G-F:  5’CCGGGCTCATCAGGTCTTT 3’  
FAM83G-R:  5’ GAGCGGTCCGACTTCTGG 3’;  
 
 
 
 
Figure D.1 Sequencing trace showing homozygous missense mutation c.101C>A, 
resulting in A34E in both siblings. Both parents were heterozygous carriers of the 
mutation 
 
 
.   
 
 
Figure D.2 Negative controls using anti-rabbit (A) and anti-mouse (B) secondary antibodies 
in normal human skin. Negative control for FAM83G mouse hair follicle immunostaining. 
Scale Bar Scale bar 20 µm. 
Sibling'1
Sibling'2
Parent'1
Parent'2
Control
c.101C>A
A B C
